-- phpMyAdmin SQL Dump
-- version 5.0.2
-- https://www.phpmyadmin.net/
--
-- Host: 127.0.0.1
-- Generation Time: Jun 04, 2021 at 01:02 PM
-- Server version: 10.4.14-MariaDB
-- PHP Version: 7.4.10

SET SQL_MODE = "NO_AUTO_VALUE_ON_ZERO";
START TRANSACTION;
SET time_zone = "+00:00";


/*!40101 SET @OLD_CHARACTER_SET_CLIENT=@@CHARACTER_SET_CLIENT */;
/*!40101 SET @OLD_CHARACTER_SET_RESULTS=@@CHARACTER_SET_RESULTS */;
/*!40101 SET @OLD_COLLATION_CONNECTION=@@COLLATION_CONNECTION */;
/*!40101 SET NAMES utf8mb4 */;

--
-- Database: `biodb_project`
--

-- --------------------------------------------------------

--
-- Table structure for table `geneinfo`
--

CREATE TABLE `geneinfo` (
  `gene_symbol` varchar(100) NOT NULL,
  `description` varchar(100) NOT NULL,
  `uniprot_id` varchar(100) NOT NULL,
  `entrez_id` varchar(100) NOT NULL,
  `chr_loc` varchar(100) NOT NULL
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4;

--
-- Dumping data for table `geneinfo`
--

INSERT INTO `geneinfo` (`gene_symbol`, `description`, `uniprot_id`, `entrez_id`, `chr_loc`) VALUES
('gene_symbol', 'description', 'uniprot_id', 'entrez_id', 'chromosomal_location'),
('A1BG', 'alpha-1-B glycoprotein ', 'P04217', '1', 'chr19: 58,345,178-58,353,499'),
('ACACB', 'acetyl-CoA carboxylase beta ', 'O00763', '32', 'chr12: 109,116,595-109,268,226'),
('AMH', 'anti-Mullerian hormone ', 'P03971', '268', 'chr19: 2,249,309-2,252,073'),
('GRINA', 'glutamate receptor, ionotropic, N-methyl D-aspartate-associated protein 1 (glutamate binding) ', 'Q7Z429', '2907', 'chr8: 143,990,058-143,993,415'),
('NR3C1', 'nuclear receptor subfamily 3 group C member 1 ', 'P04150', '2908', 'chr5: 143,277,931-143,435,512'),
('GRM3', 'glutamate receptor, metabotropic 3 ', 'Q14832', '2913', 'chr7: 86,643,914-86,864,884'),
('GRM6', 'glutamate receptor, metabotropic 6 ', 'O15303', '2916', 'chr5: 178,978,327-178,996,206'),
('GRM8', 'glutamate receptor, metabotropic 8 ', 'O00222', '2918', 'chr7: 126,438,598-127,253,294'),
('CXCL1', 'chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) ', 'P09341', '2919', 'chr4: 73,869,393-73,871,242'),
('CXCL2', 'chemokine (C-X-C motif) ligand 2 ', 'P19875', '2920', 'chr4: 74,097,035-74,099,293'),
('PDIA3', 'protein disulfide isomerase family A member 3 ', 'P30101', '2923', 'chr15: 43,746,392-43,773,279'),
('GRSF1', 'G-rich RNA sequence binding factor 1 ', 'Q12849', '2926', 'chr4: 70,815,782-70,839,945'),
('GSK3B', 'glycogen synthase kinase 3 beta ', 'P49841', '2932', 'chr3: 119,821,323-120,094,417'),
('AMHR2', 'anti-Mullerian hormone receptor, type II ', 'Q16671', '269', 'chr12: 53,423,855-53,431,534'),
('GSPT1', 'G1 to S phase transition 1 ', 'P15170', '2935', 'chr16: 11,868,128-11,916,082'),
('GSR', 'glutathione reductase ', 'P00390', '2936', 'chr8: 30,678,061-30,727,926'),
('GSTA1', 'glutathione S-transferase alpha 1 ', 'P08263', '2938', 'chr6: 52,791,664-52,803,910'),
('GSTA4', 'glutathione S-transferase alpha 4 ', 'O15217', '2941', 'chr6: 52,977,948-52,995,378'),
('GSTM1', 'glutathione S-transferase mu 1 ', 'P09488', '2944', 'chr1: 109,687,814-109,709,039'),
('GSTM2', 'glutathione S-transferase mu 2 (muscle) ', 'P28161', '2946', 'chr1: 109,668,022-109,709,551'),
('GSTM3', 'glutathione S-transferase mu 3 (brain) ', 'P21266', '2947', 'chr1: 109,733,932-109,741,038'),
('GSTM4', 'glutathione S-transferase mu 4 ', 'Q03013', '2948', 'chr1: 109,656,081-109,674,836'),
('GSTP1', 'glutathione S-transferase pi 1 ', 'P09211', '2950', 'chr11: 67,583,595-67,586,660'),
('GSTT1', 'glutathione S-transferase theta 1 ', 'P30711', '2952', 'chr22: 24,033,952-24,042,493'),
('AMPD3', 'adenosine monophosphate deaminase 3 ', 'Q01432', '272', 'chr11: 10,308,313-10,507,579'),
('GSTT2', 'glutathione S-transferase theta 2 (gene/pseudogene) ', 'P0CG29', '2953', 'chr22: 23,980,058-23,983,915'),
('GSTZ1', 'glutathione S-transferase zeta 1 ', 'O43708', '2954', 'chr14: 77,320,884-77,331,597'),
('MSH6', 'mutS homolog 6 ', 'P52701', '2956', 'chr2: 47,695,530-47,810,101'),
('GTF2A1', 'general transcription factor IIA 1 ', 'P52655', '2957', 'chr14: 81,175,452-81,221,377'),
('GTF2A2', 'general transcription factor IIA 2 ', 'P52657', '2958', 'chr15: 59,638,062-59,657,541'),
('GTF2B', 'general transcription factor IIB ', 'Q00403', '2959', 'chr1: 88,852,932-88,891,944'),
('GTF2F1', 'general transcription factor IIF subunit 1 ', 'P35269', '2962', 'chr19: 6,379,569-6,393,981'),
('GTF2F2', 'general transcription factor IIF subunit 2 ', 'P13984', '2963', 'chr13: 45,120,515-45,284,909'),
('GTF2H1', 'general transcription factor IIH subunit 1 ', 'P32780', '2965', 'chr11: 18,322,295-18,367,044'),
('GTF2H2', 'general transcription factor IIH subunit 2 ', 'Q13888', '2966', 'chr5: 71,032,670-71,067,689'),
('BIN1', 'bridging integrator 1 ', 'O00499', '274', 'chr2: 127,048,027-127,107,355'),
('GTF2H4', 'general transcription factor IIH subunit 4 ', 'Q92759', '2968', 'chr6: 30,908,184-30,914,106'),
('GTF2I', 'general transcription factor IIi ', 'P78347', '2969', 'chr7: 74,657,667-74,760,692'),
('GTF3A', 'general transcription factor IIIA ', 'Q92664', '2971', 'chr13: 27,424,544-27,435,823'),
('GTF3C2', 'general transcription factor IIIC subunit 2 ', 'Q8WUA4', '2976', 'chr2: 27,325,849-27,357,034'),
('GUCA1B', 'guanylate cyclase activator 1B ', 'Q9UMX6', '2979', 'chr6: 42,184,401-42,194,916'),
('GUK1', 'guanylate kinase 1 ', 'Q16774', '2987', 'chr1: 228,139,962-228,148,984'),
('GYPA', 'glycophorin A (MNS blood group) ', 'P02724', '2993', 'chr4: 144,109,303-144,870,953'),
('GYPC', 'glycophorin C (Gerbich blood group) ', 'P04921', '2995', 'chr2: 126,655,933-126,696,675'),
('GYS1', 'glycogen synthase 1 ', 'P13807', '2997', 'chr19: 48,968,125-48,993,310'),
('GYS2', 'glycogen synthase 2 ', 'P54840', '2998', 'chr12: 21,536,189-21,604,847'),
('AMY2B', 'amylase, alpha 2B (pancreatic) ', 'P19961', '280', 'chr1: 103,553,815-103,579,534'),
('GUCY2D', 'guanylate cyclase 2D, membrane (retina-specific) ', 'Q02846', '3000', 'chr17: 8,002,594-8,020,339'),
('HIST1H1C', 'histone cluster 1, H1c ', 'P16403', '3006', 'chr6: 26,055,787-26,056,428'),
('HIST1H1E', 'histone cluster 1, H1e ', 'P10412', '3008', 'chr6: 26,156,354-26,157,107'),
('HIST1H2AD', 'histone cluster 1, H2ad ', 'P20671', '3013', 'chr6: 26,198,851-26,199,243'),
('H2AFX', 'H2A histone family member X ', 'P16104', '3014', 'chr11: 119,093,854-119,095,467'),
('H2AFZ', 'H2A histone family member Z ', 'P0C0S5', '3015', 'chr4: 99,948,086-99,950,388'),
('HIST1H2BD', 'histone cluster 1, H2bd ', 'P58876', '3017', 'chr6: 26,158,146-26,171,349'),
('HIST1H2BB', 'histone cluster 1, H2bb ', 'P33778', '3018', 'chr6: 26,043,277-26,043,657'),
('H3F3A', 'H3 histone, family 3A ', 'P84243', '3020', 'chr1: 226,061,851-226,072,001'),
('HIST1H1A', 'histone cluster 1, H1a ', 'Q02539', '3024', 'chr6: 26,017,085-26,017,732'),
('ANG', 'angiogenin, ribonuclease, RNase A family, 5 ', 'P03950', '283', 'chr14: 20,684,177-20,698,971'),
('HSD17B10', 'hydroxysteroid (17-beta) dehydrogenase 10 ', 'Q99714', '3028', 'chrX: 53,431,258-53,434,373'),
('HAGH', 'hydroxyacylglutathione hydrolase ', 'Q16775', '3029', 'chr16: 1,795,620-1,827,194'),
('HADHB', 'hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), b', 'P55084', '3032', 'chr2: 26,243,170-26,290,468'),
('HADH', 'hydroxyacyl-CoA dehydrogenase ', 'Q16836', '3033', 'chr4: 107,989,714-108,035,175'),
('HARS', 'histidyl-tRNA synthetase ', 'P12081', '3035', 'chr5: 140,673,173-140,692,024'),
('HAS2', 'hyaluronan synthase 2 ', 'Q92819', '3037', 'chr8: 121,612,116-121,641,390'),
('HBA1', 'hemoglobin subunit alpha 1 ', 'P69905', '3039', 'chr16: 176,680-177,522'),
('HBB', 'hemoglobin subunit beta ', 'P68871', '3043', 'chr11: 5,225,464-5,229,395'),
('HBG1', 'hemoglobin subunit gamma 1 ', 'P69891', '3047', 'chr11: 5,248,083-5,249,892'),
('HCCS', 'holocytochrome c synthase ', 'P53701', '3052', 'chrX: 11,111,301-11,123,078'),
('ANGPT1', 'angiopoietin 1 ', 'Q15389', '284', 'chr8: 107,249,482-107,498,055'),
('HCLS1', 'hematopoietic cell-specific Lyn substrate 1 ', 'P14317', '3059', 'chr3: 121,631,399-121,660,927'),
('HTT', 'huntingtin ', 'P42858', '3064', 'chr4: 3,074,681-3,243,959'),
('HDAC1', 'histone deacetylase 1 ', 'Q13547', '3065', 'chr1: 32,292,086-32,333,635'),
('HDAC2', 'histone deacetylase 2 ', 'Q92769', '3066', 'chr6: 113,933,028-114,011,308'),
('HDGF', 'hepatoma-derived growth factor ', 'P51858', '3068', 'chr1: 156,742,107-156,766,925'),
('HDLBP', 'high density lipoprotein binding protein ', 'Q00341', '3069', 'chr2: 241,227,264-241,317,061'),
('HELLS', 'helicase, lymphoid-specific ', 'Q9NRZ9', '3070', 'chr10: 94,501,434-94,613,905'),
('HEXA', 'hexosaminidase A (alpha polypeptide) ', 'P06865', '3073', 'chr15: 72,340,919-72,376,476'),
('CFH', 'complement factor H ', 'P08603', '3075', 'chr1: 196,651,878-196,747,504'),
('HFE', 'hemochromatosis ', 'Q30201', '3077', 'chr6: 26,087,281-26,098,343'),
('ANGPT2', 'angiopoietin 2 ', 'O15123', '285', 'chr8: 6,499,651-6,563,409'),
('CFHR1', 'complement factor H-related 1 ', 'Q03591', '3078', 'chr1: 196,819,757-196,832,189'),
('HGD', 'homogentisate 1,2-dioxygenase ', 'Q93099', '3081', 'chr3: 120,628,173-120,682,571'),
('HGF', 'hepatocyte growth factor (hepapoietin A; scatter factor) ', 'P14210', '3082', 'chr7: 81,699,006-81,770,438'),
('NRG1', 'neuregulin 1 ', 'Q02297', '3084', 'chr8: 31,639,386-32,767,959'),
('HHEX', 'hematopoietically expressed homeobox ', 'Q03014', '3087', 'chr10: 92,689,951-92,695,646'),
('HIF1A', 'hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) ', 'Q16665', '3091', 'chr14: 61,695,513-61,748,259'),
('HIP1', 'huntingtin interacting protein 1 ', 'O00291', '3092', 'chr7: 75,533,300-75,738,962'),
('HINT1', 'histidine triad nucleotide binding protein 1 ', 'P49773', '3094', 'chr5: 131,159,027-131,171,735'),
('HIVEP1', 'human immunodeficiency virus type I enhancer binding protein 1 ', 'P15822', '3096', 'chr6: 12,008,762-12,164,999'),
('HIVEP2', 'human immunodeficiency virus type I enhancer binding protein 2 ', 'P31629', '3097', 'chr6: 142,751,467-142,956,698'),
('ANK2', 'ankyrin 2, neuronal ', 'Q01484', '287', 'chr4: 112,818,109-113,383,740'),
('HK1', 'hexokinase 1 ', 'P19367', '3098', 'chr10: 69,269,984-69,401,882'),
('HLA-A', 'major histocompatibility complex, class I, A ', 'P30443', '3105', 'chr6: 29,941,260-29,945,884'),
('HLA-B', 'major histocompatibility complex, class I, B ', 'P01889', '3106', 'chr6: 31,269,491-31,357,188'),
('HLA-C', 'major histocompatibility complex, class I, C ', 'P30499', '3107', 'chr6: 31,268,749-31,272,130'),
('HLA-DMA', 'major histocompatibility complex, class II, DM alpha ', 'P28067', '3108', 'chr6: 32,948,613-32,969,094'),
('HLA-DMB', 'major histocompatibility complex, class II, DM beta ', 'P28068', '3109', 'chr6: 32,934,629-32,941,070'),
('HLA-DOB', 'major histocompatibility complex, class II, DO beta ', 'P13765', '3112', 'chr6: 32,812,763-32,817,048'),
('HLA-DPA1', 'major histocompatibility complex, class II, DP alpha 1 ', 'P20036', '3113', 'chr6: 33,064,569-33,080,775'),
('HLA-DPB2', 'major histocompatibility complex, class II, DP beta 2 (pseudogene)', 'N/A', '3116', 'chr6: 33,151,483-33,168,112'),
('HLA-DQA1', 'major histocompatibility complex, class II, DQ alpha 1 ', 'P01909', '3117', 'chr6: 32,628,179-32,647,062'),
('ANK3', 'ankyrin 3, node of Ranvier (ankyrin G) ', 'Q12955', '288', 'chr10: 60,026,298-60,733,490'),
('HLA-DQA2', 'major histocompatibility complex, class II, DQ alpha 2 ', 'P01906', '3118', 'chr6: 32,741,342-32,747,215'),
('HLA-DQB1', 'major histocompatibility complex, class II, DQ beta 1 ', 'P01920', '3119', 'chr6: 32,659,467-32,668,383'),
('HLA-DRA', 'major histocompatibility complex, class II, DR alpha ', 'P01903', '3122', 'chr6: 32,439,842-32,445,046'),
('HLA-DRB1', 'major histocompatibility complex, class II, DR beta 1 ', 'P04229', '3123', 'chr6: 32,578,769-32,589,848'),
('HLA-DRB3', 'major histocompatibility complex, class II, DR beta 3 ', 'P79483', '3125', 'chr6: 32,444,128-32,457,245'),
('HLA-DRB4', 'major histocompatibility complex, class II, DR beta 4 ', 'P13762', '3126', 'chr6: 32,542,598-32,557,561'),
('HLA-DRB5', 'major histocompatibility complex, class II, DR beta 5 ', 'Q30154', '3127', 'chr6: 32,517,343-32,530,287'),
('HLF', 'hepatic leukemia factor ', 'Q16534', '3131', 'chr17: 55,265,012-55,325,065'),
('HLA-E', 'major histocompatibility complex, class I, E ', 'P13747', '3133', 'chr6: 30,489,467-30,494,205'),
('HLA-F', 'major histocompatibility complex, class I, F ', 'P30511', '3134', 'chr6: 29,722,775-29,738,528'),
('ACADSB', 'acyl-CoA dehydrogenase, short/branched chain ', 'P45954', '36', 'chr10: 123,008,979-123,058,311'),
('SLC25A4', 'solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4 ', 'P12235', '291', 'chr4: 185,143,241-185,150,382'),
('HLA-G', 'major histocompatibility complex, class I, G ', 'P17693', '3135', 'chr6: 29,826,967-29,831,125'),
('HLA-H', 'major histocompatibility complex, class I, H (pseudogene)', 'P01893', '3136', 'chr6: 29,879,053-29,881,769'),
('HLA-J', 'major histocompatibility complex, class I, J (pseudogene) ', 'N/A', '3137', 'chr6: 29,996,525-29,999,898'),
('MR1', 'major histocompatibility complex, class I-related ', 'Q95460', '3140', 'chr1: 181,033,425-181,061,938'),
('HMGB1', 'high mobility group box 1 ', 'P09429', '3146', 'chr13: 30,456,704-30,617,597'),
('HMGB2', 'high mobility group box 2 ', 'P26583', '3148', 'chr4: 173,331,695-173,335,125'),
('HMGB3', 'high mobility group box 3 ', 'O15347', '3149', 'chrX: 150,980,509-150,990,775'),
('HMGN2', 'high mobility group nucleosomal binding domain 2 ', 'P05204', '3151', 'chr1: 26,472,450-26,475,972'),
('HMGCL', '3-hydroxymethyl-3-methylglutaryl-CoA lyase ', 'P35914', '3155', 'chr1: 23,801,885-23,838,620'),
('HMGCR', '3-hydroxy-3-methylglutaryl-CoA reductase ', 'P04035', '3156', 'chr5: 75,336,329-75,362,104'),
('SLC25A5', 'solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 5 ', 'P05141', '292', 'chrX: 119,468,400-119,471,319'),
('HMGCS1', '3-hydroxy-3-methylglutaryl-CoA synthase 1 ', 'Q01581', '3157', 'chr5: 43,289,395-43,313,512'),
('HMGA1', 'high mobility group AT-hook 1 ', 'P17096', '3159', 'chr6: 34,236,873-34,246,231'),
('HMMR', 'hyaluronan-mediated motility receptor (RHAMM) ', 'O75330', '3161', 'chr5: 163,460,203-163,491,945'),
('HMOX1', 'heme oxygenase 1 ', 'P09601', '3162', 'chr22: 35,380,361-35,394,214'),
('NR4A1', 'nuclear receptor subfamily 4 group A member 1 ', 'P22736', '3164', 'chr12: 52,022,832-52,059,507'),
('HNMT', 'histamine N-methyltransferase ', 'P50135', '3176', 'chr2: 137,964,020-138,016,364'),
('HNRNPA1', 'heterogeneous nuclear ribonucleoprotein A1 ', 'P09651', '3178', 'chr12: 54,280,193-54,287,088'),
('HNRNPA2B1', 'heterogeneous nuclear ribonucleoprotein A2/B1 ', 'P22626', '3181', 'chr7: 26,189,927-26,201,529'),
('HNRNPAB', 'heterogeneous nuclear ribonucleoprotein A/B ', 'Q99729', '3182', 'chr5: 178,204,507-178,211,163'),
('HNRNPC', 'heterogeneous nuclear ribonucleoprotein C (C1/C2) ', 'P07910', '3183', 'chr14: 21,209,136-21,269,494'),
('ANXA1', 'annexin A1 ', 'P04083', '301', 'chr9: 73,151,757-73,170,393'),
('HNRNPD', 'heterogeneous nuclear ribonucleoprotein D ', 'Q14103', '3184', 'chr4: 82,352,498-82,374,503'),
('HNRNPH1', 'heterogeneous nuclear ribonucleoprotein H1 (H) ', 'P31943', '3187', 'chr5: 179,614,178-179,634,784'),
('HNRNPH2', 'heterogeneous nuclear ribonucleoprotein H2 (H\') ', 'P55795', '3188', 'chrX: 101,408,295-101,414,133'),
('HNRNPH3', 'heterogeneous nuclear ribonucleoprotein H3 (2H9) ', 'P31942', '3189', 'chr10: 68,331,174-68,343,191'),
('HNRNPL', 'heterogeneous nuclear ribonucleoprotein L ', 'P14866', '3191', 'chr19: 38,836,388-38,852,347'),
('HNRNPU', 'heterogeneous nuclear ribonucleoprotein U (scaffold attachment factor A) ', 'Q00839', '3192', 'chr1: 244,840,638-244,864,560'),
('HOXA1', 'homeobox A1 ', 'P49639', '3198', 'chr7: 27,092,993-27,095,996'),
('HOXA2', 'homeobox A2 ', 'O43364', '3199', 'chr7: 27,100,354-27,102,811'),
('HOXA3', 'homeobox A3 ', 'O43365', '3200', 'chr7: 27,106,184-27,152,581'),
('HOXA6', 'homeobox A6 ', 'P31267', '3203', 'chr7: 27,145,396-27,150,603'),
('ANXA2', 'annexin A2 ', 'P07355', '302', 'chr15: 60,347,134-60,402,883'),
('HOXA9', 'homeobox A9 ', 'P31269 ', '3205', 'chr7: 27,162,435-27,175,180'),
('HOXA10', 'homeobox A10 ', 'P31260', '3206', 'chr7: 27,170,591-27,180,261'),
('HOXB5', 'homeobox B5 ', 'P09067', '3215', 'chr17: 48,591,257-48,593,961'),
('HOXC4', 'homeobox C4 ', 'P09017', '3221', 'chr12: 54,016,931-54,056,030'),
('HOXD10', 'homeobox D10 ', 'P28358', '3236', 'chr2: 176,108,790-176,119,942'),
('HP', 'haptoglobin ', 'P00738', '3240', 'chr16: 72,054,592-72,061,055'),
('HPCAL1', 'hippocalcin-like 1 ', 'P37235', '3241', 'chr2: 10,302,889-10,427,617'),
('HPGD', 'hydroxyprostaglandin dehydrogenase 15-(NAD) ', 'P15428', '3248', 'chr4: 174,490,177-174,523,154'),
('HPS1', 'Hermansky-Pudlak syndrome 1 ', 'Q92902', '3257', 'chr10: 98,416,198-98,446,947'),
('AGFG1', 'ArfGAP with FG repeats 1 ', 'P52594', '3267', 'chr2: 227,472,152-227,561,214'),
('ANXA3', 'annexin A3 ', 'P12429', '306', 'chr4: 78,551,519-78,610,451'),
('HRH1', 'histamine receptor H1 ', 'P35367', '3269', 'chr3: 11,137,093-11,263,557'),
('PRMT1', 'protein arginine methyltransferase 1 ', 'Q99873', '3276', 'chr19: 49,675,786-49,689,029'),
('HES1', 'hes family bHLH transcription factor 1 ', 'Q14469', '3280', 'chr3: 194,136,145-194,138,732'),
('HSBP1', 'heat shock factor binding protein 1 ', 'O75506', '3281', 'chr16: 83,807,843-83,819,737'),
('HSD3B1', 'hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 ', 'P14060', '3283', 'chr1: 119,507,198-119,515,054'),
('HSD3B2', 'hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 ', 'P26439', '3284', 'chr1: 119,414,931-119,423,035'),
('HSD11B1', 'hydroxysteroid (11-beta) dehydrogenase 1 ', 'P28845', '3290', 'chr1: 209,686,178-209,734,950'),
('HSD11B2', 'hydroxysteroid (11-beta) dehydrogenase 2 ', 'P80365', '3291', 'chr16: 67,430,652-67,437,553'),
('HSD17B1', 'hydroxysteroid (17-beta) dehydrogenase 1 ', 'P14061', '3292', 'chr17: 42,549,214-42,555,213'),
('HSD17B2', 'hydroxysteroid (17-beta) dehydrogenase 2 ', 'P37059', '3294', 'chr16: 82,035,004-82,098,534'),
('ANXA4', 'annexin A4 ', 'P09525', '307', 'chr2: 69,644,425-69,827,100'),
('HSD17B4', 'hydroxysteroid (17-beta) dehydrogenase 4 ', 'P51659', '3295', 'chr5: 119,452,443-119,637,199'),
('HSF1', 'heat shock transcription factor 1 ', 'Q00613', '3297', 'chr8: 144,291,591-144,314,722'),
('DNAJB2', 'DnaJ heat shock protein family (Hsp40) member B2 ', 'P25686', '3300', 'chr2: 219,279,267-219,286,900'),
('DNAJA1', 'DnaJ heat shock protein family (Hsp40) member A1 ', 'P31689', '3301', 'chr9: 33,025,211-33,039,907'),
('HSPA1A', 'heat shock protein family A (Hsp70) member 1A ', 'P0DMV8', '3303', 'chr6: 31,815,464-31,817,946'),
('HSPA1B', 'heat shock protein family A (Hsp70) member 1B ', 'P0DMV9', '3304', 'chr6: 31,827,735-31,830,255'),
('HSPA1L', 'heat shock protein family A (Hsp70) member 1 like ', 'P34931', '3305', 'chr6: 31,809,619-31,815,065'),
('HSPA4', 'heat shock protein family A (Hsp70) member 4 ', 'P34932', '3308', 'chr5: 133,051,962-133,106,449'),
('HSPA5', 'heat shock protein family A (Hsp70) member 5 ', 'P11021', '3309', 'chr9: 125,234,853-125,241,330'),
('HSPA6', 'heat shock protein family A (Hsp70) member 6 ', 'P17066', '3310', 'chr1: 161,524,540-161,526,910'),
('ANXA5', 'annexin A5 ', 'P08758', '308', 'chr4: 121,667,955-121,697,113'),
('HSPB1', 'heat shock protein family B (small) member 1 ', 'P04792', '3315', 'chr7: 76,302,544-76,304,295'),
('HSPB2', 'heat shock protein family B (small) member 2 ', 'Q16082', '3316', 'chr11: 111,912,242-111,914,093'),
('HSP90AA1', 'heat shock protein 90kDa alpha family class A member 1 ', 'P07900', '3320', 'chr14: 102,080,738-102,139,699'),
('HSP90AB1', 'heat shock protein 90kDa alpha family class B member 1 ', 'P08238', '3326', 'chr6: 44,246,166-44,253,888'),
('HSPD1', 'heat shock protein family D (Hsp60) member 1 ', 'P10809', '3329', 'chr2: 197,486,581-197,516,737'),
('HSPE1', 'heat shock protein family E (Hsp10) member 1 ', 'P61604', '3336', 'chr2: 197,499,994-197,503,457'),
('DNAJB1', 'DnaJ heat shock protein family (Hsp40) member B1 ', 'P25685', '3337', 'chr19: 14,514,770-14,529,770'),
('DNAJC4', 'DnaJ heat shock protein family (Hsp40) member C4 ', 'Q9NNZ3', '3338', 'chr11: 64,230,278-64,234,286'),
('HSPG2', 'heparan sulfate proteoglycan 2 ', 'P98160', '3339', 'chr1: 21,822,245-21,937,297'),
('NDST1', 'N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1 ', 'P52848', '3340', 'chr5: 150,485,818-150,558,211'),
('ANXA6', 'annexin A6 ', 'P08133', '309', 'chr5: 151,100,712-151,157,882'),
('FOXN2', 'forkhead box N2 ', 'P32314', '3344', 'chr2: 48,314,637-48,379,294'),
('HTR2B', '5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupled ', 'P41595', '3357', 'chr2: 231,108,230-231,125,118'),
('HTR2C', '5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled ', 'P28335', '3358', 'chrX: 114,584,078-114,910,061'),
('HTR7', '5-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupled ', 'P34969', '3363', 'chr10: 90,740,823-90,857,698'),
('TNC', 'tenascin C ', 'P24821', '3371', 'chr9: 115,019,578-115,118,257'),
('IAPP', 'islet amyloid polypeptide ', 'P10997', '3375', 'chr12: 21,354,959-21,379,978'),
('ICA1', 'islet cell autoantigen 1 ', 'Q05084', '3382', 'chr7: 8,113,184-8,262,687'),
('ICAM1', 'intercellular adhesion molecule 1 ', 'P05362', '3383', 'chr19: 10,270,835-10,286,615'),
('ICT1', 'immature colon carcinoma transcript 1 ', 'Q14197', '3396', 'chr17: 75,012,670-75,021,261'),
('ID1', 'inhibitor of DNA binding 1, dominant negative helix-loop-helix protein ', 'P41134', '3397', 'chr20: 31,605,283-31,606,515'),
('ANXA11', 'annexin A11 ', 'P50995', '311', 'chr10: 80,150,889-80,205,572'),
('ID2', 'inhibitor of DNA binding 2, dominant negative helix-loop-helix protein ', 'Q02363', '3398', 'chr2: 8,678,845-8,684,453'),
('ID3', 'inhibitor of DNA binding 3, dominant negative helix-loop-helix protein ', 'Q02535', '3399', 'chr1: 23,557,918-23,559,794'),
('ID4', 'inhibitor of DNA binding 4, dominant negative helix-loop-helix protein ', 'P47928', '3400', 'chr6: 19,837,386-19,840,684'),
('IDE', 'insulin-degrading enzyme ', 'P14735', '3416', 'chr10: 92,451,684-92,574,076'),
('IDH1', 'isocitrate dehydrogenase 1 (NADP+) ', 'O75874', '3417', 'chr2: 208,236,227-208,266,074'),
('IDH2', 'isocitrate dehydrogenase 2 (NADP+), mitochondrial ', 'P48735', '3418', 'chr15: 90,083,045-90,102,504'),
('IDH3B', 'isocitrate dehydrogenase 3 (NAD+) beta ', 'O43837', '3420', 'chr20: 2,658,395-2,664,219'),
('IDI1', 'isopentenyl-diphosphate delta isomerase 1 ', 'Q13907', '3422', 'chr10: 1,039,908-1,049,170'),
('CFI', 'complement factor I ', 'P05156', '3426', 'chr4: 109,740,694-109,802,179'),
('IFI16', 'interferon, gamma-inducible protein 16 ', 'Q16666', '3428', 'chr1: 158,999,968-159,055,155'),
('AOAH', 'acyloxyacyl hydrolase ', 'P28039', '313', 'chr7: 36,512,949-36,724,549'),
('IFI27', 'interferon, alpha-inducible protein 27 ', 'P40305', '3429', 'chr14: 94,104,836-94,116,698'),
('SP110', 'Sp110 nuclear body protein  ', 'Q9HB58', '3431', 'chr2: 230,167,293-230,225,729'),
('IFNA1 ', 'interferon, alpha 13 ', 'P01562', '3447', 'chr9: 21,367,424-21,368,962'),
('IFNA16', 'interferon, alpha 16 ', 'P05015', '3449', 'chr9: 21,216,373-21,217,311'),
('IFNAR1', 'interferon (alpha, beta and omega) receptor 1 ', 'P17181', '3454', 'chr21: 33,324,477-33,359,862'),
('IFNAR2', 'interferon (alpha, beta and omega) receptor 2 ', 'P48551', '3455', 'chr21: 33,229,901-33,265,675'),
('IFNGR1', 'interferon gamma receptor 1 ', 'P15260', '3459', 'chr6: 137,197,484-137,219,449'),
('IFNGR2', 'interferon gamma receptor 2 (interferon gamma transducer 1) ', 'P38484', '3460', 'chr21: 33,402,896-33,479,348'),
('IFRD1', 'interferon-related developmental regulator 1 ', 'O00458', '3475', 'chr7: 112,422,968-112,481,017'),
('IGBP1', 'immunoglobulin (CD79A) binding protein 1 ', 'P78318', '3476', 'chrX: 70,133,449-70,166,324'),
('ACADVL', 'acyl-CoA dehydrogenase, very long chain ', 'P49748', '37', 'chr17: 7,217,125-7,225,273'),
('AOC2', 'amine oxidase, copper containing 2 ', 'O75106', '314', 'chr17: 42,844,600-42,850,707'),
('IGF1', 'insulin like growth factor 1 ', 'P05019', '3479', 'chr12: 102,395,867-102,480,645'),
('IGF1R', 'insulin like growth factor 1 receptor ', 'P08069', '3480', 'chr15: 98,648,971-98,964,530'),
('IGF2', 'insulin like growth factor 2 ', 'P01344', '3481', 'chr11: 2,129,112-2,141,238'),
('IGF2R', 'insulin like growth factor 2 receptor ', 'P11717', '3482', 'chr6: 159,969,099-160,113,507'),
('IGFBP1', 'insulin like growth factor binding protein 1 ', 'P08833', '3484', 'chr7: 45,888,357-45,893,668'),
('IGFBP2', 'insulin like growth factor binding protein 2 ', 'P18065', '3485', 'chr2: 216,632,828-216,664,436'),
('IGFBP3', 'insulin like growth factor binding protein 3 ', 'P17936', '3486', 'chr7: 45,912,245-45,921,874'),
('IGFBP4', 'insulin like growth factor binding protein 4 ', 'P22692', '3487', 'chr17: 40,443,461-40,457,731'),
('IGFBP5', 'insulin like growth factor binding protein 5 ', 'P24593', '3488', 'chr2: 216,672,105-216,695,525'),
('IGFBP6', 'insulin like growth factor binding protein 6 ', 'P24592', '3489', 'chr12: 53,097,436-53,102,345'),
('AOX1', 'aldehyde oxidase 1 ', 'Q06278', '316', 'chr2: 200,585,868-200,677,064'),
('IGFBP7', 'insulin like growth factor binding protein 7 ', 'Q16270', '3490', 'chr4: 57,030,773-57,110,385'),
('CYR61', 'cysteine-rich, angiogenic inducer, 61 ', 'O00622', '3491', 'chr1: 85,580,761-85,583,962'),
('IGHG1', 'immunoglobulin heavy constant gamma 1 (G1m marker) ', 'P01857', '3500', 'chr14: 105,736,343-105,743,071'),
('IGHM', 'immunoglobulin heavy constant mu', 'P01871', '3507', 'chr14: 105,851,708-105,856,218'),
('IGKC', 'immunoglobulin kappa constant', 'P01834', '3514', 'chr2: 88,857,161-88,857,683'),
('IL1A', 'interleukin 1 alpha ', 'P01583', '3552', 'chr2: 112,773,915-112,784,590'),
('IL1B', 'interleukin 1 beta ', 'P01584', '3553', 'chr2: 112,829,751-112,836,903'),
('IL1R1', 'interleukin 1 receptor, type I ', 'P14778', '3554', 'chr2: 102,064,544-102,179,874'),
('IL1RAP', 'interleukin 1 receptor accessory protein ', 'Q9NPH3', '3556', 'chr3: 190,514,051-190,659,750'),
('IL1RN', 'interleukin 1 receptor antagonist ', 'P18510', '3557', 'chr2: 113,107,214-113,134,016'),
('APBA1', 'amyloid beta (A4) precursor protein-binding, family A, member 1 ', 'Q02410', '320', 'chr9: 69,427,530-69,672,306'),
('IL4R', 'interleukin 4 receptor ', 'P24394', '3566', 'chr16: 27,313,668-27,364,778'),
('IL5RA', 'interleukin 5 receptor subunit alpha ', 'Q01344', '3568', 'chr3: 3,066,326-3,126,613'),
('IL6', 'interleukin 6 ', 'P05231', '3569', 'chr7: 22,725,884-22,732,002'),
('IL6R', 'interleukin 6 receptor ', 'P08887', '3570', 'chr1: 154,405,193-154,469,450'),
('IL6ST', 'interleukin 6 signal transducer ', 'P40189', '3572', 'chr5: 55,935,095-55,994,993'),
('IL7R', 'interleukin 7 receptor ', 'P16871', '3575', 'chr5: 35,852,695-35,879,603'),
('CXCL8', 'chemokine (C-X-C motif) ligand 8 ', 'P10145', '3576', 'chr4: 73,740,506-73,743,716'),
('CXCR2', 'chemokine (C-X-C motif) receptor 2 ', 'P25025', '3579', 'chr2: 218,125,289-218,137,253'),
('IL9R', 'interleukin 9 receptor ', 'Q01113', '3581', 'chrX: 155,997,581-156,010,817'),
('IL10', 'interleukin 10 ', 'P22301', '3586', 'chr1: 206,767,602-206,772,494'),
('APBB1', 'amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) ', 'O00213', '322', 'chr11: 6,395,124-6,419,414'),
('IL10RB', 'interleukin 10 receptor subunit beta ', 'Q08334', '3588', 'chr21: 33,266,358-33,310,187'),
('IL11', 'interleukin 11 ', 'P20809', '3589', 'chr19: 55,364,389-55,370,463'),
('IL12A', 'interleukin 12A ', 'P29459', '3592', 'chr3: 159,988,750-159,996,019'),
('IL12RB1', 'interleukin 12 receptor subunit beta 1 ', 'P42701', '3594', 'chr19: 18,058,995-18,098,944'),
('IL18', 'interleukin 18 ', 'Q14116', '3606', 'chr11: 112,143,251-112,164,117'),
('ILF2', 'interleukin enhancer binding factor 2 ', 'Q12905', '3608', 'chr1: 153,661,788-153,671,048'),
('ILF3', 'interleukin enhancer binding factor 3 ', 'Q12906', '3609', 'chr19: 10,654,261-10,692,417'),
('ILK', 'integrin linked kinase ', 'Q13418', '3611', 'chr11: 6,603,708-6,610,874'),
('IMPA1', 'inositol(myo)-1(or 4)-monophosphatase 1 ', 'P29218', '3612', 'chr8: 81,657,961-81,686,693'),
('INHA', 'inhibin alpha ', 'P05111', '3623', 'chr2: 219,569,162-219,575,713'),
('APBB2', 'amyloid beta (A4) precursor protein-binding, family B, member 2 ', 'Q92870', '323', 'chr4: 40,810,027-41,216,714'),
('INHBA', 'inhibin beta A ', 'P08476', '3624', 'chr7: 41,667,168-41,705,834'),
('INHBB', 'inhibin beta B ', 'P09529', '3625', 'chr2: 120,346,143-120,351,808'),
('INHBC', 'inhibin beta C ', 'P55103', '3626', 'chr12: 57,434,760-57,450,828'),
('INPP1', 'inositol polyphosphate-1-phosphatase ', 'P49441', '3628', 'chr2: 190,343,470-190,371,665'),
('INS', 'insulin ', 'P01308', '3630', 'chr11: 2,159,779-2,161,341'),
('INPP4A', 'inositol polyphosphate-4-phosphatase type I A ', 'Q96PE3', '3631', 'chr2: 98,444,854-98,594,390'),
('INPP5A', 'inositol polyphosphate-5-phosphatase A ', 'Q14642', '3632', 'chr10: 132,537,820-132,783,480'),
('INPP5D', 'inositol polyphosphate-5-phosphatase D ', 'Q92835', '3635', 'chr2: 233,059,967-233,207,903'),
('INSIG1', 'insulin induced gene 1 ', 'O15503', '3638', 'chr7: 155,297,776-155,310,235'),
('INSL3', 'insulin like 3 ', 'P51460', '3640', 'chr19: 17,816,512-17,821,574'),
('APC', 'adenomatous polyposis coli ', 'P25054', '324', 'chr5: 112,707,498-112,846,239'),
('INSM1', 'insulinoma associated 1 ', 'Q01101', '3642', 'chr20: 20,368,121-20,370,949'),
('INSR', 'insulin receptor ', 'P06213', '3643', 'chr19: 7,112,255-7,294,034'),
('IPW', 'imprinted in Prader-Willi syndrome (non-protein coding)', 'N/A', '3653', 'chr15: 25,116,545-25,122,476'),
('IRAK1', 'interleukin 1 receptor associated kinase 1 ', 'P51617', '3654', 'chrX: 154,010,500-154,019,980'),
('ITGA6', 'integrin subunit alpha 6 ', 'P23229', '3655', 'chr2: 172,427,354-172,506,282'),
('IRAK2', 'interleukin 1 receptor associated kinase 2 ', 'O43187', '3656', 'chr3: 10,164,865-10,243,743'),
('IRF1', 'interferon regulatory factor 1 ', 'P10914', '3659', 'chr5: 132,481,609-132,490,798'),
('IRF6', 'interferon regulatory factor 6 ', 'O14896', '3664', 'chr1: 209,785,623-209,806,175'),
('IRS1', 'insulin receptor substrate 1 ', 'P35568', '3667', 'chr2: 226,731,317-226,799,759'),
('ISG20', 'interferon stimulated exonuclease gene 20kDa ', 'Q96AZ6', '3669', 'chr15: 88,636,153-88,656,483'),
('APCS', 'amyloid P component, serum ', 'P02743', '325', 'chr1: 159,587,825-159,588,865'),
('ISLR', 'immunoglobulin superfamily containing leucine-rich repeat ', 'O14498', '3671', 'chr15: 74,173,671-74,176,872'),
('ITGA2', 'integrin subunit alpha 2 ', 'P17301', '3673', 'chr5: 52,989,326-53,094,779'),
('ITGA3', 'integrin subunit alpha 3 ', 'P26006', '3675', 'chr17: 50,055,968-50,090,481'),
('ITGA5', 'integrin subunit alpha 5 ', 'P08648', '3678', 'chr12: 54,395,261-54,419,460'),
('ITGA9', 'integrin subunit alpha 9 ', 'Q13797', '3680', 'chr3: 37,452,115-37,823,514'),
('ITGAE', 'integrin subunit alpha E ', 'P38570', '3682', 'chr17: 3,714,628-3,801,243'),
('ITGAM', 'integrin subunit alpha M ', 'P11215', '3684', 'chr16: 31,259,990-31,332,892'),
('ITGAV', 'integrin subunit alpha V ', 'P06756', '3685', 'chr2: 186,590,065-186,680,901'),
('ITGAX', 'integrin subunit alpha X ', 'P20702', '3687', 'chr16: 31,355,134-31,382,997'),
('ITGB1', 'integrin subunit beta 1 ', 'P05556', '3688', 'chr10: 32,900,319-33,005,792'),
('BIRC3', 'baculoviral IAP repeat containing 3 ', 'Q13489', '330', 'chr11: 102,317,450-102,339,403'),
('ITGB2', 'integrin subunit beta 2 ', 'P05107', '3689', 'chr21: 44,885,953-44,931,989'),
('ITGB3', 'integrin subunit beta 3 ', 'P05106', '3690', 'chr17: 47,253,846-47,311,816'),
('ITGB4', 'integrin subunit beta 4 ', 'P16144', '3691', 'chr17: 75,721,328-75,757,818'),
('EIF6', 'eukaryotic translation initiation factor 6 ', 'P56537', '3692', 'chr20: 35,278,907-35,284,985'),
('ITGB5', 'integrin subunit beta 5 ', 'P18084', '3693', 'chr3: 124,761,948-124,901,418'),
('ITGB8', 'integrin subunit beta 8 ', 'P26012', '3696', 'chr7: 20,330,702-20,415,754'),
('STT3A', 'STT3A, subunit of the oligosaccharyltransferase complex (catalytic) ', 'P46977', '3703', 'chr11: 125,591,712-125,625,215'),
('ITPK1', 'inositol-tetrakisphosphate 1-kinase ', 'Q13572', '3705', 'chr14: 92,936,914-93,116,320'),
('ITPKA', 'inositol-trisphosphate 3-kinase A ', 'P23677', '3706', 'chr15: 41,493,393-41,503,551'),
('ITPR1', 'inositol 1,4,5-trisphosphate receptor, type 1 ', 'Q14643', '3708', 'chr3: 4,493,348-4,847,840'),
('XIAP', 'X-linked inhibitor of apoptosis ', 'P98170', '331', 'chrX: 123,859,724-123,913,979'),
('ITPR2', 'inositol 1,4,5-trisphosphate receptor, type 2 ', 'Q14571', '3709', 'chr12: 26,336,515-26,833,198'),
('ITPR3', 'inositol 1,4,5-trisphosphate receptor, type 3 ', 'Q14573', '3710', 'chr6: 33,620,365-33,696,574'),
('JAK1', 'Janus kinase 1 ', 'P23458', '3716', 'chr1: 64,833,229-64,966,504'),
('JAK2', 'Janus kinase 2 ', 'O60674', '3717', 'chr9: 4,984,390-5,128,183'),
('JAK3', 'Janus kinase 3 ', 'P52333', '3718', 'chr19: 17,824,780-17,848,071'),
('JUN', 'jun proto-oncogene ', 'P05412', '3725', 'chr1: 58,780,788-58,784,327'),
('JUNB', 'jun B proto-oncogene ', 'P17275', '3726', 'chr19: 12,791,496-12,793,315'),
('JUND', 'jun D proto-oncogene ', 'P17535', '3727', 'chr19: 18,279,760-18,281,622'),
('JUP', 'junction plakoglobin ', 'P14923', '3728', 'chr17: 41,754,604-41,786,931'),
('ANOS1', 'anosmin 1 ', 'P23352', '3730', 'chrX: 8,528,874-8,732,186'),
('BIRC5', 'baculoviral IAP repeat containing 5 ', 'O15392', '332', 'chr17: 78,214,186-78,225,636'),
('KARS', 'lysyl-tRNA synthetase ', 'Q15046', '3735', 'chr16: 75,627,474-75,648,643'),
('KCNA1', 'potassium channel, voltage gated shaker related subfamily A, member 1 ', 'Q09470', '3736', 'chr12: 4,909,893-4,918,256'),
('KCNC3', 'potassium channel, voltage gated Shaw related subfamily C, member 3 ', 'Q14003', '3748', 'chr19: 50,311,937-50,333,515'),
('KCNG1', 'potassium channel, voltage gated modifier subfamily G, member 1 ', 'Q9UIX4', '3755', 'chr20: 51,003,656-51,023,129'),
('KCNH2', 'potassium channel, voltage gated eag related subfamily H, member 2 ', 'Q12809', '3757', 'chr7: 150,944,961-150,978,315'),
('KCNJ11', 'potassium channel, inwardly rectifying subfamily J, member 11 ', 'Q14654', '3767', 'chr11: 17,385,859-17,389,331'),
('KCNJ12', 'potassium channel, inwardly rectifying subfamily J, member 12 ', 'Q14500', '3768', 'chr17: 21,376,197-21,419,872'),
('KCNK1', 'potassium channel, two pore domain subfamily K, member 1 ', 'O00180', '3775', 'chr1: 233,614,004-233,672,512'),
('KCNK3', 'potassium channel, two pore domain subfamily K, member 3 ', 'O14649', '3777', 'chr2: 26,692,690-26,733,420'),
('KCNMA1', 'potassium channel, calcium activated large conductance subfamily M alpha, member 1 ', 'Q12791', '3778', 'chr10: 76,869,601-77,638,369'),
('ACAT2', 'acetyl-CoA acetyltransferase 2 ', 'Q9BWD1', '39', 'chr6: 159,760,328-159,779,055'),
('APLP2', 'amyloid beta (A4) precursor-like protein 2 ', 'Q06481', '334', 'chr11: 130,069,837-130,144,811'),
('KIF5C', 'kinesin family member 5C ', 'O60282', '3800', 'chr2: 148,875,250-149,026,759'),
('KIR3DL2', 'killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2 ', 'P43630', '3812', 'chr19: 54,850,443-54,867,207'),
('KISS1', 'KiSS-1 metastasis-suppressor ', 'Q15726', '3814', 'chr1: 204,190,341-204,196,486'),
('KIT', 'v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog ', 'P10721', '3815', 'chr4: 54,657,918-54,740,715'),
('KLK2', 'kallikrein related peptidase 2 ', 'P20151', '3817', 'chr19: 50,861,568-50,880,567'),
('KLRC1', 'killer cell lectin-like receptor subfamily C, member 1 ', 'P26715', '3821', 'chr12: 10,442,264-10,454,685'),
('KNG1', 'kininogen 1 ', 'P01042', '3827', 'chr3: 186,717,276-186,743,954'),
('KIF11', 'kinesin family member 11 ', 'P52732', '3832', 'chr10: 92,593,286-92,655,395'),
('KIFC1', 'kinesin family member C1 ', 'Q9BW19', '3833', 'chr6: 33,391,536-33,409,924'),
('KIF22', 'kinesin family member 22 ', 'Q14807', '3835', 'chr16: 29,790,719-29,805,385'),
('APOA1', 'apolipoprotein A-I ', 'P02647', '335', 'chr11: 116,835,751-116,837,950'),
('KPNA1', 'karyopherin alpha 1 ', 'P52294', '3836', 'chr3: 122,421,949-122,514,945'),
('KPNB1', 'karyopherin (importin) beta 1 ', 'Q14974', '3837', 'chr17: 47,649,476-47,685,505'),
('KPNA2', 'karyopherin alpha 2 (RAG cohort 1, importin alpha 1) ', 'P52292', '3838', 'chr17: 68,035,519-68,046,842'),
('KPNA3', 'karyopherin alpha 3 (importin alpha 4) ', 'O00505', '3839', 'chr13: 49,699,307-49,792,921'),
('KPNA4', 'karyopherin alpha 4 (importin alpha 3) ', 'O00629', '3840', 'chr3: 160,494,995-160,565,588'),
('KPNA5', 'karyopherin alpha 5 (importin alpha 6) ', 'O15131', '3841', 'chr6: 116,681,187-116,741,866'),
('IPO5', 'importin 5 ', 'O00410', '3843', 'chr13: 97,953,658-98,024,297'),
('KRAS', 'Kirsten rat sarcoma viral oncogene homolog ', 'P01116', '3845', 'chr12: 25,204,789-25,250,936'),
('KRT1', 'keratin 1, type II ', 'P04264', '3848', 'chr12: 52,674,736-52,680,407'),
('KRT3', 'keratin 3, type II ', 'P12035', '3850', 'chr12: 52,789,685-52,796,117'),
('APOA2', 'apolipoprotein A-II ', 'P02652', '336', 'chr1: 161,222,292-161,223,631'),
('KRT7', 'keratin 7, type II ', 'P08729', '3855', 'chr12: 52,232,520-52,252,186'),
('KRT8', 'keratin 8, type II ', 'P05787', '3856', 'chr12: 52,897,187-52,949,954'),
('KRT9', 'keratin 9, type I ', 'P35527', '3857', 'chr17: 41,565,841-41,572,058'),
('KRT13', 'keratin 13, type I ', 'P13646', '3860', 'chr17: 41,500,981-41,505,705'),
('KRT16', 'keratin 16, type I ', 'P08779', '3868', 'chr17: 41,609,778-41,615,899'),
('KRT17', 'keratin 17, type I ', 'Q04695', '3872', 'chr17: 41,619,437-41,624,842'),
('KRT18', 'keratin 18, type I ', 'P05783', '3875', 'chr12: 52,948,871-52,952,901'),
('KRT19', 'keratin 19, type I ', 'P08727', '3880', 'chr17: 41,523,617-41,528,308'),
('KTN1', 'kinectin 1 ', 'Q86UP2', '3895', 'chr14: 55,559,072-55,701,526'),
('AFF3', 'AF4/FMR2 family member 3 ', 'P51826', '3899', 'chr2: 99,545,419-100,142,739'),
('APOA4', 'apolipoprotein A-IV ', 'P06727', '337', 'chr11: 116,820,700-116,823,306'),
('LAG3', 'lymphocyte-activation gene 3 ', 'P18627', '3902', 'chr12: 6,772,512-6,778,455'),
('LAIR1', 'leukocyte-associated immunoglobulin-like receptor 1 ', 'Q6GTX8', '3903', 'chr19: 54,351,384-54,370,558'),
('LAIR2', 'leukocyte-associated immunoglobulin-like receptor 2 ', 'Q6ISS4', '3904', 'chr19: 54,497,879-54,510,687'),
('LAMA2', 'laminin subunit alpha 2 ', 'P24043', '3908', 'chr6: 128,883,141-129,516,569'),
('LAMA3', 'laminin subunit alpha 3 ', 'Q16787', '3909', 'chr18: 23,689,443-23,955,066'),
('LAMA4', 'laminin subunit alpha 4 ', 'Q16363', '3910', 'chr6: 112,108,760-112,254,939'),
('LAMB1', 'laminin subunit beta 1 ', 'P07942', '3912', 'chr7: 107,923,799-108,003,255'),
('LAMC1', 'laminin subunit gamma 1 ', 'P11047', '3915', 'chr1: 183,023,460-183,145,592'),
('LAMP1', 'lysosomal-associated membrane protein 1 ', 'P11279', '3916', 'chr13: 113,297,241-113,323,672'),
('LAMP2', 'lysosomal-associated membrane protein 2 ', 'P13473', '3920', 'chrX: 120,427,827-120,469,365'),
('APOB', 'apolipoprotein B ', 'P04114', '338', 'chr2: 21,001,429-21,044,073'),
('RPSA', 'ribosomal protein SA ', 'P08865', '3921', 'chr3: 39,406,689-39,412,542'),
('STMN1', 'stathmin 1 ', 'P16949', '3925', 'chr1: 25,884,181-25,906,991'),
('LCN2', 'lipocalin 2 ', 'P80188', '3934', 'chr9: 128,149,071-128,153,455'),
('LCP1', 'lymphocyte cytosolic protein 1 (L-plastin) ', 'P13796', '3936', 'chr13: 46,125,920-46,211,871'),
('LCT', 'lactase ', 'P09848', '3938', 'chr2: 135,787,840-135,837,180'),
('LDHA', 'lactate dehydrogenase A ', 'P00338', '3939', 'chr11: 18,394,388-18,408,425'),
('LDHB', 'lactate dehydrogenase B ', 'P07195', '3945', 'chr12: 21,635,342-21,757,857'),
('LDLR', 'low density lipoprotein receptor ', 'P01130', '3949', 'chr19: 11,089,362-11,133,816'),
('LEP', 'leptin ', 'P41159', '3952', 'chr7: 128,241,284-128,257,628'),
('LEPR', 'leptin receptor ', 'P48357', '3953', 'chr1: 65,420,652-65,641,559'),
('APOC1', 'apolipoprotein C-I ', 'P02654', '341', 'chr19: 44,914,247-44,919,349'),
('LETM1', 'leucine zipper-EF-hand containing transmembrane protein 1 ', 'O95202', '3954', 'chr4: 1,811,479-1,856,247'),
('LGALS1', 'lectin, galactoside-binding, soluble, 1 ', 'P09382', '3956', 'chr22: 37,675,608-37,679,806'),
('LGALS3', 'lectin, galactoside-binding, soluble, 3 ', 'P17931', '3958', 'chr14: 55,124,110-55,145,413'),
('LGALS7', 'lectin, galactoside-binding, soluble, 7 ', 'P47929', '3963', 'chr19: 38,770,971-38,773,492'),
('LGALS8', 'lectin, galactoside-binding, soluble, 8 ', 'O00214', '3964', 'chr1: 236,518,000-236,552,981'),
('LHB', 'luteinizing hormone beta polypeptide ', 'P01229', '3972', 'chr19: 49,015,980-49,017,081'),
('LHCGR', 'luteinizing hormone/choriogonadotropin receptor ', 'P22888', '3973', 'chr2: 48,686,775-48,755,730'),
('LIF', 'leukemia inhibitory factor ', 'P15018', '3976', 'chr22: 30,240,447-30,246,851'),
('LIFR', 'leukemia inhibitory factor receptor alpha ', 'P42702', '3977', 'chr5: 38,474,963-38,608,354'),
('LIG1', 'ligase I, DNA, ATP-dependent ', 'P18858', '3978', 'chr19: 48,115,445-48,170,603'),
('AQP8', 'aquaporin 8 ', 'O94778', '343', 'chr16: 25,215,731-25,228,940'),
('ABLIM1', 'actin binding LIM protein 1 ', 'O14639', '3983', 'chr10: 114,431,113-114,685,003'),
('LIMK2', 'LIM domain kinase 2 ', 'P53671', '3985', 'chr22: 31,212,239-31,280,080'),
('LIMS1', 'LIM and senescent cell antigen-like domains 1 ', 'P48059', '3987', 'chr2: 108,534,355-108,687,246'),
('LIPA', 'lipase A, lysosomal acid, cholesterol esterase ', 'P38571', '3988', 'chr10: 89,213,569-89,414,557'),
('LIPE', 'lipase, hormone-sensitive ', 'Q05469', '3991', 'chr19: 42,401,507-42,427,426'),
('FADS1', 'fatty acid desaturase 1 ', 'O60427', '3992', 'chr11: 61,799,625-61,829,318'),
('LMNA', 'lamin A/C ', 'P02545', '4000', 'chr1: 156,082,573-156,140,089'),
('LMNB1', 'lamin B1 ', 'P20700', '4001', 'chr5: 126,776,623-126,837,020'),
('LMO2', 'LIM domain only 2 ', 'P25791', '4005', 'chr11: 33,858,576-33,892,289'),
('LNPEP', 'leucyl/cystinyl aminopeptidase ', 'Q9UIQ6', '4012', 'chr5: 96,935,394-97,037,515'),
('APOC3', 'apolipoprotein C-III ', 'P02656', '345', 'chr11: 116,829,706-116,833,072'),
('VWA5A', 'von Willebrand factor A domain containing 5A ', 'O00534', '4013', 'chr11: 124,115,362-124,147,721'),
('LOX', 'lysyl oxidase ', 'P28300', '4015', 'chr5: 122,063,195-122,078,360'),
('LOXL1', 'lysyl oxidase like 1 ', 'Q08397', '4016', 'chr15: 73,925,989-73,952,137'),
('LOXL2', 'lysyl oxidase like 2 ', 'Q9Y4K0', '4017', 'chr8: 23,297,189-23,425,328'),
('LPL', 'lipoprotein lipase ', 'P06858', '4023', 'chr8: 19,901,717-19,967,258'),
('LPP', 'LIM domain containing preferred translocation partner in lipoma ', 'Q93052', '4026', 'chr3: 188,153,284-188,890,671'),
('LRMP', 'lymphoid-restricted membrane protein ', 'Q12912', '4033', 'chr12: 25,004,342-25,108,334'),
('LRP2', 'LDL receptor related protein 2 ', 'P98164', '4036', 'chr2: 169,127,109-169,362,685'),
('LRP6', 'LDL receptor related protein 6 ', 'O75581', '4040', 'chr12: 12,116,025-12,267,012'),
('LRP5', 'LDL receptor related protein 5 ', 'O75197', '4041', 'chr11: 68,312,609-68,449,275'),
('APOD', 'apolipoprotein D ', 'P05090', '347', 'chr3: 195,568,702-195,584,205'),
('LRPAP1', 'LDL receptor related protein associated protein 1 ', 'P30533', '4043', 'chr4: 3,506,376-3,532,559'),
('LSAMP', 'limbic system-associated membrane protein ', 'Q13449', '4045', 'chr3: 115,802,363-117,139,389'),
('LSP1', 'lymphocyte-specific protein 1 ', 'P33241', '4046', 'chr11: 1,852,970-1,892,267'),
('LSS', 'lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) ', 'P48449', '4047', 'chr21: 46,188,141-46,228,824'),
('LTBP1', 'latent transforming growth factor beta binding protein 1 ', 'Q14766', '4052', 'chr2: 32,946,972-33,399,509'),
('LTBP3', 'latent transforming growth factor beta binding protein 3 ', 'Q9NS15', '4054', 'chr11: 65,538,805-65,558,930'),
('LTBR', 'lymphotoxin beta receptor ', 'P36941', '4055', 'chr12: 6,375,045-6,391,571'),
('LTK', 'leukocyte receptor tyrosine kinase ', 'P29376', '4058', 'chr15: 41,503,638-41,513,887'),
('BCAM', 'basal cell adhesion molecule (Lutheran blood group) ', 'P50895', '4059', 'chr19: 44,809,059-44,821,420'),
('LUM', 'lumican ', 'P51884', '4060', 'chr12: 91,102,629-91,111,831'),
('APOE', 'apolipoprotein E ', 'P02649', '348', 'chr19: 44,905,754-44,909,393'),
('LY6E', 'lymphocyte antigen 6 complex, locus E ', 'Q16553', '4061', 'chr8: 143,017,982-143,023,832'),
('LY75', 'lymphocyte antigen 75 ', 'O60449', '4065', 'chr2: 159,803,355-159,904,749'),
('LYN', 'LYN proto-oncogene, Src family tyrosine kinase ', 'P07948', '4067', 'chr8: 55,879,813-56,014,168'),
('LYZ', 'lysozyme ', 'P61626', '4069', 'chr12: 69,348,341-69,354,234'),
('TM4SF1', 'transmembrane 4 L six family member 1 ', 'P30408', '4071', 'chr3: 149,369,022-149,377,865'),
('EPCAM', 'epithelial cell adhesion molecule ', 'P16422', '4072', 'chr2: 47,345,158-47,387,601'),
('CAPRIN1', 'cell cycle associated protein 1 ', 'Q14444', '4076', 'chr11: 34,051,683-34,101,156'),
('NBR1', 'neighbor of BRCA1 gene 1 ', 'Q14596', '4077', 'chr17: 43,170,481-43,211,689'),
('MAB21L1', 'mab-21-like 1 (C. elegans) ', 'Q13394', '4081', 'chr13: 35,474,182-35,477,209'),
('MARCKS', 'myristoylated alanine-rich protein kinase C substrate ', 'P29966', '4082', 'chr6: 113,857,362-113,863,471'),
('ASIC2', 'acid sensing ion channel subunit 2 ', 'Q16515', '40', 'chr17: 33,013,087-34,174,964'),
('APOH', 'apolipoprotein H ', 'P02749', '350', 'chr17: 66,212,033-66,256,525'),
('MXD1', 'MAX dimerization protein 1 ', 'Q05195', '4084', 'chr2: 69,897,688-69,942,945'),
('MAD2L1', 'MAD2 mitotic arrest deficient-like 1 (yeast) ', 'Q13257', '4085', 'chr4: 120,055,608-120,067,074'),
('SMAD1', 'SMAD family member 1 ', 'Q15797', '4086', 'chr4: 145,481,194-145,558,079'),
('SMAD2', 'SMAD family member 2 ', 'Q15796', '4087', 'chr18: 47,808,957-47,931,146'),
('SMAD3', 'SMAD family member 3 ', 'P84022', '4088', 'chr15: 67,063,763-67,195,195'),
('SMAD4', 'SMAD family member 4 ', 'Q13485', '4089', 'chr18: 51,028,394-51,085,045'),
('SMAD5', 'SMAD family member 5 ', 'Q99717', '4090', 'chr5: 136,132,845-136,188,747'),
('SMAD6', 'SMAD family member 6 ', 'O43541', '4091', 'chr15: 66,702,228-66,782,848'),
('SMAD7', 'SMAD family member 7 ', 'O15105', '4092', 'chr18: 48,919,853-48,950,711'),
('SMAD9', 'SMAD family member 9 ', 'O15198', '4093', 'chr13: 36,844,831-36,920,765'),
('APP', 'amyloid beta (A4) precursor protein ', 'P05067', '351', 'chr21: 25,880,550-26,171,128'),
('MAF', 'v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog ', 'O75444', '4094', 'chr16: 79,585,843-79,600,714'),
('MAFG', 'v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog G ', 'O15525', '4097', 'chr17: 81,918,270-81,927,714'),
('MAG', 'myelin associated glycoprotein ', 'P20916', '4099', 'chr19: 35,292,125-35,313,804'),
('MAGEB4', 'MAGE family member B4 ', 'O15481', '4115', 'chrX: 30,242,052-30,244,193'),
('MAK', 'male germ cell-associated kinase ', 'P20794', '4117', 'chr6: 10,762,723-10,838,555'),
('MAL', 'mal, T-cell differentiation protein ', 'P21145', '4118', 'chr2: 95,025,677-95,053,996'),
('MAN1A1', 'mannosidase, alpha, class 1A, member 1 ', 'P33908', '4121', 'chr6: 119,177,209-119,349,761'),
('MAN2A2', 'mannosidase, alpha, class 2A, member 2 ', 'P49641', '4122', 'chr15: 90,902,218-90,922,584'),
('MAN2B1', 'mannosidase, alpha, class 2B, member 1 ', 'O00754', '4125', 'chr19: 12,646,511-12,666,742'),
('MAOA', 'monoamine oxidase A ', 'P21397', '4128', 'chrX: 43,654,907-43,746,824'),
('APRT', 'adenine phosphoribosyltransferase ', 'P07741', '353', 'chr16: 88,809,339-88,811,944'),
('MAOB', 'monoamine oxidase B ', 'P27338', '4129', 'chrX: 43,766,611-43,882,447'),
('MAP1A', 'microtubule associated protein 1A ', 'P78559', '4130', 'chr15: 43,510,958-43,531,620'),
('MAP1B', 'microtubule associated protein 1B ', 'P46821', '4131', 'chr5: 72,107,234-72,209,570'),
('MAP2', 'microtubule associated protein 2 ', 'P11137', '4133', 'chr2: 209,424,058-209,734,118'),
('MAPT', 'microtubule associated protein tau ', 'P10636', '4137', 'chr17: 45,894,382-46,028,334'),
('MARK1', 'MAP/microtubule affinity-regulating kinase 1 ', 'Q9P0L2', '4139', 'chr1: 220,528,183-220,664,461'),
('MAT2A', 'methionine adenosyltransferase II, alpha ', 'P31153', '4144', 'chr2: 85,539,165-85,545,280'),
('MATN2', 'matrilin 2 ', 'O00339', '4147', 'chr8: 97,868,840-98,036,716'),
('MAZ', 'MYC-associated zinc finger protein (purine-binding transcription factor) ', 'P56270', '4150', 'chr16: 29,806,106-29,811,164'),
('MBL2', 'mannose-binding lectin (protein C) 2, soluble ', 'P11226', '4153', 'chr10: 52,765,380-52,771,700'),
('KLK3', 'kallikrein related peptidase 3 ', 'P07288', '354', 'chr19: 50,854,915-50,860,764'),
('MBNL1', 'muscleblind like splicing regulator 1 ', 'Q9NR56', '4154', 'chr3: 152,243,828-152,465,780'),
('MC2R', 'melanocortin 2 receptor (adrenocorticotropic hormone) ', 'Q01718', '4158', 'chr18: 13,882,044-13,915,707'),
('MC4R', 'melanocortin 4 receptor ', 'P32245', '4160', 'chr18: 60,371,110-60,372,775'),
('MCAM', 'melanoma cell adhesion molecule ', 'P43121', '4162', 'chr11: 119,308,529-119,321,521'),
('CHST6', 'carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 6 ', 'Q9GZX3', '4166', 'chr16: 75,472,052-75,495,384'),
('MCL1', 'myeloid cell leukemia 1 ', 'Q07820', '4170', 'chr1: 150,574,551-150,579,738'),
('MCM2', 'minichromosome maintenance complex component 2 ', 'P49736', '4171', 'chr3: 127,598,223-127,622,436'),
('MCM3', 'minichromosome maintenance complex component 3 ', 'P25205', '4172', 'chr6: 52,264,009-52,284,881'),
('MCM4', 'minichromosome maintenance complex component 4 ', 'P33991', '4173', 'chr8: 47,960,185-47,978,160'),
('MCM5', 'minichromosome maintenance complex component 5 ', 'P33992', '4174', 'chr22: 35,400,063-35,425,430'),
('FAS', 'Fas cell surface death receptor ', 'P25445', '355', 'chr10: 88,990,582-89,015,785'),
('MCM6', 'minichromosome maintenance complex component 6 ', 'Q14566', '4175', 'chr2: 135,839,626-135,876,426'),
('MCM7', 'minichromosome maintenance complex component 7 ', 'P33993', '4176', 'chr7: 100,092,728-100,101,940'),
('CD46', 'CD46 molecule, complement regulatory protein ', 'P15529', '4179', 'chr1: 207,752,057-207,795,513'),
('MDFI', 'MyoD family inhibitor ', 'Q99750', '4188', 'chr6: 41,636,882-41,654,246'),
('DNAJB9', 'DnaJ heat shock protein family (Hsp40) member B9 ', 'Q9UBS3', '4189', 'chr7: 108,569,568-108,574,850'),
('MDH1', 'malate dehydrogenase 1 ', 'P40925', '4190', 'chr2: 63,588,609-63,607,197'),
('MDH2', 'malate dehydrogenase 2 ', 'P40926', '4191', 'chr7: 76,048,051-76,067,508'),
('MDK', 'midkine (neurite growth-promoting factor 2) ', 'P21741', '4192', 'chr11: 46,380,756-46,383,837'),
('MDM2', 'MDM2 proto-oncogene, E3 ubiquitin protein ligase ', 'Q00987', '4193', 'chr12: 68,808,176-68,850,686'),
('MDM4', 'MDM4, p53 regulator ', 'O15151', '4194', 'chr1: 204,516,379-204,558,120'),
('SHROOM2', 'shroom family member 2 ', 'Q13796', '357', 'chrX: 9,786,456-9,949,443'),
('ME2', 'malic enzyme 2, NAD(+)-dependent, mitochondrial ', 'P23368', '4200', 'chr18: 50,878,734-50,954,257'),
('MEF2A', 'myocyte enhancer factor 2A ', 'Q02078', '4205', 'chr15: 99,565,417-99,716,466'),
('MEF2C', 'myocyte enhancer factor 2C ', 'Q06413', '4208', 'chr5: 88,717,117-88,904,257'),
('MEF2D', 'myocyte enhancer factor 2D ', 'Q14814', '4209', 'chr1: 156,463,727-156,500,828'),
('MEIS1', 'Meis homeobox 1 ', 'O00470', '4211', 'chr2: 66,433,452-66,573,869'),
('MEIS3P1', 'Meis homeobox 3 pseudogene 1', 'A6NDR6', '4213', 'chr17: 15,786,618-15,787,575'),
('MAP3K4', 'mitogen-activated protein kinase kinase kinase 4 ', 'Q9Y6R4', '4216', 'chr6: 160,991,727-161,117,385');
INSERT INTO `geneinfo` (`gene_symbol`, `description`, `uniprot_id`, `entrez_id`, `chr_loc`) VALUES
('MAP3K5', 'mitogen-activated protein kinase kinase kinase 5 ', 'Q99683', '4217', 'chr6: 136,557,047-136,792,518'),
('MEOX1', 'mesenchyme homeobox 1 ', 'P50221', '4222', 'chr17: 43,640,388-43,661,954'),
('MEST', 'mesoderm specific transcript ', 'Q5EB52', '4232', 'chr7: 130,486,171-130,506,296'),
('AQP2', 'aquaporin 2 (collecting duct) ', 'P41181', '359', 'chr12: 49,950,741-49,958,881'),
('MET', 'MET proto-oncogene, receptor tyrosine kinase ', 'P08581', '4233', 'chr7: 116,672,390-116,798,386'),
('MFAP2', 'microfibrillar associated protein 2 ', 'P55001', '4237', 'chr1: 16,974,502-16,980,835'),
('MFAP3', 'microfibrillar associated protein 3 ', 'P55082', '4238', 'chr5: 154,038,906-154,220,478'),
('MFGE8', 'milk fat globule-EGF factor 8 protein ', 'Q08431', '4240', 'chr15: 88,898,683-88,913,411'),
('MFI2', 'antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5 ', 'P08582', '4241', 'chr3: 196,988,621-197,029,816'),
('MGAT2', 'mannosyl (alpha-1,6-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase ', 'Q10469', '4247', 'chr14: 49,620,795-49,623,481'),
('SCGB2A2', 'secretoglobin, family 2A, member 2 ', 'Q13296', '4250', 'chr11: 62,270,155-62,273,156'),
('KITLG', 'KIT ligand ', 'P21583', '4254', 'chr12: 88,492,793-88,580,851'),
('MGP', 'matrix Gla protein ', 'P08493', '4256', 'chr12: 14,881,181-14,885,926'),
('MGST1', 'microsomal glutathione S-transferase 1 ', 'P10620', '4257', 'chr12: 16,347,142-16,609,259'),
('AQP3', 'aquaporin 3 (Gill blood group) ', 'Q92482', '360', 'chr9: 33,441,154-33,447,611'),
('MGST2', 'microsomal glutathione S-transferase 2 ', 'Q99735', '4258', 'chr4: 139,665,768-139,740,745'),
('MGST3', 'microsomal glutathione S-transferase 3 ', 'O14880', '4259', 'chr1: 165,630,861-165,661,796'),
('CD99', 'CD99 molecule ', 'P14209', '4267', 'chrX: 2,691,179-2,741,309'),
('MICB', 'MHC class I polypeptide-related sequence B ', 'Q29980', '4277', 'chr6: 31,494,881-31,511,124'),
('MID1', 'midline 1 ', 'O15344', '4281', 'chrX: 10,445,310-10,833,654'),
('MIF', 'macrophage migration inhibitory factor (glycosylation-inhibiting factor) ', 'P14174', '4282', 'chr22: 23,894,004-23,895,227'),
('MIP', 'major intrinsic protein of lens fiber ', 'P30301', '4284', 'chr12: 56,449,502-56,469,166'),
('MIPEP', 'mitochondrial intermediate peptidase ', 'Q99797', '4285', 'chr13: 23,730,189-23,889,419'),
('MITF', 'microphthalmia-associated transcription factor ', 'O75030', '4286', 'chr3: 69,739,435-69,968,337'),
('ATXN3', 'ataxin 3 ', 'P54252', '4287', 'chr14: 92,038,652-92,106,621'),
('AQP9', 'aquaporin 9 ', 'O43315', '366', 'chr15: 58,138,169-58,185,911'),
('MKI67', 'marker of proliferation Ki-67 ', 'P46013', '4288', 'chr10: 128,096,659-128,126,385'),
('MKLN1', 'muskelin 1 ', 'Q9UL63', '4289', 'chr7: 131,110,096-131,496,636'),
('MLH1', 'mutL homolog 1 ', 'P40692', '4292', 'chr3: 36,993,332-37,050,918'),
('FOXO4', 'forkhead box O4 ', 'P98177', '4303', 'chrX: 71,096,197-71,103,535'),
('MME', 'membrane metallo-endopeptidase ', 'P08473', '4311', 'chr3: 155,024,124-155,183,729'),
('MMP1', 'matrix metallopeptidase 1 ', 'P03956', '4312', 'chr11: 102,789,920-102,798,160'),
('MMP2', 'matrix metallopeptidase 2 ', 'P08253', '4313', 'chr16: 55,389,700-55,506,691'),
('MMP8', 'matrix metallopeptidase 8 ', 'P22894', '4317', 'chr11: 102,711,795-102,727,050'),
('MMP9', 'matrix metallopeptidase 9 ', 'P14780', '4318', 'chr20: 46,008,908-46,016,561'),
('MMP10', 'matrix metallopeptidase 10 ', 'P09238', '4319', 'chr11: 102,770,503-102,780,628'),
('AR', 'androgen receptor ', 'P10275', '367', 'chrX: 67,544,032-67,730,619'),
('MMP11', 'matrix metallopeptidase 11 ', 'P24347', '4320', 'chr22: 23,768,226-23,784,316'),
('MMP14', 'matrix metallopeptidase 14 ', 'P50281', '4323', 'chr14: 22,836,557-22,849,027'),
('MMP15', 'matrix metallopeptidase 15 ', 'P51511', '4324', 'chr16: 58,025,566-58,046,901'),
('MMP16', 'matrix metallopeptidase 16 ', 'P51512', '4325', 'chr8: 88,032,009-88,328,025'),
('MMP19', 'matrix metallopeptidase 19 ', 'Q99542', '4327', 'chr12: 55,835,433-55,842,966'),
('ALDH6A1', 'aldehyde dehydrogenase 6 family member A1 ', 'Q02252', '4329', 'chr14: 74,056,850-74,084,493'),
('MN1', 'meningioma (disrupted in balanced translocation) 1 ', 'Q10571', '4330', 'chr22: 27,748,277-27,801,498'),
('MNDA', 'myeloid cell nuclear differentiation antigen ', 'P41218', '4332', 'chr1: 158,831,317-158,849,506'),
('MNT', 'MAX network transcriptional repressor ', 'Q99583', '4335', 'chr17: 2,384,060-2,401,118'),
('CD200', 'CD200 molecule ', 'P41217', '4345', 'chr3: 112,332,347-112,362,812'),
('ACO2', 'aconitase 2 ', 'Q99798', '50', 'chr22: 41,469,125-41,528,989'),
('ARCN1', 'archain 1 ', 'P48444', '372', 'chr11: 118,572,390-118,603,033'),
('MPG', 'N-methylpurine DNA glycosylase ', 'P29372', '4350', 'chr16: 77,007-85,853'),
('MPO', 'myeloperoxidase ', 'P05164', '4353', 'chr17: 58,269,856-58,280,935'),
('MPP1', 'membrane protein, palmitoylated 1 ', 'Q00013', '4354', 'chrX: 154,778,684-154,821,007'),
('MPST', 'mercaptopyruvate sulfurtransferase ', 'P25325', '4357', 'chr22: 37,019,635-37,029,822'),
('MPV17', 'MpV17 mitochondrial inner membrane protein ', 'P39210', '4358', 'chr2: 27,309,492-27,325,680'),
('MRC1', 'mannose receptor, C type 1 ', 'P22897', '4360', 'chr10: 17,809,344-17,911,170'),
('MRE11A', 'MRE11 homolog A, double strand break repair nuclease ', 'P49959', '4361', 'chr11: 94,415,578-94,493,908'),
('ABCC1', 'ATP binding cassette subfamily C member 1 ', 'P33527', '4363', 'chr16: 15,949,577-16,143,074'),
('CITED1', 'Cbp/p300-interacting transactivator, with Glu/Asp rich carboxy-terminal domain, 1 ', 'Q99966', '4435', 'chrX: 72,301,638-72,307,187'),
('MSH2', 'mutS homolog 2 ', 'P43246', '4436', 'chr2: 47,402,969-47,562,311'),
('TRIM23', 'tripartite motif containing 23 ', 'P36406', '373', 'chr5: 65,589,680-65,625,975'),
('MSH3', 'mutS homolog 3 ', 'P20585', '4437', 'chr5: 80,654,648-80,876,460'),
('MST1', 'macrophage stimulating 1 ', 'P26927', '4485', 'chr3: 49,683,947-49,689,501'),
('MT1E', 'metallothionein 1E ', 'P04732', '4493', 'chr16: 56,625,475-56,627,112'),
('MT1F', 'metallothionein 1F ', 'P04733', '4494', 'chr16: 56,657,694-56,660,698'),
('MT1G', 'metallothionein 1G ', 'P13640', '4495', 'chr16: 56,666,731-56,668,065'),
('MT1H', 'metallothionein 1H ', 'P80294', '4496', 'chr16: 56,669,814-56,671,129'),
('MT1M', 'metallothionein 1M ', 'Q8N339', '4499', 'chr16: 56,632,233-56,633,986'),
('MT1X', 'metallothionein 1X ', 'P80297', '4501', 'chr16: 56,682,424-56,684,196'),
('MT2A', 'metallothionein 2A ', 'P02795', '4502', 'chr16: 56,608,199-56,609,497'),
('MT3', 'metallothionein 3 ', 'P25713', '4504', 'chr16: 56,589,074-56,591,088'),
('AREG', 'amphiregulin ', 'P15514', '374', 'chr4: 74,445,134-74,455,009'),
('MTAP', 'methylthioadenosine phosphorylase ', 'Q13126', '4507', 'chr9: 21,802,543-21,937,651'),
('MTCP1', 'mature T-cell proliferation 1 ', 'P56278', '4515', 'chrX: 155,061,622-155,147,937'),
('MTF1', 'metal-regulatory transcription factor 1 ', 'Q14872', '4520', 'chr1: 37,809,567-37,859,620'),
('NUDT1', 'nudix hydrolase 1 ', 'P36639', '4521', 'chr7: 2,242,222-2,251,146'),
('MTHFD1', 'methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1, methenyltetrahydrofolate cyclohydrolase', 'P11586', '4522', 'chr14: 64,388,031-64,463,457'),
('MTHFR', 'methylenetetrahydrofolate reductase (NAD(P)H) ', 'P42898', '4524', 'chr1: 11,785,723-11,806,920'),
('MTM1', 'myotubularin 1 ', 'Q13496', '4534', 'chrX: 150,568,619-150,673,322'),
('MTNR1A', 'melatonin receptor 1A ', 'P48039', '4543', 'chr4: 186,533,655-186,555,567'),
('MTNR1B', 'melatonin receptor 1B ', 'P49286', '4544', 'chr11: 92,969,720-92,985,066'),
('MTR', '5-methyltetrahydrofolate-homocysteine methyltransferase ', 'Q99707', '4548', 'chr1: 236,795,281-236,903,981'),
('ARF1', 'ADP ribosylation factor 1 ', 'P84077', '375', 'chr1: 228,082,660-228,099,212'),
('MUC1', 'mucin 1, cell surface associated ', 'P15941', '4582', 'chr1: 155,185,824-155,192,916'),
('MUC3A', 'mucin 3A, cell surface associated ', 'Q02505', '4584', 'chr7: 100,949,555-100,968,346'),
('MUC4', 'mucin 4, cell surface associated ', 'Q99102', '4585', 'chr3: 195,746,765-195,812,277'),
('MUC5AC', 'mucin 5AC, oligomeric mucus/gel-forming ', 'P98088', '4586', 'chr11: 1,157,953-1,201,138'),
('TRIM37', 'tripartite motif containing 37 ', 'O94972', '4591', 'chr17: 58,982,638-59,106,921'),
('MUSK', 'muscle, skeletal, receptor tyrosine kinase ', 'O15146', '4593', 'chr9: 110,668,771-110,801,620'),
('MUTYH', 'mutY DNA glycosylase ', 'Q9UIF7', '4595', 'chr1: 45,329,163-45,340,470'),
('MVD', 'mevalonate diphosphate decarboxylase ', 'P53602', '4597', 'chr16: 88,651,935-88,663,161'),
('MVK', 'mevalonate kinase ', 'Q03426', '4598', 'chr12: 109,573,255-109,598,117'),
('MXI1', 'MAX interactor 1, dimerization protein ', 'P50539', '4601', 'chr10: 110,207,605-110,287,365'),
('ARF4', 'ADP ribosylation factor 4 ', 'P18085', '378', 'chr3: 57,571,363-57,598,220'),
('MYBL1', 'v-myb avian myeloblastosis viral oncogene homolog-like 1 ', 'P10243', '4603', 'chr8: 66,562,175-66,614,247'),
('MYBPC1', 'myosin binding protein C, slow type ', 'Q00872', '4604', 'chr12: 101,568,353-101,686,018'),
('MYBL2', 'v-myb avian myeloblastosis viral oncogene homolog-like 2 ', 'P10244', '4605', 'chr20: 43,667,019-43,716,496'),
('MYC', 'v-myc avian myelocytomatosis viral oncogene homolog ', 'P01106', '4609', 'chr8: 127,735,434-127,741,434'),
('MYCN', 'v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog ', 'P04198', '4613', 'chr2: 15,940,564-15,947,007'),
('GADD45B', 'growth arrest and DNA damage inducible beta ', 'O75293', '4616', 'chr19: 2,476,122-2,478,259'),
('MYH2', 'myosin, heavy chain 2, skeletal muscle, adult ', 'Q9UKX2', '4620', 'chr17: 10,521,148-10,549,957'),
('MYH4', 'myosin, heavy chain 4, skeletal muscle ', 'Q9Y623', '4622', 'chr17: 10,443,290-10,469,559'),
('MYH9', 'myosin, heavy chain 9, non-muscle ', 'P35579', '4627', 'chr22: 36,281,281-36,388,018'),
('MYH11', 'myosin, heavy chain 11, smooth muscle ', 'P35749', '4629', 'chr16: 15,703,172-15,857,033'),
('ARL4D', 'ADP ribosylation factor like GTPase 4D ', 'P49703', '379', 'chr17: 43,398,959-43,401,137'),
('MYL4', 'myosin light chain 4 ', 'P12829', '4635', 'chr17: 47,200,446-47,223,679'),
('MYL5', 'myosin light chain 5 ', 'Q02045', '4636', 'chr4: 673,580-682,033'),
('MYL6', 'myosin light chain 6 ', 'P60660', '4637', 'chr12: 56,158,161-56,163,496'),
('MYLK', 'myosin light chain kinase ', 'Q15746', '4638', 'chr3: 123,610,049-123,884,331'),
('MYO1C', 'myosin IC ', 'O00159', '4641', 'chr17: 1,464,098-1,492,812'),
('MYO1D', 'myosin ID ', 'O94832', '4642', 'chr17: 32,492,522-32,877,177'),
('MYO1E', 'myosin IE ', 'Q12965', '4643', 'chr15: 59,132,434-59,372,900'),
('MYO5A', 'myosin VA ', 'Q9Y4I1', '4644', 'chr15: 52,307,283-52,529,050'),
('MYO5B', 'myosin VB ', 'Q9ULV0', '4645', 'chr18: 49,822,813-50,195,093'),
('MYO6', 'myosin VI ', 'Q9UM54', '4646', 'chr6: 75,749,192-75,919,537'),
('ARF5', 'ADP ribosylation factor 5 ', 'P84085', '381', 'chr7: 127,588,345-127,591,705'),
('MYO9B', 'myosin IXB ', 'Q13459', '4650', 'chr19: 17,075,781-17,214,537'),
('MYO10', 'myosin X ', 'Q9HD67', '4651', 'chr5: 16,661,914-16,936,276'),
('PPP1R12A', 'protein phosphatase 1 regulatory subunit 12A ', 'O14974', '4659', 'chr12: 79,773,563-79,935,460'),
('PPP1R12B', 'protein phosphatase 1 regulatory subunit 12B ', 'O60237', '4660', 'chr1: 202,348,699-202,592,706'),
('NACA', 'nascent polypeptide-associated complex alpha subunit ', 'E9PAV3', '4666', 'chr12: 56,712,428-56,731,628'),
('NACA', 'nascent polypeptide-associated complex alpha subunit ', 'Q13765', '4666', 'chr12: 56,712,428-56,731,628'),
('NAGLU', 'N-acetylglucosaminidase, alpha ', 'P54802', '4669', 'chr17: 42,536,172-42,544,449'),
('HNRNPM', 'heterogeneous nuclear ribonucleoprotein M ', 'P52272', '4670', 'chr19: 8,444,767-8,489,114'),
('NAP1L1', 'nucleosome assembly protein 1-like 1 ', 'P55209', '4673', 'chr12: 76,036,587-76,085,033'),
('NAP1L2', 'nucleosome assembly protein 1-like 2 ', 'Q9ULW6', '4674', 'chrX: 73,212,299-73,214,848'),
('RHOA', 'ras homolog family member A ', 'P61586', '387', 'chr3: 49,359,145-49,412,998'),
('NAP1L3', 'nucleosome assembly protein 1-like 3 ', 'Q99457', '4675', 'chrX: 93,670,930-93,673,568'),
('NAP1L4', 'nucleosome assembly protein 1-like 4 ', 'Q99733', '4676', 'chr11: 2,944,431-2,992,377'),
('NASP', 'nuclear autoantigenic sperm protein (histone-binding) ', 'P49321', '4678', 'chr1: 45,583,846-45,618,904'),
('NBL1', 'neuroblastoma 1, DAN family BMP antagonist ', 'P41271', '4681', 'chr1: 19,640,554-19,658,456'),
('NBN', 'nibrin ', 'O60934', '4683', 'chr8: 89,933,336-90,003,228'),
('NCAM1', 'neural cell adhesion molecule 1 ', 'P13591', '4684', 'chr11: 112,961,247-113,278,436'),
('NCAM2', 'neural cell adhesion molecule 2 ', 'O15394', '4685', 'chr21: 20,998,315-21,543,329'),
('NCBP1', 'nuclear cap binding protein subunit 1 ', 'Q09161', '4686', 'chr9: 97,633,626-97,673,748'),
('NCF2', 'neutrophil cytosolic factor 2 ', 'P19878', '4688', 'chr1: 183,555,563-183,590,876'),
('NCF4', 'neutrophil cytosolic factor 4 ', 'Q15080', '4689', 'chr22: 36,860,988-36,878,015'),
('RHOB', 'ras homolog family member B ', 'P62745', '388', 'chr2: 20,447,074-20,449,445'),
('NDP', 'Norrie disease (pseudoglioma) ', 'Q00604', '4693', 'chrX: 43,948,776-43,973,504'),
('NDUFA1', 'NADH:ubiquinone oxidoreductase subunit A1 ', 'O15239', '4694', 'chrX: 119,871,487-119,876,662'),
('NDUFA2', 'NADH:ubiquinone oxidoreductase subunit A2 ', 'O43678', '4695', 'chr5: 140,638,740-140,647,785'),
('NDUFA4', 'NDUFA4, mitochondrial complex associated ', 'O00483', '4697', 'chr7: 10,931,951-10,940,256'),
('NDUFA5', 'NADH:ubiquinone oxidoreductase subunit A5 ', 'Q16718', '4698', 'chr7: 123,536,997-123,558,255'),
('NDUFA7', 'NADH:ubiquinone oxidoreductase subunit A7 ', 'O95182', '4701', 'chr19: 8,308,768-8,321,396'),
('NDUFA10', 'NADH:ubiquinone oxidoreductase subunit A10 ', 'O95299', '4705', 'chr2: 239,892,450-240,025,402'),
('NDUFAB1', 'NADH:ubiquinone oxidoreductase subunit AB1 ', 'O14561', '4706', 'chr16: 23,581,002-23,596,356'),
('NDUFB4', 'NADH:ubiquinone oxidoreductase subunit B4 ', 'O95168', '4710', 'chr3: 120,596,309-120,602,500'),
('NDUFB6', 'NADH:ubiquinone oxidoreductase subunit B6 ', 'O95139', '4712', 'chr9: 32,552,999-32,573,184'),
('ARHGAP5', 'Rho GTPase activating protein 5 ', 'Q13017', '394', 'chr14: 32,076,114-32,159,728'),
('NDUFB7', 'NADH:ubiquinone oxidoreductase subunit B7 ', 'P17568', '4713', 'chr19: 14,566,078-14,572,062'),
('NDUFB8', 'NADH:ubiquinone oxidoreductase subunit B8 ', 'O95169', '4714', 'chr10: 100,523,740-100,530,000'),
('NDUFB10', 'NADH:ubiquinone oxidoreductase subunit B10 ', 'O96000', '4716', 'chr16: 1,959,508-1,961,975'),
('NDUFS1', 'NADH:ubiquinone oxidoreductase core subunit S1 ', 'P28331', '4719', 'chr2: 206,114,817-206,159,603'),
('NDUFS2', 'NADH:ubiquinone oxidoreductase core subunit S2 ', 'O75306', '4720', 'chr1: 161,197,104-161,214,395'),
('NDUFS4', 'NADH:ubiquinone oxidoreductase subunit S4 ', 'O43181', '4724', 'chr5: 53,560,633-53,683,340'),
('NDUFS6', 'NADH:ubiquinone oxidoreductase subunit S6 ', 'O75380', '4726', 'chr5: 1,801,400-1,816,605'),
('NDUFS8', 'NADH:ubiquinone oxidoreductase core subunit S8 ', 'O00217', '4728', 'chr11: 68,030,617-68,036,644'),
('NDUFV2', 'NADH:ubiquinone oxidoreductase core subunit V2 ', 'P19404', '4729', 'chr18: 9,102,630-9,134,345'),
('NDUFV3', 'NADH:ubiquinone oxidoreductase subunit V3 ', 'P56181', '4731', 'chr21: 42,879,644-42,913,304'),
('ACOX1', 'acyl-CoA oxidase 1, palmitoyl ', 'Q15067', '51', 'chr17: 75,941,507-75,979,363'),
('ARHGAP6', 'Rho GTPase activating protein 6 ', 'O43182', '395', 'chrX: 11,137,543-11,665,701'),
('DRG1', 'developmentally regulated GTP binding protein 1 ', 'Q9Y295', '4733', 'chr22: 31,399,523-31,530,634'),
('SEPT2', 'septin 2 ', 'Q15019', '4735', 'chr2: 241,315,100-241,354,027'),
('RPL10A', 'ribosomal protein L10a ', 'P62906', '4736', 'chr6: 35,468,408-35,470,785'),
('NEDD8', 'neural precursor cell expressed, developmentally down-regulated 8 ', 'Q15843', '4738', 'chr14: 24,216,852-24,232,454'),
('NEDD9', 'neural precursor cell expressed, developmentally down-regulated 9 ', 'Q14511', '4739', 'chr6: 11,183,298-11,382,348'),
('NEFH', 'neurofilament, heavy polypeptide ', 'P12036', '4744', 'chr22: 29,480,230-29,491,390'),
('NEK1', 'NIMA-related kinase 1 ', 'Q96PY6', '4750', 'chr4: 169,392,857-169,612,629'),
('NEK2', 'NIMA-related kinase 2 ', 'P51955', '4751', 'chr1: 211,658,657-211,675,630'),
('NEK3', 'NIMA-related kinase 3 ', 'P51956', '4752', 'chr13: 52,132,639-52,159,861'),
('NELL2', 'neural EGFL like 2 ', 'Q99435', '4753', 'chr12: 44,508,275-44,921,848'),
('ARHGDIA', 'Rho GDP dissociation inhibitor (GDI) alpha ', 'P52565', '396', 'chr17: 81,867,721-81,871,406'),
('NEU1', 'neuraminidase 1 (lysosomal sialidase) ', 'Q99519', '4758', 'chr6: 31,857,659-31,862,906'),
('NF2', 'neurofibromin 2 (merlin) ', 'P35240', '4771', 'chr22: 29,603,556-29,698,598'),
('NFATC1', 'nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 ', 'O95644', '4772', 'chr18: 79,395,856-79,529,325'),
('NFATC2', 'nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 ', 'Q13469', '4773', 'chr20: 51,386,957-51,562,831'),
('NFATC4', 'nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4 ', 'Q14934', '4776', 'chr14: 24,365,673-24,379,604'),
('NFE2L1', 'nuclear factor, erythroid 2 like 1 ', 'Q14494', '4779', 'chr17: 48,048,329-48,061,487'),
('NFIB', 'nuclear factor I/B ', 'O00712', '4781', 'chr9: 14,081,843-14,398,983'),
('NFIC', 'nuclear factor I/C (CCAAT-binding transcription factor) ', 'P08651', '4782', 'chr19: 3,314,403-3,469,217'),
('NFIL3', 'nuclear factor, interleukin 3 regulated ', 'Q16649', '4783', 'chr9: 91,409,045-91,423,862'),
('NFKB1', 'nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 ', 'P19838', '4790', 'chr4: 102,501,329-102,617,302'),
('ARHGDIB', 'Rho GDP dissociation inhibitor (GDI) beta ', 'P52566', '397', 'chr12: 14,942,017-14,961,728'),
('NFKBIL1', 'nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 1 ', 'Q9UBC1', '4795', 'chr6: 31,546,870-31,558,829'),
('TONSL', 'tonsoku-like, DNA repair protein ', 'Q96HA7', '4796', 'chr8: 144,428,775-144,444,444'),
('NFRKB', 'nuclear factor related to kappaB binding protein ', 'Q6P4R8', '4798', 'chr11: 129,863,636-129,895,590'),
('NFYB', 'nuclear transcription factor Y subunit beta ', 'P25208', '4801', 'chr12: 104,117,077-104,138,289'),
('NFYC', 'nuclear transcription factor Y subunit gamma ', 'Q13952', '4802', 'chr1: 40,691,648-40,771,603'),
('NGF', 'nerve growth factor (beta polypeptide) ', 'P01138', '4803', 'chr1: 115,285,918-115,338,236'),
('NGFR', 'nerve growth factor receptor ', 'P08138', '4804', 'chr17: 49,495,293-49,515,017'),
('SNU13', 'SNU13 homolog, small nuclear ribonucleoprotein (U4/U6.U5) ', 'P55769', '4809', 'chr22: 41,673,930-41,690,504'),
('NHS', 'NHS actin remodeling regulator ', 'Q6T4R5', '4810', 'chrX: 17,375,420-17,735,994'),
('NID1', 'nidogen 1 ', 'P14543', '4811', 'chr1: 235,975,830-236,065,162'),
('ARNT', 'aryl hydrocarbon receptor nuclear translocator ', 'P27540', '405', 'chr1: 150,809,705-150,876,768'),
('NKG7', 'natural killer cell granule protein 7 ', 'Q16617', '4818', 'chr19: 51,371,606-51,372,715'),
('NKTR', 'natural killer cell triggering receptor ', 'P30414', '4820', 'chr3: 42,600,614-42,648,741'),
('NMB', 'neuromedin B ', 'P08949', '4828', 'chr15: 84,655,129-84,658,563'),
('NME1', 'NME/NM23 nucleoside diphosphate kinase 1 ', 'P15531', '4830', 'chr17: 51,153,536-51,162,428'),
('NME4', 'NME/NM23 nucleoside diphosphate kinase 4 ', 'O00746', '4833', 'chr16: 396,725-410,367'),
('NQO2', 'NAD(P)H dehydrogenase, quinone 2 ', 'P16083', '4835', 'chr6: 2,987,987-3,028,869'),
('NNMT', 'nicotinamide N-methyltransferase ', 'P40261', '4837', 'chr11: 114,257,787-114,313,285'),
('NOP2', 'NOP2 nucleolar protein ', 'P46087', '4839', 'chr12: 6,556,863-6,568,691'),
('NONO', 'non-POU domain containing, octamer-binding ', 'Q15233', '4841', 'chrX: 71,283,192-71,301,168'),
('NOS3', 'nitric oxide synthase 3 ', 'P29474', '4846', 'chr7: 150,990,995-151,014,588'),
('ARNTL', 'aryl hydrocarbon receptor nuclear translocator like ', 'O00327', '406', 'chr11: 13,276,652-13,387,266'),
('CNOT3', 'CCR4-NOT transcription complex subunit 3 ', 'O75175', '4849', 'chr19: 54,137,728-54,155,681'),
('CNOT4', 'CCR4-NOT transcription complex subunit 4 ', 'O95628', '4850', 'chr7: 135,361,795-135,510,127'),
('NOTCH1', 'notch 1 ', 'P46531', '4851', 'chr9: 136,494,444-136,545,862'),
('NOTCH2', 'notch 2 ', 'Q04721', '4853', 'chr1: 119,911,553-120,069,626'),
('NOVA1', 'neuro-oncological ventral antigen 1 ', 'P51513', '4857', 'chr14: 26,443,093-26,597,754'),
('NOVA2', 'neuro-oncological ventral antigen 2 ', 'Q9UNW9', '4858', 'chr19: 45,933,734-45,973,546'),
('PNP', 'purine nucleoside phosphorylase ', 'P00491', '4860', 'chr14: 20,468,954-20,477,094'),
('NPAS2', 'neuronal PAS domain protein 2 ', 'Q99743', '4862', 'chr2: 100,820,152-100,996,829'),
('NPAT', 'nuclear protein, ataxia-telangiectasia locus ', 'Q14207', '4863', 'chr11: 108,157,215-108,222,642'),
('NPC1', 'Niemann-Pick disease, type C1 ', 'O15118', '4864', 'chr18: 23,506,184-23,586,898'),
('ARSA', 'arylsulfatase A ', 'P15289', '410', 'chr22: 50,622,754-50,628,173'),
('NPHP1', 'nephronophthisis 1 (juvenile) ', 'O15259', '4867', 'chr2: 110,122,311-110,205,066'),
('NPM1', 'nucleophosmin (nucleolar phosphoprotein B23, numatrin) ', 'P06748', '4869', 'chr5: 171,387,116-171,411,137'),
('NPPB', 'natriuretic peptide B ', 'P16860', '4879', 'chr1: 11,857,464-11,858,931'),
('NPR2', 'natriuretic peptide receptor 2 ', 'P20594', '4882', 'chr9: 35,792,154-35,809,732'),
('NPR3', 'natriuretic peptide receptor 3 ', 'P17342', '4883', 'chr5: 32,689,070-32,791,724'),
('NPTX2', 'neuronal pentraxin II ', 'P47972', '4885', 'chr7: 98,617,297-98,629,868'),
('NPY1R', 'neuropeptide Y receptor Y1 ', 'P25929', '4886', 'chr4: 163,323,961-163,344,832'),
('NPY2R', 'neuropeptide Y receptor Y2 ', 'P49146', '4887', 'chr4: 155,208,629-155,217,078'),
('NPY6R', 'neuropeptide Y receptor Y6 (pseudogene)', 'Q99463', '4888', 'chr5: 137,801,193-137,810,751'),
('NPY5R', 'neuropeptide Y receptor Y5 ', 'Q15761', '4889', 'chr4: 163,343,939-163,351,934'),
('ARSB', 'arylsulfatase B ', 'P15848', '411', 'chr5: 78,777,209-78,986,087'),
('SLC11A2', 'solute carrier family 11 (proton-coupled divalent metal ion transporter), member 2 ', 'P49281', '4891', 'chr12: 50,979,401-51,028,566'),
('NRAS', 'neuroblastoma RAS viral (v-ras) oncogene homolog ', 'P01111', '4893', 'chr1: 114,704,469-114,716,894'),
('NRCAM', 'neuronal cell adhesion molecule ', 'Q92823', '4897', 'chr7: 108,147,623-108,456,717'),
('NRDC', 'nardilysin convertase ', 'O43847', '4898', 'chr1: 51,789,191-51,878,937'),
('YBX1', 'Y-box binding protein 1 ', 'P67809', '4904', 'chr1: 42,682,427-42,702,349'),
('NSF', 'N-ethylmaleimide sensitive factor ', 'P46459', '4905', 'chr17: 46,590,669-46,757,464'),
('NT5E', '5\'-nucleotidase, ecto (CD73) ', 'P21589', '4907', 'chr6: 85,449,584-85,495,791'),
('NTHL1', 'nth-like DNA glycosylase 1 ', 'P78549', '4913', 'chr16: 2,039,815-2,047,866'),
('NTRK1', 'neurotrophic tyrosine kinase, receptor, type 1 ', 'P04629', '4914', 'chr1: 156,815,640-156,881,850'),
('NTRK2', 'neurotrophic tyrosine kinase, receptor, type 2 ', 'Q16620', '4915', 'chr9: 84,668,551-85,027,070'),
('STS', 'steroid sulfatase (microsomal), isozyme S ', 'P08842', '412', 'chrX: 7,219,456-7,354,810'),
('ROR1', 'receptor tyrosine kinase-like orphan receptor 1 ', 'Q01973', '4919', 'chr1: 63,774,022-64,181,498'),
('NTS', 'neurotensin ', 'P30990', '4922', 'chr12: 85,874,295-85,882,992'),
('NUCB1', 'nucleobindin 1 ', 'Q02818', '4924', 'chr19: 48,900,050-48,923,372'),
('NUCB2', 'nucleobindin 2 ', 'P80303', '4925', 'chr11: 17,208,153-17,349,974'),
('NUP88', 'nucleoporin 88kDa ', 'Q99567', '4927', 'chr17: 5,360,963-5,420,160'),
('NR4A2', 'nuclear receptor subfamily 4 group A member 2 ', 'P43354', '4929', 'chr2: 156,324,432-156,342,348'),
('OAZ1', 'ornithine decarboxylase antizyme 1 ', 'P54368', '4946', 'chr19: 2,269,509-2,273,490'),
('OAZ2', 'ornithine decarboxylase antizyme 2 ', 'O95190', '4947', 'chr15: 64,687,573-64,703,281'),
('OCRL', 'oculocerebrorenal syndrome of Lowe ', 'Q01968', '4952', 'chrX: 129,539,849-129,592,561'),
('ODC1', 'ornithine decarboxylase 1 ', 'P11926', '4953', 'chr2: 10,439,968-10,448,504'),
('ARSD', 'arylsulfatase D ', 'P51689', '414', 'chrX: 2,903,970-2,929,351'),
('ODF2', 'outer dense fiber of sperm tails 2 ', 'Q5BJF6', '4957', 'chr9: 128,455,186-128,501,292'),
('OMD', 'osteomodulin ', 'Q99983', '4958', 'chr9: 92,414,245-92,424,461'),
('OGDH', 'oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) ', 'Q02218', '4967', 'chr7: 44,606,572-44,709,066'),
('OGN', 'osteoglycin ', 'P20774', '4969', 'chr9: 92,383,967-92,404,696'),
('OLR1', 'oxidized low density lipoprotein (lectin-like) receptor 1 ', 'P78380', '4973', 'chr12: 10,158,301-10,172,138'),
('OPA1', 'optic atrophy 1 (autosomal dominant) ', 'O60313', '4976', 'chr3: 193,593,144-193,697,823'),
('TNFRSF11B', 'tumor necrosis factor receptor superfamily member 11b ', 'O00300', '4982', 'chr8: 118,923,557-118,952,200'),
('OPRL1', 'opiate receptor-like 1 ', 'P41146', '4987', 'chr20: 64,080,173-64,100,643'),
('ORC1', 'origin recognition complex subunit 1 ', 'Q13415', '4998', 'chr1: 52,372,829-52,404,459'),
('ORC5', 'origin recognition complex subunit 5 ', 'O43913', '5001', 'chr7: 104,126,341-104,208,047'),
('ASAH1', 'N-acylsphingosine amidohydrolase (acid ceramidase) 1 ', 'Q13510', '427', 'chr8: 18,055,992-18,084,998'),
('SLC22A18', 'solute carrier family 22 member 18 ', 'Q96BI1', '5002', 'chr11: 2,899,721-2,925,246'),
('ORM1', 'orosomucoid 1 ', 'P02763', '5004', 'chr9: 114,323,056-114,326,475'),
('ORM2', 'orosomucoid 2 ', 'P19652', '5005', 'chr9: 114,329,869-114,333,252'),
('OSBP', 'oxysterol binding protein ', 'P22059', '5007', 'chr11: 59,574,398-59,616,144'),
('OTX2', 'orthodenticle homeobox 2 ', 'P32243', '5015', 'chr14: 56,799,905-56,810,479'),
('OXCT1', '3-oxoacid CoA-transferase 1 ', 'P55809', '5019', 'chr5: 41,730,065-41,870,519'),
('OXTR', 'oxytocin receptor ', 'P30559', '5021', 'chr3: 8,750,408-8,769,628'),
('P2RX4', 'purinergic receptor P2X, ligand gated ion channel, 4 ', 'Q99571', '5025', 'chr12: 121,209,857-121,234,106'),
('P4HA1', 'prolyl 4-hydroxylase, alpha polypeptide I ', 'P13674', '5033', 'chr10: 73,007,217-73,096,974'),
('P4HB', 'prolyl 4-hydroxylase, beta polypeptide ', 'P07237', '5034', 'chr17: 81,843,159-81,860,694'),
('ACPP', 'acid phosphatase, prostate ', 'P15309', '55', 'chr3: 132,317,367-132,368,298'),
('ASCL1', 'achaete-scute family bHLH transcription factor 1 ', 'P50553', '429', 'chr12: 102,957,686-102,960,516'),
('PA2G4', 'proliferation-associated 2G4 ', 'Q9UQ80', '5036', 'chr12: 56,104,319-56,113,907'),
('PEBP1', 'phosphatidylethanolamine binding protein 1 ', 'P30086', '5037', 'chr12: 118,135,858-118,145,584'),
('PABPC3', 'poly(A) binding protein, cytoplasmic 3 ', 'Q9H361', '5042', 'chr13: 25,095,868-25,099,254'),
('FURIN', 'furin (paired basic amino acid cleaving enzyme) ', 'P09958', '5045', 'chr15: 90,868,592-90,883,458'),
('PCSK6', 'proprotein convertase subtilisin/kexin type 6 ', 'P29122', '5046', 'chr15: 101,297,142-101,525,202'),
('PAEP', 'progestagen-associated endometrial protein ', 'P09466', '5047', 'chr9: 135,561,756-135,566,955'),
('PAFAH1B2', 'platelet activating factor acetylhydrolase 1b catalytic subunit 2 ', 'P68402', '5049', 'chr11: 117,144,267-117,176,894'),
('PAFAH1B3', 'platelet activating factor acetylhydrolase 1b catalytic subunit 3 ', 'Q15102', '5050', 'chr19: 42,297,033-42,303,546'),
('PRDX1', 'peroxiredoxin 1 ', 'Q06830', '5052', 'chr1: 45,511,036-45,523,047'),
('SERPINE1', 'serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 ', 'P05121', '5054', 'chr7: 101,127,089-101,139,266'),
('ASNA1', 'arsA arsenite transporter, ATP-binding, homolog 1 (bacterial) ', 'O43681', '439', 'chr19: 12,737,139-12,748,323'),
('PAK2', 'p21 protein (Cdc42/Rac)-activated kinase 2 ', 'Q13177', '5062', 'chr3: 196,739,857-196,832,647'),
('PAK3', 'p21 protein (Cdc42/Rac)-activated kinase 3 ', 'O75914', '5063', 'chrX: 110,944,285-111,227,361'),
('PAM', 'peptidylglycine alpha-amidating monooxygenase ', 'P19021', '5066', 'chr5: 102,753,981-103,031,105'),
('CNTN3', 'contactin 3 ', 'Q9P232', '5067', 'chr3: 74,262,568-74,521,140'),
('PAPPA', 'pregnancy-associated plasma protein A, pappalysin 1 ', 'Q13219', '5069', 'chr9: 116,153,804-116,402,322'),
('PARK2', 'parkin RBR E3 ubiquitin protein ligase ', 'O60260', '5071', 'chr6: 161,347,420-162,727,771'),
('PARN', 'poly(A)-specific ribonuclease ', 'O95453', '5073', 'chr16: 14,435,701-14,632,728'),
('PAWR', 'PRKC, apoptosis, WT1, regulator ', 'Q96IZ0', '5074', 'chr12: 79,574,979-79,691,097'),
('PAX4', 'paired box 4 ', 'O43316', '5078', 'chr7: 127,610,292-127,618,114'),
('PDCL', 'phosducin like ', 'Q13371', '5082', 'chr9: 122,798,389-122,828,631'),
('ASNS', 'asparagine synthetase (glutamine-hydrolyzing) ', 'P08243', '440', 'chr7: 97,852,118-97,872,542'),
('PBX1', 'pre-B-cell leukemia homeobox 1 ', 'P40424', '5087', 'chr1: 164,555,584-164,899,296'),
('PBX2', 'pre-B-cell leukemia homeobox 2 ', 'P40425', '5089', 'chr6: 32,184,741-32,190,186'),
('PC', 'pyruvate carboxylase ', 'P11498', '5091', 'chr11: 66,848,233-66,958,376'),
('PCBP1', 'poly(rC) binding protein 1 ', 'Q15365', '5093', 'chr2: 70,087,454-70,089,203'),
('PCCA', 'propionyl-CoA carboxylase alpha subunit ', 'P05165', '5095', 'chr13: 100,089,015-100,530,437'),
('PCDH1', 'protocadherin 1 ', 'Q08174', '5097', 'chr5: 141,853,111-141,879,246'),
('PCDHGC3', 'protocadherin gamma subfamily C, 3 ', 'Q9UN70', '5098', 'chr5: 141,475,947-141,512,979'),
('PCDH9', 'protocadherin 9 ', 'Q9HC56', '5101', 'chr13: 66,302,834-67,230,445'),
('SERPINA5', 'serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5 ', 'P05154', '5104', 'chr14: 94,561,442-94,593,120'),
('PCK1', 'phosphoenolpyruvate carboxykinase 1 ', 'P35558', '5105', 'chr20: 57,561,080-57,568,112'),
('ASPH', 'aspartate beta-hydroxylase ', 'Q12797', '444', 'chr8: 61,500,556-61,714,640'),
('PCK2', 'phosphoenolpyruvate carboxykinase 2 (mitochondrial) ', 'Q16822', '5106', 'chr14: 24,094,053-24,110,598'),
('PCM1', 'pericentriolar material 1 ', 'Q15154', '5108', 'chr8: 17,922,840-18,029,944'),
('PCMT1', 'protein-L-isoaspartate (D-aspartate) O-methyltransferase ', 'P22061', '5110', 'chr6: 149,749,443-149,811,420'),
('PCNA', 'proliferating cell nuclear antigen ', 'P12004', '5111', 'chr20: 5,114,953-5,126,626'),
('PCNT', 'pericentrin ', 'O95613', '5116', 'chr21: 46,324,122-46,445,769'),
('PCOLCE', 'procollagen C-endopeptidase enhancer ', 'Q15113', '5118', 'chr7: 100,602,177-100,608,175'),
('PCOS1', 'polycystic ovary syndrome 1', 'N/A', '5120', 'chr19'),
('PCSK1', 'proprotein convertase subtilisin/kexin type 1 ', 'P29120', '5122', 'chr5: 96,390,415-96,434,143'),
('PCSK5', 'proprotein convertase subtilisin/kexin type 5 ', 'Q92824', '5125', 'chr9: 75,890,644-76,362,339'),
('CDK16', 'cyclin-dependent kinase 16 ', 'Q00536', '5127', 'chrX: 47,217,860-47,229,997'),
('ASS1', 'argininosuccinate synthase 1 ', 'P00966', '445', 'chr9: 130,444,929-130,501,274'),
('PCYT1A', 'phosphate cytidylyltransferase 1, choline, alpha ', 'P49585', '5130', 'chr3: 196,214,222-196,287,957'),
('PDC', 'phosducin ', 'P20941', '5132', 'chr1: 186,443,566-186,461,122'),
('PDCD2', 'programmed cell death 2 ', 'Q16342', '5134', 'chr6: 170,575,295-170,584,692'),
('PDE3A', 'phosphodiesterase 3A ', 'Q14432', '5139', 'chr12: 20,369,245-20,684,381'),
('PDE3B', 'phosphodiesterase 3B ', 'Q13370', '5140', 'chr11: 14,643,723-14,872,044'),
('PDE4C', 'phosphodiesterase 4C ', 'Q08493', '5143', 'chr19: 18,207,961-18,255,419'),
('PDE4D', 'phosphodiesterase 4D ', 'Q08499', '5144', 'chr5: 58,969,038-60,522,120'),
('PDE6D', 'phosphodiesterase 6D ', 'O43924', '5147', 'chr2: 231,732,425-231,786,272'),
('PDE7A', 'phosphodiesterase 7A ', 'Q13946', '5150', 'chr8: 65,717,510-65,842,322'),
('PDE8A', 'phosphodiesterase 8A ', 'O60658', '5151', 'chr15: 84,980,440-85,139,145'),
('SERPINC1', 'serpin peptidase inhibitor, clade C (antithrombin), member 1 ', 'P01008', '462', 'chr1: 173,903,804-173,917,378'),
('PDE9A', 'phosphodiesterase 9A ', 'O76083', '5152', 'chr21: 42,653,636-42,775,509'),
('PDGFA', 'platelet-derived growth factor alpha polypeptide ', 'P04085', '5154', 'chr7: 497,258-520,296'),
('PDGFB', 'platelet-derived growth factor beta polypeptide ', 'P01127', '5155', 'chr22: 39,223,359-39,244,751'),
('PDGFRA', 'platelet-derived growth factor receptor, alpha polypeptide ', 'P16234', '5156', 'chr4: 54,229,097-54,298,247'),
('PDGFRB', 'platelet-derived growth factor receptor, beta polypeptide ', 'P09619', '5159', 'chr5: 150,113,837-150,155,872'),
('PDHA1', 'pyruvate dehydrogenase (lipoamide) alpha 1 ', 'P08559', '5160', 'chrX: 19,343,893-19,361,705'),
('PDHB', 'pyruvate dehydrogenase (lipoamide) beta ', 'P11177', '5162', 'chr3: 58,427,630-58,433,857'),
('PDK1', 'pyruvate dehydrogenase kinase, isozyme 1 ', 'Q15118', '5163', 'chr2: 172,555,373-172,608,669'),
('PDK4', 'pyruvate dehydrogenase kinase, isozyme 4 ', 'Q16654', '5166', 'chr7: 95,583,499-95,596,491'),
('ENPP1', 'ectonucleotide pyrophosphatase/phosphodiesterase 1 ', 'P22413', '5167', 'chr6: 131,808,016-131,895,155'),
('ZFHX3', 'zinc finger homeobox 3 ', 'Q15911', '463', 'chr16: 72,782,885-73,144,447'),
('ENPP2', 'ectonucleotide pyrophosphatase/phosphodiesterase 2 ', 'Q13822', '5168', 'chr8: 119,557,086-119,673,453'),
('ENPP3', 'ectonucleotide pyrophosphatase/phosphodiesterase 3 ', 'O14638', '5169', 'chr6: 131,628,442-131,747,418'),
('PECAM1', 'platelet/endothelial cell adhesion molecule 1 ', 'P16284', '5175', 'chr17: 64,319,415-64,413,776'),
('SERPINF1', 'serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member', 'P36955', '5176', 'chr17: 1,761,959-1,777,574'),
('PEG3', 'paternally expressed 3 ', 'Q9GZU2', '5178', 'chr19: 56,810,083-56,840,728'),
('PENK', 'proenkephalin ', 'P01210', '5179', 'chr8: 56,436,674-56,446,734'),
('PER1', 'period circadian clock 1 ', 'O15534', '5187', 'chr17: 8,140,472-8,156,506'),
('GATB', 'glutamyl-tRNA(Gln) amidotransferase, subunit B ', 'O75879', '5188', 'chr4: 151,670,504-151,761,023'),
('PEX12', 'peroxisomal biogenesis factor 12 ', 'O00623', '5193', 'chr17: 35,574,795-35,578,863'),
('PEX14', 'peroxisomal biogenesis factor 14 ', 'O75381', '5195', 'chr1: 10,472,288-10,630,758'),
('ATF1', 'activating transcription factor 1 ', 'P18846', '466', 'chr12: 50,763,710-50,821,122'),
('PF4', 'platelet factor 4 ', 'P02776', '5196', 'chr4: 73,981,077-73,982,124'),
('PFAS', 'phosphoribosylformylglycinamidine synthase ', 'O15067', '5198', 'chr17: 8,247,618-8,270,491'),
('CFP', 'complement factor properdin ', 'P27918', '5199', 'chrX: 47,623,172-47,630,305'),
('PFDN4', 'prefoldin subunit 4 ', 'Q9NQP4', '5203', 'chr20: 54,207,847-54,228,052'),
('PFDN5', 'prefoldin subunit 5 ', 'Q99471', '5204', 'chr12: 53,295,291-53,299,450'),
('ATP8B1', 'ATPase, aminophospholipid transporter, class I, type 8B, member 1 ', 'O43520', '5205', 'chr18: 57,646,426-57,803,101'),
('PFKFB1', '6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1 ', 'P16118', '5207', 'chrX: 54,932,961-54,998,534'),
('PFKFB2', '6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 ', 'O60825', '5208', 'chr1: 207,034,366-207,081,024'),
('PFKFB3', '6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 ', 'Q16875', '5209', 'chr10: 6,144,934-6,254,644'),
('PFKFB4', '6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 ', 'Q16877', '5210', 'chr3: 48,517,684-48,562,015'),
('ATF3', 'activating transcription factor 3 ', 'P18847', '467', 'chr1: 212,565,334-212,620,777'),
('PFKL', 'phosphofructokinase, liver ', 'P17858', '5211', 'chr21: 44,300,051-44,327,376'),
('PFN1', 'profilin 1 ', 'P07737', '5216', 'chr17: 4,945,652-4,949,061'),
('PGAM1', 'phosphoglycerate mutase 1 ', 'P18669', '5223', 'chr10: 97,426,160-97,433,441'),
('PGD', 'phosphogluconate dehydrogenase ', 'P52209', '5226', 'chr1: 10,398,592-10,420,144'),
('PGF', 'placental growth factor ', 'P49763', '5228', 'chr14: 74,941,834-74,955,784'),
('PGGT1B', 'protein geranylgeranyltransferase type I, beta subunit ', 'P53609', '5229', 'chr5: 115,204,012-115,262,872'),
('PGK1', 'phosphoglycerate kinase 1 ', 'P00558', '5230', 'chrX: 78,065,188-78,129,296'),
('PGM1', 'phosphoglucomutase 1 ', 'P36871', '5236', 'chr1: 63,593,276-63,660,245'),
('PGR', 'progesterone receptor ', 'P06401', '5241', 'chr11: 101,029,624-101,130,524'),
('PHB', 'prohibitin ', 'P35232', '5245', 'chr17: 49,404,049-49,414,905'),
('ATF4', 'activating transcription factor 4 ', 'P18848', '468', 'chr22: 39,519,695-39,522,685'),
('SLC25A3', 'solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 3 ', 'Q00325', '5250', 'chr12: 98,593,591-98,606,379'),
('PHKA1', 'phosphorylase kinase, alpha 1 (muscle) ', 'P46020', '5255', 'chrX: 72,578,814-72,714,319'),
('PHKA2', 'phosphorylase kinase, alpha 2 (liver) ', 'P46019', '5256', 'chrX: 18,892,300-18,984,598'),
('SERPINA1', 'serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 ', 'P01009', '5265', 'chr14: 94,376,747-94,390,693'),
('SERPINB5', 'serpin peptidase inhibitor, clade B (ovalbumin), member 5 ', 'P36952', '5268', 'chr18: 63,476,761-63,505,085'),
('SERPINE2', 'serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2 ', 'P07093', '5270', 'chr2: 223,975,112-224,039,319'),
('SERPINB9', 'serpin peptidase inhibitor, clade B (ovalbumin), member 9 ', 'P50453', '5272', 'chr6: 2,887,266-2,903,280'),
('SERPINI1', 'serpin peptidase inhibitor, clade I (neuroserpin), member 1 ', 'Q99574', '5274', 'chr3: 167,735,243-167,825,568'),
('SERPINB13', 'serpin peptidase inhibitor, clade B (ovalbumin), member 13 ', 'Q9UIV8', '5275', 'chr18: 63,586,989-63,604,639'),
('PIGA', 'phosphatidylinositol glycan anchor biosynthesis class A ', 'P37287', '5277', 'chrX: 15,319,451-15,335,580'),
('ACTA2', 'actin, alpha 2, smooth muscle, aorta ', 'P62736', '59', 'chr10: 88,935,074-88,991,339'),
('RERE', 'arginine-glutamic acid dipeptide (RE) repeats ', 'Q9P2R6', '473', 'chr1: 8,352,397-8,817,643'),
('PIGC', 'phosphatidylinositol glycan anchor biosynthesis class C ', 'Q92535', '5279', 'chr1: 172,370,189-172,444,086'),
('PIGF', 'phosphatidylinositol glycan anchor biosynthesis class F ', 'Q07326', '5281', 'chr2: 46,580,937-46,617,119'),
('PIGH', 'phosphatidylinositol glycan anchor biosynthesis class H ', 'Q14442', '5283', 'chr14: 67,581,955-67,600,287'),
('PIK3C2A', 'phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha ', 'O00443', '5286', 'chr11: 17,077,730-17,207,983'),
('PIK3C3', 'phosphatidylinositol 3-kinase catalytic subunit type 3 ', 'Q8NEB9', '5289', 'chr18: 41,955,206-42,087,830'),
('PIK3CA', 'phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha ', 'P42336', '5290', 'chr3: 179,148,114-179,240,093'),
('PIK3CB', 'phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta ', 'P42338', '5291', 'chr3: 138,652,699-138,834,938'),
('PIK3CD', 'phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta ', 'O00329', '5293', 'chr1: 9,651,732-9,729,114'),
('PIK3CG', 'phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma ', 'P48736', '5294', 'chr7: 106,865,278-106,907,145'),
('PIK3R1', 'phosphoinositide-3-kinase regulatory subunit 1 ', 'P27986', '5295', 'chr5: 68,215,720-68,301,821'),
('ATOX1', 'antioxidant 1 copper chaperone ', 'O00244', '475', 'chr5: 151,742,316-151,772,532'),
('PI4KB', 'phosphatidylinositol 4-kinase, catalytic, beta ', 'Q9UBF8', '5298', 'chr1: 151,291,797-151,327,715'),
('PIN4', 'peptidylprolyl cis/trans isomerase, NIMA-interacting 4 ', 'Q9Y237', '5303', 'chrX: 72,181,353-72,302,926'),
('PIP4K2A', 'phosphatidylinositol-5-phosphate 4-kinase, type II, alpha ', 'P48426 ', '5305', 'chr10: 22,534,849-22,714,555'),
('PITPNA', 'phosphatidylinositol transfer protein alpha ', 'Q00169', '5306', 'chr17: 1,517,718-1,562,816'),
('PITX2', 'paired-like homeodomain 2 ', 'Q99697', '5308', 'chr4: 110,617,423-110,642,123'),
('PKD1', 'polycystic kidney disease 1 (autosomal dominant) ', 'P98161', '5310', 'chr16: 2,088,710-2,135,898'),
('PKD2', 'polycystic kidney disease 2 (autosomal dominant) ', 'Q13563', '5311', 'chr4: 88,007,668-88,077,777'),
('PKM', 'pyruvate kinase, muscle ', 'P14618', '5315', 'chr15: 72,199,029-72,231,822'),
('PKP2', 'plakophilin 2 ', 'Q99959', '5318', 'chr12: 32,790,745-32,896,840'),
('PLA2G2A', 'phospholipase A2 group IIA ', 'P14555', '5320', 'chr1: 19,975,431-19,980,416'),
('ATP1A2', 'ATPase, Na+/K+ transporting, alpha 2 polypeptide ', 'P50993', '477', 'chr1: 160,115,759-160,143,591'),
('PLA2G4A', 'phospholipase A2 group IVA ', 'P47712', '5321', 'chr1: 186,828,953-186,988,981'),
('PLA2G5', 'phospholipase A2 group V ', 'P39877', '5322', 'chr1: 20,028,179-20,091,190'),
('PLAG1', 'PLAG1 zinc finger ', 'Q6DJT9', '5324', 'chr8: 56,160,904-56,211,324'),
('PLAGL1', 'PLAG1 like zinc finger 1 ', 'Q9UM63', '5325', 'chr6: 143,940,300-144,064,599'),
('PLAT', 'plasminogen activator, tissue ', 'P00750', '5327', 'chr8: 42,175,233-42,207,724'),
('PLAU', 'plasminogen activator, urokinase ', 'P00749', '5328', 'chr10: 73,909,177-73,917,497'),
('PLAUR', 'plasminogen activator, urokinase receptor ', 'Q03405', '5329', 'chr19: 43,646,095-43,670,547'),
('PLCD1', 'phospholipase C delta 1 ', 'P51178', '5333', 'chr3: 38,007,496-38,029,762'),
('PLCL1', 'phospholipase C like 1 ', 'Q15111', '5334', 'chr2: 197,804,702-198,572,581'),
('PLCG2', 'phospholipase C gamma 2 ', 'P16885', '5336', 'chr16: 81,739,097-81,962,693'),
('ATP12A', 'ATPase, H+/K+ transporting, nongastric, alpha polypeptide ', 'P54707', '479', 'chr13: 24,680,411-24,712,493'),
('PLD1', 'phospholipase D1 ', 'Q13393', '5337', 'chr3: 171,600,405-171,810,950'),
('PLG', 'plasminogen ', 'P00747', '5340', 'chr6: 160,702,238-160,753,315'),
('PLIN1', 'perilipin 1 ', 'O60240', '5346', 'chr15: 89,664,365-89,679,427'),
('PLK1', 'polo-like kinase 1 ', 'P53350', '5347', 'chr16: 23,677,656-23,690,367'),
('FXYD1', 'FXYD domain containing ion transport regulator 1 ', 'O00168', '5348', 'chr19: 35,138,808-35,143,109'),
('PLN', 'phospholamban ', 'P26678', '5350', 'chr6: 118,548,298-118,560,730'),
('PLOD1', 'procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1 ', 'Q02809', '5351', 'chr1: 11,934,205-11,975,538'),
('PLOD2', 'procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2 ', 'O00469', '5352', 'chr3: 146,069,440-146,163,653'),
('PLP1', 'proteolipid protein 1 ', 'P60201', '5354', 'chrX: 103,773,718-103,792,619'),
('PLRG1', 'pleiotropic regulator 1 ', 'O43660', '5356', 'chr4: 154,535,006-154,550,435'),
('ATP1B1', 'ATPase, Na+/K+ transporting, beta 1 polypeptide ', 'P05026', '481', 'chr1: 169,105,697-169,132,722'),
('PLS1', 'plastin 1 ', 'Q14651', '5357', 'chr3: 142,596,387-142,713,664'),
('PLSCR1', 'phospholipid scramblase 1 ', 'O15162', '5359', 'chr3: 146,515,180-146,544,864'),
('PLXNA1', 'plexin A1 ', 'Q9UIW2', '5361', 'chr3: 126,988,594-127,037,392'),
('PLXNA2', 'plexin A2 ', 'O75051', '5362', 'chr1: 208,022,242-208,244,320'),
('PMAIP1', 'phorbol-12-myristate-13-acetate-induced protein 1 ', 'Q13794', '5366', 'chr18: 59,899,948-59,904,306'),
('PMM2', 'phosphomannomutase 2 ', 'O15305', '5373', 'chr16: 8,788,823-8,849,331'),
('PMP2', 'peripheral myelin protein 2 ', 'P02689', '5375', 'chr8: 81,440,326-81,447,523'),
('PMP22', 'peripheral myelin protein 22 ', 'Q01453', '5376', 'chr17: 15,229,777-15,265,326'),
('PMS1', 'PMS1 homolog 1, mismatch repair system component ', 'P54277', '5378', 'chr2: 189,784,085-189,877,629'),
('PMS2P5', 'PMS1 homolog 2, mismatch repair system component pseudogene 5', 'A8MQ11', '5383', 'chr7: 74,894,116-74,897,835'),
('ATP1B3', 'ATPase, Na+/K+ transporting, beta 3 polypeptide ', 'P54709', '483', 'chr3: 141,876,124-141,926,514'),
('PMS2P3', 'PMS1 homolog 2, mismatch repair system component pseudogene 3', 'Q13401', '5387', 'chr7: 75,502,930-75,528,148'),
('EXOSC9', 'exosome component 9 ', 'Q06265', '5393', 'chr4: 121,801,317-121,817,021'),
('PNMT', 'phenylethanolamine N-methyltransferase ', 'P11086', '5409', 'chr17: 39,667,981-39,670,475'),
('PNN', 'pinin, desmosome associated protein ', 'Q9H307', '5411', 'chr14: 39,175,183-39,183,218'),
('POLA1', 'polymerase (DNA directed), alpha 1, catalytic subunit ', 'P09884', '5422', 'chrX: 24,693,919-24,996,986'),
('POLD1', 'polymerase (DNA directed), delta 1, catalytic subunit ', 'P28340', '5424', 'chr19: 50,384,204-50,418,018'),
('POLE', 'polymerase (DNA directed), epsilon, catalytic subunit ', 'Q07864', '5426', 'chr12: 132,623,753-132,687,365'),
('POLE2', 'polymerase (DNA directed), epsilon 2, accessory subunit ', 'P56282', '5427', 'chr14: 49,643,555-49,688,422'),
('POLG', 'polymerase (DNA directed), gamma ', 'P54098', '5428', 'chr15: 89,305,198-89,334,861'),
('POLH', 'polymerase (DNA directed), eta ', 'Q9Y253', '5429', 'chr6: 43,576,150-43,615,660'),
('ATP2A2', 'ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 ', 'P16615', '488', 'chr12: 110,280,756-110,351,093'),
('POLR2A', 'polymerase (RNA) II (DNA directed) polypeptide A, 220kDa ', 'P24928', '5430', 'chr17: 7,484,366-7,514,616'),
('POLR2B', 'polymerase (RNA) II (DNA directed) polypeptide B, 140kDa ', 'P30876', '5431', 'chr4: 56,977,722-57,031,168'),
('POLR2D', 'polymerase (RNA) II (DNA directed) polypeptide D ', 'O15514', '5433', 'chr2: 127,843,551-127,858,157'),
('POLR2E', 'polymerase (RNA) II (DNA directed) polypeptide E, 25kDa ', 'P19388', '5434', 'chr19: 1,086,579-1,095,380'),
('POLR2G', 'polymerase (RNA) II (DNA directed) polypeptide G ', 'P62487', '5436', 'chr11: 62,761,544-62,766,710'),
('POLR2I', 'polymerase (RNA) II (DNA directed) polypeptide I, 14.5kDa ', 'P36954', '5438', 'chr19: 36,113,710-36,115,346'),
('POLR2J', 'polymerase (RNA) II (DNA directed) polypeptide J, 13.3kDa ', 'P52435', '5439', 'chr7: 102,473,118-102,478,907'),
('POLR2K', 'polymerase (RNA) II (DNA directed) polypeptide K, 7.0kDa ', 'P53803', '5440', 'chr8: 100,150,584-100,154,002'),
('POLR2L', 'polymerase (RNA) II (DNA directed) polypeptide L, 7.6kDa ', 'P62875', '5441', 'chr11: 837,356-842,545'),
('POMC', 'proopiomelanocortin ', 'P01189', '5443', 'chr2: 25,160,853-25,168,903'),
('ATP2B1', 'ATPase, Ca++ transporting, plasma membrane 1 ', 'P20020', '490', 'chr12: 89,588,049-89,709,300'),
('PON1', 'paraoxonase 1 ', 'P27169', '5444', 'chr7: 95,297,676-95,324,707'),
('POU2F1', 'POU class 2 homeobox 1 ', 'P14859', '5451', 'chr1: 167,220,829-167,427,345'),
('POU3F1', 'POU class 3 homeobox 1 ', 'Q03052', '5453', 'chr1: 38,044,611-38,046,794'),
('POU5F1', 'POU class 5 homeobox 1 ', 'Q01860', '5460', 'chr6: 31,164,337-31,180,731'),
('POU6F1', 'POU class 6 homeobox 1 ', 'Q14863', '5463', 'chr12: 51,186,936-51,217,708'),
('PPARA', 'peroxisome proliferator-activated receptor alpha ', 'Q07869', '5465', 'chr22: 46,150,521-46,243,756'),
('PPARD', 'peroxisome proliferator-activated receptor delta ', 'Q03181', '5467', 'chr6: 35,342,558-35,428,191'),
('PPARG', 'peroxisome proliferator-activated receptor gamma ', 'P37231', '5468', 'chr3: 12,287,368-12,434,356'),
('PPAT', 'phosphoribosyl pyrophosphate amidotransferase ', 'Q06203', '5471', 'chr4: 56,393,362-56,435,615'),
('PPBP', 'pro-platelet basic protein ', 'P02775', '5473', 'chr4: 73,987,038-73,988,197'),
('ATP2B4', 'ATPase, Ca++ transporting, plasma membrane 4 ', 'P23634', '493', 'chr1: 203,626,561-203,744,081'),
('PPIA', 'peptidylprolyl isomerase A (cyclophilin A) ', 'P62937', '5478', 'chr7: 44,796,680-44,824,564'),
('PPIB', 'peptidylprolyl isomerase B (cyclophilin B) ', 'P23284', '5479', 'chr15: 64,155,812-64,163,205'),
('PPIC', 'peptidylprolyl isomerase C (cyclophilin C) ', 'P45877', '5480', 'chr5: 123,023,250-123,036,741'),
('PPID', 'peptidylprolyl isomerase D ', 'Q08752', '5481', 'chr4: 158,709,134-158,723,396'),
('PPL', 'periplakin ', 'O60437', '5493', 'chr16: 4,882,507-4,960,741'),
('PPM1A', 'protein phosphatase, Mg2+/Mn2+ dependent 1A ', 'P35813 ', '5494', 'chr14: 60,245,752-60,299,087'),
('PPM1B', 'protein phosphatase, Mg2+/Mn2+ dependent 1B ', 'O75688', '5495', 'chr2: 44,167,969-44,244,384'),
('PPM1G', 'protein phosphatase, Mg2+/Mn2+ dependent 1G ', 'O15355', '5496', 'chr2: 27,381,194-27,409,687'),
('PPP1CA', 'protein phosphatase 1, catalytic subunit, alpha isozyme ', 'P62136', '5499', 'chr11: 67,398,183-67,421,183'),
('PPP1CB', 'protein phosphatase 1, catalytic subunit, beta isozyme ', 'P62140', '5500', 'chr2: 28,751,640-28,802,940'),
('ALDH7A1', 'aldehyde dehydrogenase 7 family member A1 ', 'P49419', '501', 'chr5: 126,531,200-126,595,418'),
('PPP1CC', 'protein phosphatase 1, catalytic subunit, gamma isozyme ', 'P36873', '5501', 'chr12: 110,719,680-110,742,939'),
('PPP1R1A', 'protein phosphatase 1 regulatory inhibitor subunit 1A ', 'Q13522', '5502', 'chr12: 54,575,387-54,588,659'),
('PPP1R2', 'protein phosphatase 1 regulatory inhibitor subunit 2 ', 'P41236', '5504', 'chr3: 195,514,425-195,543,386'),
('PPP1R3A', 'protein phosphatase 1 regulatory subunit 3A ', 'Q16821', '5506', 'chr7: 113,876,777-114,075,920'),
('PPP1R3D', 'protein phosphatase 1 regulatory subunit 3D ', 'O95685', '5509', 'chr20: 59,936,668-59,940,297'),
('PPP1R7', 'protein phosphatase 1 regulatory subunit 7 ', 'Q15435', '5510', 'chr2: 241,149,576-241,183,652'),
('PPP1R10', 'protein phosphatase 1 regulatory subunit 10 ', 'Q96QC0', '5514', 'chr6: 30,600,400-30,618,612'),
('PPP2CB', 'protein phosphatase 2, catalytic subunit, beta isozyme ', 'P62714', '5516', 'chr8: 30,774,457-30,814,314'),
('PPP2R1A', 'protein phosphatase 2 regulatory subunit A, alpha ', 'P30153', '5518', 'chr19: 52,190,039-52,229,533'),
('PPP2R1B', 'protein phosphatase 2 regulatory subunit A, beta ', 'P30154', '5519', 'chr11: 111,726,908-111,766,427'),
('ACTB', 'actin, beta ', 'P60709', '60', 'chr7: 5,527,151-5,563,784'),
('ATP5C1', 'ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1 ', 'P36542', '509', 'chr10: 7,788,129-7,807,815'),
('PPP2R3A', 'protein phosphatase 2 regulatory subunit B\'\', alpha ', 'Q06190', '5523', 'chr3: 135,965,673-136,147,891'),
('PPP2R4', 'protein phosphatase 2A regulatory subunit 4 ', 'Q15257', '5524', 'chr9: 129,110,950-129,148,946'),
('PPP2R5A', 'protein phosphatase 2 regulatory subunit B\', alpha ', 'Q15172', '5525', 'chr1: 212,285,537-212,361,863'),
('PPP2R5B', 'protein phosphatase 2 regulatory subunit B\', beta ', 'Q15173', '5526', 'chr11: 64,917,553-64,934,473'),
('PPP2R5C', 'protein phosphatase 2 regulatory subunit B\', gamma ', 'Q13362', '5527', 'chr14: 101,761,798-101,927,989'),
('PPP2R5D', 'protein phosphatase 2 regulatory subunit B\', delta ', 'Q14738', '5528', 'chr6: 42,984,499-43,012,342'),
('PPP3CA', 'protein phosphatase 3, catalytic subunit, alpha isozyme ', 'Q08209', '5530', 'chr4: 101,023,409-101,348,278');
INSERT INTO `geneinfo` (`gene_symbol`, `description`, `uniprot_id`, `entrez_id`, `chr_loc`) VALUES
('PPP4C', 'protein phosphatase 4 catalytic subunit ', 'P60510', '5531', 'chr16: 30,075,978-30,085,377'),
('PPP3R2', 'protein phosphatase 3 regulatory subunit B, beta ', 'Q96LZ3', '5535', 'chr9: 101,591,615-101,595,021'),
('PPP6C', 'protein phosphatase 6, catalytic subunit ', 'O00743', '5537', 'chr9: 125,146,573-125,189,939'),
('ATP5D', 'ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit ', 'P30049', '513', 'chr19: 1,241,746-1,244,826'),
('PPT1', 'palmitoyl-protein thioesterase 1 ', 'P50897', '5538', 'chr1: 40,071,461-40,097,727'),
('PRB1', 'proline-rich protein BstNI subfamily 1 ', 'P04280', '5542', 'chr12: 11,351,823-11,395,566'),
('PRB3', 'proline-rich protein BstNI subfamily 3 ', 'Q04118', '5544', 'chr12: 11,265,924-11,269,805'),
('PRB4', 'proline-rich protein BstNI subfamily 4 ', 'P10163', '5545', 'chr12: 11,307,083-11,310,435'),
('PREP', 'prolyl endopeptidase ', 'P48147', '5550', 'chr6: 105,277,565-105,403,084'),
('SRGN', 'serglycin ', 'P10124', '5552', 'chr10: 69,088,106-69,104,811'),
('PRG2', 'proteoglycan 2, bone marrow (natural killer cell activator, eosinophil granule major basic protein) ', 'P13727', '5553', 'chr11: 57,386,794-57,390,657'),
('PRIM1', 'primase, DNA, polypeptide 1 (49kDa) ', 'P49642', '5557', 'chr12: 56,731,596-56,752,373'),
('PRIM2', 'primase, DNA, polypeptide 2 (58kDa) ', 'P49643', '5558', 'chr6: 57,314,805-57,646,849'),
('PRKAA2', 'protein kinase, AMP-activated, alpha 2 catalytic subunit ', 'P54646', '5563', 'chr1: 56,645,322-56,715,335'),
('ATP5E', 'ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit ', 'P56381', '514', 'chr20: 59,025,467-59,032,382'),
('PRKACA', 'protein kinase, cAMP-dependent, alpha catalytic subunit ', 'P17612', '5566', 'chr19: 14,091,688-14,118,084'),
('PKIA', 'protein kinase (cAMP-dependent, catalytic) inhibitor alpha ', 'P61925', '5569', 'chr8: 78,516,139-78,605,267'),
('PRKAG1', 'protein kinase, AMP-activated, gamma 1 non-catalytic subunit ', 'P54619', '5571', 'chr12: 49,002,274-49,019,197'),
('PRKAR1A', 'protein kinase, cAMP-dependent, regulatory subunit type I alpha ', 'P10644', '5573', 'chr17: 68,511,780-68,551,319'),
('PRKAR2A', 'protein kinase, cAMP-dependent, regulatory subunit type II alpha ', 'P13861', '5576', 'chr3: 48,744,597-48,847,846'),
('PRKAR2B', 'protein kinase, cAMP-dependent, regulatory subunit type II beta ', 'P31323', '5577', 'chr7: 107,044,649-107,161,811'),
('PRKCA', 'protein kinase C, alpha ', 'P17252', '5578', 'chr17: 66,302,636-66,810,743'),
('PRKCB', 'protein kinase C, beta ', 'P05771', '5579', 'chr16: 23,836,001-24,220,611'),
('PRKCD', 'protein kinase C, delta ', 'Q05655', '5580', 'chr3: 53,156,009-53,192,717'),
('PRKCI', 'protein kinase C, iota ', 'P41743', '5584', 'chr3: 170,222,365-170,305,981'),
('ATP5G2', 'ATP synthase, H+ transporting, mitochondrial Fo complex subunit C2 (subunit 9) ', 'Q06055', '517', 'chr12: 53,632,726-53,677,408'),
('PKN1', 'protein kinase N1 ', 'Q16512', '5585', 'chr19: 14,433,053-14,471,867'),
('PKN2', 'protein kinase N2 ', 'Q16513', '5586', 'chr1: 88,684,222-88,836,255'),
('PRKD1', 'protein kinase D1 ', 'Q15139', '5587', 'chr14: 29,576,479-30,191,898'),
('PRKCQ', 'protein kinase C, theta ', 'Q04759', '5588', 'chr10: 6,427,143-6,580,301'),
('PRKCSH', 'protein kinase C substrate 80K-H ', 'P14314', '5589', 'chr19: 11,435,288-11,450,968'),
('PRKDC', 'protein kinase, DNA-activated, catalytic polypeptide ', 'P78527', '5591', 'chr8: 47,773,108-47,960,183'),
('MAPK1', 'mitogen-activated protein kinase 1 ', 'P28482', '5594', 'chr22: 21,754,500-21,867,680'),
('MAPK3', 'mitogen-activated protein kinase 3 ', 'P27361', '5595', 'chr16: 30,114,105-30,123,506'),
('MAPK7', 'mitogen-activated protein kinase 7 ', 'Q13164', '5598', 'chr17: 19,377,721-19,383,544'),
('MAPK8', 'mitogen-activated protein kinase 8 ', 'P45983', '5599', 'chr10: 48,306,639-48,439,360'),
('ATP5G3', 'ATP synthase, H+ transporting, mitochondrial Fo complex subunit C3 (subunit 9) ', 'P48201', '518', 'chr2: 175,176,258-175,184,607'),
('MAPK9', 'mitogen-activated protein kinase 9 ', 'P45984', '5601', 'chr5: 180,233,143-180,292,099'),
('MAPK13', 'mitogen-activated protein kinase 13 ', 'O15264', '5603', 'chr6: 36,127,809-36,144,524'),
('MAP2K1', 'mitogen-activated protein kinase kinase 1 ', 'Q02750', '5604', 'chr15: 66,386,817-66,492,312'),
('MAP2K2', 'mitogen-activated protein kinase kinase 2 ', 'P36507', '5605', 'chr19: 4,090,321-4,124,129'),
('MAP2K5', 'mitogen-activated protein kinase kinase 5 ', 'Q13163', '5607', 'chr15: 67,542,709-67,807,123'),
('MAP2K6', 'mitogen-activated protein kinase kinase 6 ', 'P52564', '5608', 'chr17: 69,414,698-69,543,331'),
('MAP2K7', 'mitogen-activated protein kinase kinase 7 ', 'O14733', '5609', 'chr19: 7,903,843-7,914,478'),
('DNAJC3', 'DnaJ heat shock protein family (Hsp40) member C3 ', 'Q13217', '5611', 'chr13: 95,677,139-95,794,989'),
('PRKX', 'protein kinase, X-linked ', 'P51817', '5613', 'chrX: 3,604,370-3,713,608'),
('PRKY', 'protein kinase, Y-linked, pseudogene', 'O43930', '5616', 'chrY: 7,273,972-7,381,548'),
('ATP5I', 'ATP synthase, H+ transporting, mitochondrial Fo complex subunit E ', 'P56385', '521', 'chr4: 672,436-674,338'),
('PRL', 'prolactin ', 'P01236', '5617', 'chr6: 22,287,244-22,297,501'),
('PRLR', 'prolactin receptor ', 'P16471', '5618', 'chr5: 35,048,756-35,230,589'),
('PRNP', 'prion protein ', 'P04156', '5621', 'chr20: 4,686,236-4,701,590'),
('PRODH', 'proline dehydrogenase (oxidase) 1 ', 'O43272', '5625', 'chr22: 18,912,777-18,936,553'),
('PROX1', 'prospero homeobox 1 ', 'Q92786', '5629', 'chr1: 213,983,181-214,041,502'),
('PRPS1', 'phosphoribosyl pyrophosphate synthetase 1 ', 'P60891', '5631', 'chrX: 107,628,424-107,651,026'),
('PRPS2', 'phosphoribosyl pyrophosphate synthetase 2 ', 'P11908', '5634', 'chrX: 12,791,355-12,824,222'),
('PRRG1', 'proline rich Gla (G-carboxyglutamic acid) 1 ', 'O14668', '5638', 'chrX: 37,349,275-37,457,295'),
('PRSS1', 'protease, serine 1 ', 'P07477', '5644', 'chr7: 142,749,468-142,753,076'),
('PRSS3', 'protease, serine 3 ', 'P35030', '5646', 'chr9: 33,750,466-33,799,231'),
('ATP5J', 'ATP synthase, H+ transporting, mitochondrial Fo complex subunit F6 ', 'P18859', '522', 'chr21: 25,716,503-25,735,673'),
('HTRA1', 'HtrA serine peptidase 1 ', 'Q92743', '5654', 'chr10: 122,461,525-122,514,908'),
('KLK10', 'kallikrein related peptidase 10 ', 'O43240', '5655', 'chr19: 51,012,739-51,020,175'),
('PSAP', 'prosaposin ', 'P07602', '5660', 'chr10: 71,816,298-71,851,375'),
('PSEN1', 'presenilin 1 ', 'P49768', '5663', 'chr14: 73,136,418-73,223,691'),
('PSEN2', 'presenilin 2 ', 'P49810', '5664', 'chr1: 226,870,184-226,896,105'),
('PSG3', 'pregnancy specific beta-1-glycoprotein 3 ', 'Q16557', '5671', 'chr19: 42,721,638-42,740,569'),
('PSG7', 'pregnancy specific beta-1-glycoprotein 7 (gene/pseudogene) ', 'Q13046', '5676', 'chr19: 42,924,132-42,937,178'),
('PSKH1', 'protein serine kinase H1 ', 'P11801', '5681', 'chr16: 67,893,272-67,929,678'),
('PSMA1', 'proteasome subunit alpha 1 ', 'P25786', '5682', 'chr11: 14,504,874-14,643,635'),
('PSMA2', 'proteasome subunit alpha 2 ', 'P25787', '5683', 'chr7: 42,916,857-42,932,223'),
('ATP6V1B2', 'ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2 ', 'P21281', '526', 'chr8: 20,197,367-20,226,819'),
('PSMA3', 'proteasome subunit alpha 3 ', 'P25788', '5684', 'chr14: 58,244,831-58,272,012'),
('PSMA4', 'proteasome subunit alpha 4 ', 'P25789', '5685', 'chr15: 78,540,405-78,552,419'),
('PSMB1', 'proteasome subunit beta 1 ', 'P20618', '5689', 'chr6: 170,535,117-170,553,341'),
('PSMB3', 'proteasome subunit beta 3 ', 'P49720', '5691', 'chr17: 38,752,736-38,764,231'),
('PSMB4', 'proteasome subunit beta 4 ', 'P28070', '5692', 'chr1: 151,399,534-151,401,944'),
('PSMB5', 'proteasome subunit beta 5 ', 'P28074', '5693', 'chr14: 23,016,543-23,035,230'),
('PSMB8', 'proteasome subunit beta 8 ', 'P28062', '5696', 'chr6: 32,840,717-32,844,703'),
('PSMB9', 'proteasome subunit beta 9 ', 'P28065', '5698', 'chr6: 32,844,136-32,859,585'),
('PSMB10', 'proteasome subunit beta 10 ', 'P40306', '5699', 'chr16: 67,934,502-67,937,087'),
('PSMC1', 'proteasome 26S subunit, ATPase 1 ', 'P62191', '5700', 'chr14: 90,256,495-90,275,429'),
('ATP6V1C1', 'ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1 ', 'P21283', '528', 'chr8: 103,021,063-103,073,051'),
('PSMC2', 'proteasome 26S subunit, ATPase 2 ', 'P35998', '5701', 'chr7: 103,344,254-103,369,395'),
('PSMC3', 'proteasome 26S subunit, ATPase 3 ', 'P17980', '5702', 'chr11: 47,418,769-47,426,473'),
('PSMC4', 'proteasome 26S subunit, ATPase 4 ', 'P43686', '5704', 'chr19: 39,971,005-39,981,441'),
('PSMC6', 'proteasome 26S subunit, ATPase 6 ', 'P62333', '5706', 'chr14: 52,707,172-52,728,587'),
('PSMD2', 'proteasome 26S subunit, non-ATPase 2 ', 'Q13200', '5708', 'chr3: 184,298,709-184,309,054'),
('PSMD3', 'proteasome 26S subunit, non-ATPase 3 ', 'O43242', '5709', 'chr17: 39,980,797-39,997,960'),
('PSMD7', 'proteasome 26S subunit, non-ATPase 7 ', 'P51665', '5713', 'chr16: 74,296,775-74,306,288'),
('PSMD10', 'proteasome 26S subunit, non-ATPase 10 ', 'O75832', '5716', 'chrX: 108,084,207-108,091,618'),
('PSMD11', 'proteasome 26S subunit, non-ATPase 11 ', 'O00231', '5717', 'chr17: 32,444,261-32,483,318'),
('PSMD12', 'proteasome 26S subunit, non-ATPase 12 ', 'O00232', '5718', 'chr17: 67,337,916-67,366,627'),
('ATP6V1G2', 'ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2 ', 'O95670', '534', 'chr6: 31,544,462-31,548,427'),
('PTAFR', 'platelet-activating factor receptor ', 'P25105', '5724', 'chr1: 28,147,166-28,193,936'),
('PTBP1', 'polypyrimidine tract binding protein 1 ', 'P26599', '5725', 'chr19: 797,075-812,327'),
('PTCH1', 'patched 1 ', 'Q13635', '5727', 'chr9: 95,442,980-95,517,057'),
('PTEN', 'phosphatase and tensin homolog ', 'P60484', '5728', 'chr10: 87,863,113-87,971,930'),
('PTGDR', 'prostaglandin D2 receptor (DP) ', 'Q13258', '5729', 'chr14: 52,267,713-52,276,724'),
('PTGDS', 'prostaglandin D2 synthase ', 'P41222', '5730', 'chr9: 136,975,092-136,981,742'),
('PTGER2', 'prostaglandin E receptor 2 ', 'P43116', '5732', 'chr14: 52,314,305-52,328,606'),
('PTGER3', 'prostaglandin E receptor 3 ', 'P43115', '5733', 'chr1: 70,852,353-71,047,808'),
('PTGER4', 'prostaglandin E receptor 4 ', 'P35408', '5734', 'chr5: 40,679,498-40,693,735'),
('PTGFR', 'prostaglandin F receptor (FP) ', 'P43088', '5737', 'chr1: 78,303,884-78,539,749'),
('A2M', 'alpha-2-macroglobulin ', 'P01023', '2', 'chr12: 9,067,664-9,116,229'),
('ACTC1', 'actin, alpha, cardiac muscle 1 ', 'P68032', '70', 'chr15: 34,788,096-34,796,139'),
('ATP6V0A1', 'ATPase, H+ transporting, lysosomal V0 subunit a1 ', 'Q93050', '535', 'chr17: 42,458,844-42,522,611'),
('PTGIS', 'prostaglandin I2 (prostacyclin) synthase ', 'Q16647', '5740', 'chr20: 49,503,874-49,568,146'),
('PTH', 'parathyroid hormone ', 'P01270', '5741', 'chr11: 13,492,055-13,496,181'),
('PTGS1', 'prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) ', 'P23219', '5742', 'chr9: 122,370,530-122,395,703'),
('PTGS2', 'prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) ', 'P35354', '5743', 'chr1: 186,671,791-186,680,427'),
('PTHLH', 'parathyroid hormone-like hormone ', 'P12272', '5744', 'chr12: 27,958,084-27,972,705'),
('PTH2R', 'parathyroid hormone 2 receptor ', 'P49190', '5746', 'chr2: 208,359,714-208,854,503'),
('PTK2', 'protein tyrosine kinase 2 ', 'Q05397', '5747', 'chr8: 140,657,900-141,002,216'),
('PTK7', 'protein tyrosine kinase 7 (inactive) ', 'Q13308', '5754', 'chr6: 43,076,268-43,161,719'),
('TWF1', 'twinfilin actin binding protein 1 ', 'Q12792', '5756', 'chr12: 43,793,723-43,806,375'),
('PTMA', 'prothymosin, alpha ', 'P06454', '5757', 'chr2: 231,706,895-231,713,541'),
('ATP5O', 'ATP synthase, H+ transporting, mitochondrial F1 complex, O subunit ', 'P48047', '539', 'chr21: 33,903,453-33,915,980'),
('PTMS', 'parathymosin ', 'P20962', '5763', 'chr12: 6,765,516-6,770,952'),
('PTPN2', 'protein tyrosine phosphatase, non-receptor type 2 ', 'P17706', '5771', 'chr18: 12,785,478-12,929,643'),
('PTPN4', 'protein tyrosine phosphatase, non-receptor type 4 (megakaryocyte) ', 'P29074', '5775', 'chr2: 119,759,631-119,983,818'),
('PTPN9', 'protein tyrosine phosphatase, non-receptor type 9 ', 'P43378', '5780', 'chr15: 75,463,251-75,579,289'),
('PTPN11', 'protein tyrosine phosphatase, non-receptor type 11 ', 'Q06124', '5781', 'chr12: 112,418,351-112,509,913'),
('PTPRB', 'protein tyrosine phosphatase, receptor type, B ', 'P23467', '5787', 'chr12: 70,515,866-70,637,440'),
('PTPRC', 'protein tyrosine phosphatase, receptor type, C ', 'P08575', '5788', 'chr1: 198,638,671-198,757,283'),
('PTPRD', 'protein tyrosine phosphatase, receptor type, D ', 'P23468', '5789', 'chr9: 8,314,246-10,612,723'),
('PTPRF', 'protein tyrosine phosphatase, receptor type, F ', 'P10586', '5792', 'chr1: 43,525,187-43,623,666'),
('PTPRG', 'protein tyrosine phosphatase, receptor type, G ', 'P23470', '5793', 'chr3: 61,561,569-62,297,613'),
('ATRX', 'alpha thalassemia/mental retardation syndrome X-linked ', 'P46100', '546', 'chrX: 77,504,878-77,786,269'),
('PTPRH', 'protein tyrosine phosphatase, receptor type, H ', 'Q9HD43', '5794', 'chr19: 55,181,248-55,209,506'),
('PTPRJ', 'protein tyrosine phosphatase, receptor type, J ', 'Q12913', '5795', 'chr11: 47,980,558-48,170,841'),
('PTPRK', 'protein tyrosine phosphatase, receptor type, K ', 'Q15262', '5796', 'chr6: 127,968,779-128,520,674'),
('PTPRM', 'protein tyrosine phosphatase, receptor type, M ', 'P28827', '5797', 'chr18: 7,566,782-8,406,861'),
('PTPRO', 'protein tyrosine phosphatase, receptor type, O ', 'Q16827', '5800', 'chr12: 15,322,397-15,597,399'),
('PTX3', 'pentraxin 3 ', 'P26022', '5806', 'chr3: 157,436,789-157,443,628'),
('RAD1', 'RAD1 checkpoint DNA exonuclease ', 'O60671', '5810', 'chr5: 34,905,264-34,918,989'),
('PURA', 'purine-rich element binding protein A ', 'Q00577', '5813', 'chr5: 140,107,777-140,125,619'),
('PURB', 'purine-rich element binding protein B ', 'Q96QR8', '5814', 'chr7: 44,876,293-44,885,361'),
('PVR', 'poliovirus receptor ', 'P15151', '5817', 'chr19: 44,643,798-44,663,583'),
('AUH', 'AU RNA binding protein/enoyl-CoA hydratase ', 'Q13825', '549', 'chr9: 91,213,815-91,361,913'),
('NECTIN1', 'poliovirus receptor-related 1 (herpesvirus entry mediator C) ', 'Q15223', '5818', 'chr11: 119,623,408-119,729,084'),
('PVT1', 'Pvt1 oncogene (non-protein coding)', 'N/A', '5820', 'chr8: 127,794,533-128,101,253'),
('ABCD3', 'ATP binding cassette subfamily D member 3 ', 'P28288', '5825', 'chr1: 94,418,455-94,518,666'),
('ABCD4', 'ATP binding cassette subfamily D member 4 ', 'O14678', '5826', 'chr14: 74,285,423-74,303,056'),
('ALDH18A1', 'aldehyde dehydrogenase 18 family member A1 ', 'P54886', '5832', 'chr10: 95,605,929-95,656,706'),
('PCYT2', 'phosphate cytidylyltransferase 2, ethanolamine ', 'Q99447', '5833', 'chr17: 81,900,965-81,911,464'),
('PYGB', 'phosphorylase, glycogen; brain ', 'P11216', '5834', 'chr20: 25,248,069-25,298,014'),
('PYGM', 'phosphorylase, glycogen, muscle ', 'P11217', '5837', 'chr11: 64,746,389-64,760,297'),
('QDPR', 'quinoid dihydropteridine reductase ', 'P09417', '5860', 'chr4: 17,460,261-17,512,234'),
('RAB1A', 'RAB1A, member RAS oncogene family ', 'P62820', '5861', 'chr2: 65,070,701-65,130,106'),
('AVPR2', 'arginine vasopressin receptor 2 ', 'P30518', '554', 'chrX: 153,902,531-153,907,166'),
('RAB2A', 'RAB2A, member RAS oncogene family ', 'P61019', '5862', 'chr8: 60,516,857-60,623,627'),
('RAB3B', 'RAB3B, member RAS oncogene family ', 'P20337', '5865', 'chr1: 51,907,956-51,990,764'),
('RAB5A', 'RAB5A, member RAS oncogene family ', 'P20339', '5868', 'chr3: 19,947,079-19,985,175'),
('RAB5B', 'RAB5B, member RAS oncogene family ', 'P61020', '5869', 'chr12: 55,973,913-55,996,683'),
('RAB27A', 'RAB27A, member RAS oncogene family ', 'P51159', '5873', 'chr15: 55,202,966-55,319,113'),
('RAB27B', 'RAB27B, member RAS oncogene family ', 'O00194', '5874', 'chr18: 54,717,860-54,895,516'),
('RABGGTB', 'Rab geranylgeranyltransferase, beta subunit ', 'P53611', '5876', 'chr1: 75,786,197-75,795,079'),
('RAB5C', 'RAB5C, member RAS oncogene family ', 'P51148', '5878', 'chr17: 42,124,976-42,155,044'),
('RAC1', 'ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) ', 'P63000', '5879', 'chr7: 6,374,523-6,403,977'),
('RAC2', 'ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) ', 'P15153', '5880', 'chr22: 37,225,261-37,244,448'),
('AZGP1', 'alpha-2-glycoprotein 1, zinc-binding ', 'P25311', '563', 'chr7: 99,966,720-99,976,157'),
('RAC3', 'ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3) ', 'P60763', '5881', 'chr17: 82,031,624-82,034,204'),
('RAD9A', 'RAD9 checkpoint clamp component A ', 'Q99638', '5883', 'chr11: 67,317,871-67,398,410'),
('RAD21', 'RAD21 cohesin complex component ', 'O60216', '5885', 'chr8: 116,845,935-116,874,866'),
('RAD23A', 'RAD23 homolog A, nucleotide excision repair protein ', 'P54725', '5886', 'chr19: 12,945,855-12,953,642'),
('RAD23B', 'RAD23 homolog B, nucleotide excision repair protein ', 'P54727', '5887', 'chr9: 107,283,137-107,332,194'),
('RAD51', 'RAD51 recombinase ', 'Q06609', '5888', 'chr15: 40,694,774-40,732,339'),
('RAD51C', 'RAD51 paralog C ', 'O43502', '5889', 'chr17: 58,692,573-58,735,611'),
('RAD51D', 'RAD51 paralog D ', 'O75771', '5892', 'chr17: 35,092,208-35,121,522'),
('RAF1', 'Raf-1 proto-oncogene, serine/threonine kinase ', 'P04049', '5894', 'chr3: 12,583,601-12,664,226'),
('RAG1', 'recombination activating gene 1 ', 'P15918', '5896', 'chr11: 36,510,709-36,593,156'),
('B2M', 'beta-2-microglobulin ', 'P61769', '567', 'chr15: 44,711,477-44,718,877'),
('RALA', 'v-ral simian leukemia viral oncogene homolog A (ras related) ', 'P11233', '5898', 'chr7: 39,623,483-39,708,124'),
('RALB', 'v-ral simian leukemia viral oncogene homolog B ', 'P11234', '5899', 'chr2: 120,240,064-120,294,713'),
('RALGDS', 'ral guanine nucleotide dissociation stimulator ', 'Q12967', '5900', 'chr9: 133,097,720-133,149,334'),
('RANBP1', 'RAN binding protein 1 ', 'P43487', '5902', 'chr22: 20,115,938-20,127,357'),
('RANBP2', 'RAN binding protein 2 ', 'P49792', '5903', 'chr2: 108,719,481-108,785,811'),
('RANGAP1', 'Ran GTPase activating protein 1 ', 'P46060', '5905', 'chr22: 41,245,611-41,286,251'),
('RAP1A', 'RAP1A, member of RAS oncogene family ', 'P62834', '5906', 'chr1: 111,542,218-111,716,691'),
('RAP1GDS1', 'RAP1, GTP-GDP dissociation stimulator 1 ', 'P52306', '5910', 'chr4: 98,261,384-98,443,861'),
('RAP2A', 'RAP2A, member of RAS oncogene family ', 'P10114', '5911', 'chr13: 97,434,222-97,469,128'),
('RAP2B', 'RAP2B, member of RAS oncogene family ', 'P61225', '5912', 'chr3: 153,162,270-153,170,620'),
('BACH1', 'BTB and CNC homology 1, basic leucine zipper transcription factor 1 ', 'O14867', '571', 'chr21: 29,194,071-29,630,751'),
('RARS', 'arginyl-tRNA synthetase ', 'P54136', '5917', 'chr5: 168,486,445-168,519,299'),
('RARRES1', 'retinoic acid receptor responder (tazarotene induced) 1 ', 'P49788', '5918', 'chr3: 158,696,892-158,732,696'),
('RARRES2', 'retinoic acid receptor responder (tazarotene induced) 2 ', 'Q99969', '5919', 'chr7: 150,338,317-150,341,674'),
('RASA1', 'RAS p21 protein activator (GTPase activating protein) 1 ', 'P20936', '5921', 'chr5: 87,267,888-87,391,931'),
('RASA2', 'RAS p21 protein activator 2 ', 'Q15283', '5922', 'chr3: 141,487,047-141,615,342'),
('RB1', 'retinoblastoma 1 ', 'P06400', '5925', 'chr13: 48,303,751-48,481,986'),
('KDM5A', 'lysine (K)-specific demethylase 5A ', 'P29375', '5927', 'chr12: 280,129-389,454'),
('RBBP4', 'retinoblastoma binding protein 4 ', 'Q09028', '5928', 'chr1: 32,651,142-32,686,211'),
('RBBP5', 'retinoblastoma binding protein 5 ', 'Q15291', '5929', 'chr1: 205,086,142-205,122,015'),
('RBBP6', 'retinoblastoma binding protein 6 ', 'Q7Z6E9', '5930', 'chr16: 24,537,693-24,572,863'),
('BAD', 'BCL2 associated agonist of cell death ', 'Q92934', '572', 'chr11: 64,269,830-64,284,704'),
('RBL1', 'retinoblastoma-like 1 ', 'P28749', '5933', 'chr20: 36,996,349-37,095,995'),
('RBM3', 'RNA binding motif (RNP1, RRM) protein 3 ', 'P98179', '5935', 'chrX: 48,574,449-48,579,066'),
('RBM4', 'RNA binding motif protein 4 ', 'Q9BWF3', '5936', 'chr11: 66,638,617-66,666,682'),
('RBMS1', 'RNA binding motif, single stranded interacting protein 1 ', 'P29558', '5937', 'chr2: 160,272,151-160,493,794'),
('RBMS2', 'RNA binding motif, single stranded interacting protein 2 ', 'Q15434', '5939', 'chr12: 56,521,929-56,596,196'),
('RBP1', 'retinol binding protein 1 ', 'P09455', '5947', 'chr3: 139,517,434-139,539,829'),
('RBP4', 'retinol binding protein 4 ', 'P02753', '5950', 'chr10: 93,591,687-93,601,744'),
('RCN1', 'reticulocalbin 1 ', 'Q15293', '5954', 'chr11: 31,812,391-32,105,755'),
('RCN2', 'reticulocalbin 2 ', 'Q14257', '5955', 'chr15: 76,931,619-76,954,392'),
('RDX', 'radixin ', 'P35241', '5962', 'chr11: 110,174,880-110,296,722'),
('BARD1', 'BRCA1 associated RING domain 1 ', 'Q99728', '580', 'chr2: 214,725,646-214,809,711'),
('RECQL', 'RecQ helicase-like ', 'P46063', '5965', 'chr12: 21,468,911-21,501,669'),
('REL', 'v-rel avian reticuloendotheliosis viral oncogene homolog ', 'Q04864', '5966', 'chr2: 60,881,521-60,931,610'),
('RELA', 'v-rel avian reticuloendotheliosis viral oncogene homolog A ', 'Q04206', '5970', 'chr11: 65,653,596-65,663,094'),
('RELB', 'v-rel avian reticuloendotheliosis viral oncogene homolog B ', 'Q01201', '5971', 'chr19: 45,001,430-45,038,198'),
('REV3L', 'REV3 like, DNA directed polymerase zeta catalytic subunit ', 'O60673', '5980', 'chr6: 111,299,028-111,483,715'),
('RFC2', 'replication factor C subunit 2 ', 'P35250', '5982', 'chr7: 74,231,499-74,254,458'),
('RFC3', 'replication factor C subunit 3 ', 'P40938', '5983', 'chr13: 33,818,049-33,966,558'),
('RFC4', 'replication factor C subunit 4 ', 'P35249', '5984', 'chr3: 186,789,880-186,807,058'),
('RFC5', 'replication factor C subunit 5 ', 'P40937', '5985', 'chr12: 118,013,588-118,033,130'),
('RFNG', 'RFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase ', 'Q9Y644 ', '5986', 'chr17: 82,047,902-82,051,831'),
('ACTG1', 'actin gamma 1 ', 'P63261', '71', 'chr17: 81,509,971-81,523,847'),
('BAX', 'BCL2-associated X protein ', 'Q07812', '581', 'chr19: 48,954,815-48,961,798'),
('RFX2', 'regulatory factor X2 ', 'P48378', '5990', 'chr19: 5,993,164-6,199,572'),
('RFX5', 'regulatory factor X5 ', 'P48382', '5993', 'chr1: 151,340,640-151,347,357'),
('RGS2', 'regulator of G-protein signaling 2 ', 'P41220', '5997', 'chr1: 192,809,039-192,812,283'),
('RGS3', 'regulator of G-protein signaling 3 ', 'P49796', '5998', 'chr9: 113,444,731-113,597,743'),
('RGS4', 'regulator of G-protein signaling 4 ', 'P49798', '5999', 'chr1: 163,068,775-163,076,802'),
('RGS7', 'regulator of G-protein signaling 7 ', 'P49802', '6000', 'chr1: 240,775,515-241,357,230'),
('RGS10', 'regulator of G-protein signaling 10 ', 'O43665', '6001', 'chr10: 119,499,828-119,542,708'),
('RGS12', 'regulator of G-protein signaling 12 ', 'O14924', '6002', 'chr4: 3,293,028-3,439,913'),
('RHEB', 'Ras homolog enriched in brain ', 'Q15382', '6009', 'chr7: 151,466,012-151,520,120'),
('RING1', 'ring finger protein 1 ', 'Q06587', '6015', 'chr6: 33,208,495-33,212,722'),
('BBS1', 'Bardet-Biedl syndrome 1 ', 'Q8NFJ9', '582', 'chr11: 66,510,606-66,533,627'),
('RIT1', 'Ras-like without CAAX 1 ', 'Q92963', '6016', 'chr1: 155,897,808-155,911,404'),
('RNASE1', 'ribonuclease, RNase A family, 1 (pancreatic) ', 'P07998', '6035', 'chr14: 20,801,228-20,803,278'),
('RNASE2', 'ribonuclease, RNase A family, 2 (liver, eosinophil-derived neurotoxin) ', 'P10153', '6036', 'chr14: 20,955,452-20,956,436'),
('RNASE4', 'ribonuclease, RNase A family, 4 ', 'P34096', '6038', 'chr14: 20,684,100-20,701,215'),
('RNASEL', 'ribonuclease L (2\',5\'-oligoisoadenylate synthetase-dependent) ', 'Q05823', '6041', 'chr1: 182,573,634-182,589,256'),
('BRD2', 'bromodomain containing 2 ', 'P25440', '6046', 'chr6: 32,968,660-32,981,505'),
('RNF6', 'ring finger protein (C3H2C3 type) 6 ', 'Q9Y252', '6049', 'chr13: 26,132,115-26,222,493'),
('RNH1', 'ribonuclease/angiogenin inhibitor 1 ', 'P13489', '6050', 'chr11: 494,512-507,300'),
('ABCE1', 'ATP binding cassette subfamily E member 1 ', 'P61221', '6059', 'chr4: 145,097,932-145,129,179'),
('RNU2-1  ', 'R , U2 small nuclear 1 ', 'N/A', '6066', 'chr17: 43,233,787-43,233,977'),
('BBS2', 'Bardet-Biedl syndrome 2 ', 'Q9BXC9', '583', 'chr16: 56,466,836-56,520,283'),
('SNORA73A', 'small nucleolar R , H/ACA box 73A', 'N/A', '6080', 'chr1: 28,507,366-28,507,571'),
('SNORD21', 'small nucleolar R , C/D box 21', 'N/A', '6083', 'chr1: 92,837,289-92,837,383'),
('ROBO2', 'roundabout guidance receptor 2 ', 'Q9HCK4', '6092', 'chr3: 75,906,695-77,649,964'),
('RORA', 'RAR-related orphan receptor A ', 'P35398', '6095', 'chr15: 60,488,284-61,229,319'),
('RORB', 'RAR-related orphan receptor B ', 'Q92753', '6096', 'chr9: 74,497,365-74,693,177'),
('RP9', 'retinitis pigmentosa 9 (autosomal dominant) ', 'Q8TA86', '6100', 'chr7: 33,094,797-33,109,401'),
('RP2', 'retinitis pigmentosa 2 (X-linked recessive) ', 'O75695', '6102', 'chrX: 46,836,940-46,882,358'),
('RPGR', 'retinitis pigmentosa GTPase regulator ', 'Q92834', '6103', 'chrX: 38,269,163-38,327,564'),
('RPA3', 'replication protein A3 ', 'P35244', '6119', 'chr7: 7,636,518-7,718,607'),
('RPL4', 'ribosomal protein L4 ', 'P36578', '6124', 'chr15: 66,498,015-66,524,532'),
('BCAT1', 'branched chain amino-acid transaminase 1, cytosolic ', 'P54687', '586', 'chr12: 24,810,022-24,949,459'),
('RPL5', 'ribosomal protein L5 ', 'P46777', '6125', 'chr1: 92,832,025-92,841,924'),
('RPL7', 'ribosomal protein L7 ', 'P18124', '6129', 'chr8: 73,290,267-73,295,789'),
('RPL7A', 'ribosomal protein L7a ', 'P62424', '6130', 'chr9: 133,348,214-133,351,426'),
('RPL10', 'ribosomal protein L10 ', 'P27635', '6134', 'chrX: 154,389,955-154,409,168'),
('RPL11', 'ribosomal protein L11 ', 'P62913', '6135', 'chr1: 23,691,779-23,696,425'),
('RPL12', 'ribosomal protein L12 ', 'P30050', '6136', 'chr9: 127,447,674-127,451,405'),
('RPL13', 'ribosomal protein L13 ', 'P26373', '6137', 'chr16: 89,560,657-89,566,828'),
('RPL15', 'ribosomal protein L15 ', 'P61313', '6138', 'chr3: 23,916,545-23,923,692'),
('RPL17', 'ribosomal protein L17 ', 'P18621', '6139', 'chr18: 49,488,453-49,492,523'),
('RPL18', 'ribosomal protein L18 ', 'Q07020', '6141', 'chr19: 48,615,328-48,619,536'),
('BCKDHA', 'branched chain keto acid dehydrogenase E1, alpha polypeptide ', 'P12694', '593', 'chr19: 41,397,460-41,425,005'),
('RPL18A', 'ribosomal protein L18a ', 'Q02543', '6142', 'chr19: 17,859,876-17,864,153'),
('RPL19', 'ribosomal protein L19 ', 'P84098', '6143', 'chr17: 39,200,283-39,204,727'),
('RPL21', 'ribosomal protein L21 ', 'P46778', '6144', 'chr13: 27,251,309-27,256,691'),
('RPL22', 'ribosomal protein L22 ', 'P35268', '6146', 'chr1: 6,181,269-6,209,389'),
('RPL23A', 'ribosomal protein L23a ', 'P62750', '6147', 'chr17: 28,719,393-28,724,359'),
('MRPL23', 'mitochondrial ribosomal protein L23 ', 'Q16540', '6150', 'chr11: 1,947,278-1,984,522'),
('RPL24', 'ribosomal protein L24 ', 'P83731', '6152', 'chr3: 101,681,091-101,686,782'),
('RPL26', 'ribosomal protein L26 ', 'P61254', '6154', 'chr17: 8,377,520-8,383,213'),
('RPL27', 'ribosomal protein L27 ', 'P61353', '6155', 'chr17: 42,998,273-43,002,959'),
('RPL30', 'ribosomal protein L30 ', 'P62888', '6156', 'chr8: 98,024,851-98,046,469'),
('BCKDHB', 'branched chain keto acid dehydrogenase E1, beta polypeptide ', 'P21953', '594', 'chr6: 80,106,647-80,346,270'),
('RPL27A', 'ribosomal protein L27a ', 'P46776', '6157', 'chr11: 8,682,411-8,714,759'),
('RPL28', 'ribosomal protein L28 ', 'P46779', '6158', 'chr19: 55,385,345-55,403,250'),
('RPL29', 'ribosomal protein L29 ', 'P47914', '6159', 'chr3: 51,993,600-51,995,942'),
('RPL31', 'ribosomal protein L31 ', 'P62899', '6160', 'chr2: 101,001,715-101,024,032'),
('RPL32', 'ribosomal protein L32 ', 'P62910', '6161', 'chr3: 12,834,485-12,841,588'),
('RPL34', 'ribosomal protein L34 ', 'P49207', '6164', 'chr4: 108,620,566-108,630,412'),
('RPL35A', 'ribosomal protein L35a ', 'P18077', '6165', 'chr3: 197,949,987-197,956,610'),
('RPL36AL', 'ribosomal protein L36a like ', 'Q969Q0', '6166', 'chr14: 49,618,519-49,620,685'),
('RPL37', 'ribosomal protein L37 ', 'P61927', '6167', 'chr5: 40,825,262-40,835,335'),
('RPL37A', 'ribosomal protein L37a ', 'P61513', '6168', 'chr2: 216,498,189-216,579,180'),
('BCL2', 'B-cell CLL/lymphoma 2 ', 'P10415', '596', 'chr18: 63,123,346-63,320,128'),
('RPL38', 'ribosomal protein L38 ', 'P63173', '6169', 'chr17: 74,203,582-74,210,655'),
('RPL41', 'ribosomal protein L41 ', 'P62945', '6171', 'chr12: 56,116,586-56,117,943'),
('RPL36A', 'ribosomal protein L36a ', 'P83881', '6173', 'chrX: 101,390,824-101,396,154'),
('RPLP0', 'ribosomal protein, large, P0 ', 'P05388', '6175', 'chr12: 120,196,686-120,201,235'),
('RPLP1', 'ribosomal protein, large, P1 ', 'P05386', '6176', 'chr15: 69,452,784-69,456,194'),
('RPLP2', 'ribosomal protein, large, P2 ', 'P05387', '6181', 'chr11: 809,647-812,880'),
('MRPL12', 'mitochondrial ribosomal protein L12 ', 'P52815', '6182', 'chr17: 81,703,357-81,707,526'),
('MRPS12', 'mitochondrial ribosomal protein S12 ', 'O15235', '6183', 'chr19: 38,930,548-38,933,162'),
('RPS2', 'ribosomal protein S2 ', 'P15880', '6187', 'chr16: 1,962,052-1,964,860'),
('RPS3A', 'ribosomal protein S3A ', 'P61247', '6189', 'chr4: 151,099,573-151,104,652'),
('BCL2L2', 'BCL2L2-PABPN1 readthrough ', 'Q92843', '599', 'chr14: 23,298,790-23,311,759'),
('RPS4Y1', 'ribosomal protein S4, Y-linked 1 ', 'P22090', '6192', 'chrY: 2,841,486-2,932,000'),
('RPS5', 'ribosomal protein S5 ', 'P46782', '6193', 'chr19: 58,386,400-58,394,806'),
('RPS6', 'ribosomal protein S6 ', 'P62753', '6194', 'chr9: 19,375,715-19,380,254'),
('RPS6KA1', 'ribosomal protein S6 kinase, 90kDa, polypeptide 1 ', 'Q15418', '6195', 'chr1: 26,529,761-26,575,030'),
('RPS6KA2', 'ribosomal protein S6 kinase, 90kDa, polypeptide 2 ', 'Q15349', '6196', 'chr6: 166,409,364-166,906,451'),
('RPS7', 'ribosomal protein S7 ', 'P62081', '6201', 'chr2: 3,575,205-3,580,919'),
('RPS8', 'ribosomal protein S8 ', 'P62241', '6202', 'chr1: 44,775,251-44,778,779'),
('RPS9', 'ribosomal protein S9 ', 'P46781', '6203', 'chr19: 54,200,742-54,249,003'),
('RPS10', 'ribosomal protein S10 ', 'P46783', '6204', 'chr6: 34,417,454-34,426,125'),
('RPS11', 'ribosomal protein S11 ', 'P62280', '6205', 'chr19: 49,496,365-49,499,689'),
('BCL3', 'B-cell CLL/lymphoma 3 ', 'P20749', '602', 'chr19: 44,747,705-44,760,044'),
('RPS13', 'ribosomal protein S13 ', 'P62277', '6207', 'chr11: 17,074,389-17,077,787'),
('RPS14', 'ribosomal protein S14 ', 'P62263', '6208', 'chr5: 150,443,190-150,449,756'),
('RPS15A', 'ribosomal protein S15a ', 'P62244', '6210', 'chr16: 18,781,295-18,790,383'),
('RPS16', 'ribosomal protein S16 ', 'P62249', '6217', 'chr19: 39,433,207-39,435,948'),
('RPS17', 'ribosomal protein S17 ', 'P08708', '6218', 'chr15: 82,536,753-82,540,564'),
('RPS18', 'ribosomal protein S18 ', 'P62269', '6222', 'chr6: 33,272,010-33,276,510'),
('RPS20', 'ribosomal protein S20 ', 'P60866', '6224', 'chr8: 56,067,295-56,074,581'),
('RPS21', 'ribosomal protein S21 ', 'P63220', '6227', 'chr20: 62,387,116-62,388,520'),
('RPS25', 'ribosomal protein S25 ', 'P62851', '6230', 'chr11: 119,015,712-119,018,691'),
('RPS26', 'ribosomal protein S26 ', 'P62854', '6231', 'chr12: 56,041,853-56,044,675'),
('BCL6', 'B-cell CLL/lymphoma 6 ', 'P41182', '604', 'chr3: 187,721,377-187,745,727'),
('RPS27', 'ribosomal protein S27 ', 'P42677', '6232', 'chr1: 153,990,759-153,992,150'),
('RPS27A', 'ribosomal protein S27a ', 'P62979', '6233', 'chr2: 55,231,903-55,235,853'),
('RRAD', 'Ras-related associated with diabetes ', 'P55042', '6236', 'chr16: 66,921,679-66,925,644'),
('RRAS', 'related RAS viral (r-ras) oncogene homolog ', 'P10301', '6237', 'chr19: 49,635,292-49,640,201'),
('RRBP1', 'ribosome binding protein 1 ', 'Q9P2E9', '6238', 'chr20: 17,613,678-17,682,295'),
('RRM1', 'ribonucleotide reductase M1 ', 'P23921', '6240', 'chr11: 4,094,707-4,138,876'),
('RRM2', 'ribonucleotide reductase M2 ', 'P31350', '6241', 'chr2: 10,120,698-10,131,419'),
('CLIP1', 'CAP-Gly domain containing linker protein 1 ', 'P30622', '6249', 'chr12: 122,271,432-122,422,632'),
('RXRB', 'retinoid X receptor beta ', 'P28702', '6257', 'chr6: 33,193,588-33,200,688'),
('RYR2', 'ryanodine receptor 2 (cardiac) ', 'Q92736', '6262', 'chr1: 237,042,205-237,833,988'),
('ACTG2', 'actin, gamma 2, smooth muscle, enteric ', 'P63267', '72', 'chr2: 73,892,314-73,919,865'),
('OPN1SW', 'opsin 1 (cone pigments), short-wave-sensitive ', 'P03999', '611', 'chr7: 128,772,491-128,775,790'),
('RYR3', 'ryanodine receptor 3 ', 'Q15413', '6263', 'chr15: 33,310,945-33,866,121'),
('S100A2', 'S100 calcium binding protein A2 ', 'P29034', '6273', 'chr1: 153,561,108-153,567,890'),
('S100A4', 'S100 calcium binding protein A4 ', 'P26447', '6275', 'chr1: 153,543,613-153,550,136'),
('S100A6', 'S100 calcium binding protein A6 ', 'P06703', '6277', 'chr1: 153,534,599-153,536,244'),
('S100A7', 'S100 calcium binding protein A7 ', 'P31151', '6278', 'chr1: 153,457,744-153,460,701'),
('S100A8', 'S100 calcium binding protein A8 ', 'P05109', '6279', 'chr1: 153,390,032-153,391,188'),
('S100A9', 'S100 calcium binding protein A9 ', 'P06702', '6280', 'chr1: 153,357,854-153,361,027'),
('S100A10', 'S100 calcium binding protein A10 ', 'P60903', '6281', 'chr1: 151,982,915-151,994,390'),
('S100A11', 'S100 calcium binding protein A11 ', 'P31949', '6282', 'chr1: 152,032,506-152,047,907'),
('S100A13', 'S100 calcium binding protein A13 ', 'Q99584', '6284', 'chr1: 153,618,787-153,631,360'),
('BCR', 'breakpoint cluster region ', 'P11274', '613', 'chr22: 23,179,704-23,318,037'),
('S100B', 'S100 calcium binding protein B ', 'P04271', '6285', 'chr21: 46,598,962-46,605,208'),
('S100P', 'S100 calcium binding protein P ', 'P25815', '6286', 'chr4: 6,693,069-6,697,170'),
('SAA1', 'serum amyloid A1 ', 'P0DJI8', '6288', 'chr11: 18,266,174-18,269,977'),
('SAA2', 'serum amyloid A2 ', 'P0DJI9', '6289', 'chr11: 18,239,223-18,248,643'),
('VPS52', 'VPS52 GARP complex subunit ', 'Q8N1B4', '6293', 'chr6: 33,250,272-33,272,047'),
('ACSM3', 'acyl-CoA synthetase medium-chain family member 3 ', 'Q53FZ2', '6296', 'chr16: 20,610,243-20,797,581'),
('SALL2', 'spalt-like transcription factor 2 ', 'Q9Y467 ', '6297', 'chr14: 21,521,081-21,537,216'),
('SARS', 'seryl-tRNA synthetase ', 'P49591', '6301', 'chr1: 109,213,918-109,238,169'),
('TSPAN31', 'tetraspanin 31 ', 'Q12999', '6302', 'chr12: 57,738,013-57,750,211'),
('SAT1', 'spermidine/spermine N1-acetyltransferase 1 ', 'P21673', '6303', 'chrX: 23,783,173-23,786,226'),
('BCS1L', 'BCS1 homolog, ubiquinol-cytochrome c reductase complex chaperone ', 'Q9Y276', '617', 'chr2: 218,658,764-218,663,443'),
('SATB1', 'SATB homeobox 1 ', 'Q01826', '6304', 'chr3: 18,345,387-18,445,588'),
('SBF1', 'SET binding factor 1 ', 'O95248', '6305', 'chr22: 50,445,000-50,475,024'),
('MSMO1', 'methylsterol monooxygenase 1 ', 'Q15800', '6307', 'chr4: 165,327,623-165,343,160'),
('SC5D', 'sterol-C5-desaturase ', 'O75845', '6309', 'chr11: 121,292,453-121,308,694'),
('ATXN1', 'ataxin 1 ', 'P54253', '6310', 'chr6: 16,299,112-16,761,491'),
('SERPINB3', 'serpin peptidase inhibitor, clade B (ovalbumin), member 3 ', 'P29508', '6317', 'chr18: 63,655,197-63,661,963'),
('SERPINB4', 'serpin peptidase inhibitor, clade B (ovalbumin), member 4 ', 'P48594', '6318', 'chr18: 63,637,259-63,644,298'),
('SCD', 'stearoyl-CoA desaturase (delta-9-desaturase) ', 'O00767', '6319', 'chr10: 100,347,124-100,364,834'),
('SCML1', 'sex comb on midleg-like 1 (Drosophila) ', 'Q9UN30', '6322', 'chrX: 17,737,449-17,754,988'),
('SCN9A', 'sodium channel, voltage gated, type IX alpha subunit ', 'Q15858', '6335', 'chr2: 166,195,185-166,375,993'),
('BDNF', 'brain-derived neurotrophic factor ', 'P23560', '627', 'chr11: 27,654,893-27,722,058'),
('SCNN1A', 'sodium channel, non voltage gated 1 alpha subunit ', 'P37088', '6337', 'chr12: 6,346,843-6,377,730'),
('SCNN1G', 'sodium channel, non voltage gated 1 gamma subunit ', 'P51170', '6340', 'chr16: 23,182,715-23,216,883'),
('SCP2', 'sterol carrier protein 2 ', 'P22307', '6342', 'chr1: 52,927,229-53,051,703'),
('SCT', 'secretin ', 'P09683', '6343', 'chr11: 626,431-627,143'),
('CCL2', 'chemokine (C-C motif) ligand 2 ', 'P13500', '6347', 'chr17: 34,255,218-34,257,203'),
('CCL3', 'chemokine (C-C motif) ligand 3 ', 'P10147', '6348', 'chr17: 36,088,256-36,090,169'),
('CCL4', 'chemokine (C-C motif) ligand 4 ', 'P13236', '6351', 'chr17: 36,103,590-36,105,621'),
('CCL5', 'chemokine (C-C motif) ligand 5 ', 'P13501', '6352', 'chr17: 35,871,491-35,880,793'),
('CCL8', 'chemokine (C-C motif) ligand 8 ', 'P80075', '6355', 'chr17: 34,319,036-34,321,402'),
('CCL20', 'chemokine (C-C motif) ligand 20 ', 'P78556', '6364', 'chr2: 227,813,842-227,817,564'),
('CFB', 'complement factor B ', 'P00751', '629', 'chr6: 31,945,650-31,952,084'),
('CXCL6', 'chemokine (C-X-C motif) ligand 6 ', 'P80162', '6372', 'chr4: 73,836,497-73,849,064'),
('CXCL5', 'chemokine (C-X-C motif) ligand 5 ', 'P42830', '6374', 'chr4: 73,995,642-73,998,779'),
('SDC1', 'syndecan 1 ', 'P18827', '6382', 'chr2: 20,200,797-20,225,433'),
('SDC2', 'syndecan 2 ', 'P34741', '6383', 'chr8: 96,493,351-96,611,780'),
('SDC4', 'syndecan 4 ', 'P31431', '6385', 'chr20: 45,325,288-45,348,424'),
('SDCBP', 'syndecan binding protein ', 'O00560', '6386', 'chr8: 58,552,924-58,582,860'),
('CXCL12', 'chemokine (C-X-C motif) ligand 12 ', 'P48061', '6387', 'chr10: 44,370,165-44,386,493'),
('SDF2', 'stromal cell-derived factor 2 ', 'Q99470', '6388', 'chr17: 28,648,356-28,662,189'),
('SDHA', 'succinate dehydrogenase complex subunit A, flavoprotein (Fp) ', 'P31040', '6389', 'chr5: 218,241-256,700'),
('SDHB', 'succinate dehydrogenase complex subunit B, iron sulfur (Ip) ', 'P21912', '6390', 'chr1: 17,018,722-17,054,170'),
('BGLAP', 'bone gamma-carboxyglutamate (gla) protein ', 'P02818', '632', 'chr1: 156,241,962-156,243,321'),
('SDHC', 'succinate dehydrogenase complex subunit C ', 'Q99643', '6391', 'chr1: 161,314,257-161,375,340'),
('SEC13', 'SEC13 homolog, nuclear pore and COPII coat complex component ', 'P55735', '6396', 'chr3: 10,293,131-10,321,178'),
('SEC14L1', 'SEC14-like lipid binding 1 ', 'Q92503', '6397', 'chr17: 77,086,716-77,217,101'),
('SECTM1', 'secreted and transmembrane 1 ', 'Q8WVN6', '6398', 'chr17: 82,321,024-82,334,074'),
('TRAPPC2', 'trafficking protein particle complex 2 ', 'P0DI81', '6399', 'chrX: 13,712,244-13,734,635'),
('SEL1L', 'sel-1 suppressor of lin-12-like (C. elegans) ', 'Q9UBV2', '6400', 'chr14: 81,471,549-81,533,861'),
('SELE', 'selectin E ', 'P16581', '6401', 'chr1: 169,722,641-169,764,705'),
('SELL', 'selectin L ', 'P14151', '6402', 'chr1: 169,690,667-169,711,698'),
('SELPLG', 'selectin P ligand ', 'Q14242', '6404', 'chr12: 108,622,277-108,633,959'),
('SEPP1', 'selenoprotein P, plasma, 1 ', 'P49908', '6414', 'chr5: 42,799,880-42,887,392'),
('BGN', 'biglycan ', 'P21810', '633', 'chrX: 153,494,939-153,509,554'),
('SET', 'SET nuclear proto-oncogene ', 'Q01105', '6418', 'chr9: 128,683,424-128,696,400'),
('SFPQ', 'splicing factor proline/glutamine-rich ', 'P23246', '6421', 'chr1: 35,176,378-35,193,148'),
('SFRP1', 'secreted frizzled-related protein 1 ', 'Q8N474', '6422', 'chr8: 41,261,958-41,309,497'),
('SFRP4', 'secreted frizzled-related protein 4 ', 'Q6FHJ7', '6424', 'chr7: 37,905,932-38,025,695'),
('SFRP5', 'secreted frizzled-related protein 5 ', 'Q5T4F7', '6425', 'chr10: 97,766,751-97,771,952'),
('SRSF1', 'serine/arginine-rich splicing factor 1 ', 'Q07955', '6426', 'chr17: 58,003,360-58,007,346'),
('SRSF2', 'serine/arginine-rich splicing factor 2 ', 'Q01130', '6427', 'chr17: 76,734,115-76,737,374'),
('SRSF5', 'serine/arginine-rich splicing factor 5 ', 'Q13243', '6430', 'chr14: 69,726,900-69,772,005'),
('SRSF6', 'serine/arginine-rich splicing factor 6 ', 'Q13247', '6431', 'chr20: 43,457,928-43,464,247'),
('TRA2B', 'transformer 2 beta homolog (Drosophila) ', 'P62995', '6434', 'chr3: 185,915,906-185,938,136'),
('BICD1', 'bicaudal D homolog 1 (Drosophila) ', 'Q96G01', '636', 'chr12: 32,106,835-32,383,633'),
('SFTPC', 'surfactant protein C ', 'P11686', '6440', 'chr8: 22,156,913-22,164,479'),
('SGCB', 'sarcoglycan beta ', 'Q16585', '6443', 'chr4: 52,020,706-52,038,482'),
('SGCD', 'sarcoglycan delta ', 'Q92629', '6444', 'chr5: 155,870,344-156,767,788'),
('SCG5', 'secretogranin V ', 'P05408', '6447', 'chr15: 32,641,676-32,697,098'),
('SGSH', 'N-sulfoglucosamine sulfohydrolase ', 'P51688', '6448', 'chr17: 80,206,716-80,220,923'),
('SGTA', 'small glutamine-rich tetratricopeptide repeat (TPR)-containing, alpha ', 'O43765', '6449', 'chr19: 2,754,714-2,783,371'),
('SH3BGR', 'SH3 domain binding glutamate-rich protein ', 'P55822', '6450', 'chr21: 39,445,855-39,515,506'),
('ITSN1', 'intersectin 1 ', 'Q15811', '6453', 'chr21: 33,642,400-33,899,861'),
('SH3GL2', 'SH3-domain GRB2-like 2 ', 'Q99962', '6456', 'chr9: 17,579,082-17,797,129'),
('SH3GL1P2', 'SH3-domain GRB2-like 1 pseudogene 2', 'N/A', '6459', 'chr17: 30,624,413-30,625,494'),
('BID', 'BH3 interacting domain death agonist ', 'P55957', '637', 'chr22: 17,734,138-17,774,770'),
('SHB', 'Src homology 2 domain containing adaptor protein B ', 'Q15464', '6461', 'chr9: 37,919,134-38,069,211'),
('SHBG', 'sex hormone-binding globulin ', 'P04278', '6462', 'chr17: 7,613,946-7,633,383'),
('SHMT1', 'serine hydroxymethyltransferase 1 (soluble) ', 'P34896', '6470', 'chr17: 18,327,860-18,363,563'),
('SHOX2', 'short stature homeobox 2 ', 'O60902', '6474', 'chr3: 158,095,954-158,106,503'),
('SIAH1', 'siah E3 ubiquitin protein ligase 1 ', 'Q8IUQ4', '6477', 'chr16: 48,356,364-48,448,402'),
('SIAH2', 'siah E3 ubiquitin protein ligase 2 ', 'O43255', '6478', 'chr3: 150,741,127-150,763,477'),
('ST6GAL1', 'ST6 beta-galactosamide alpha-2,6-sialyltranferase 1 ', 'P15907', '6480', 'chr3: 186,930,485-187,078,553'),
('ST3GAL1', 'ST3 beta-galactoside alpha-2,3-sialyltransferase 1 ', 'Q11201', '6482', 'chr8: 133,454,848-133,571,940'),
('ST3GAL2', 'ST3 beta-galactoside alpha-2,3-sialyltransferase 2 ', 'Q16842', '6483', 'chr16: 70,375,978-70,439,237'),
('ST3GAL4', 'ST3 beta-galactoside alpha-2,3-sialyltransferase 4 ', 'Q11206', '6484', 'chr11: 126,355,640-126,440,344'),
('BLM', 'Bloom syndrome, RecQ helicase-like ', 'P54132', '641', 'chr15: 90,717,327-90,816,165'),
('ST3GAL3', 'ST3 beta-galactoside alpha-2,3-sialyltransferase 3 ', 'Q11203', '6487', 'chr1: 43,705,824-43,931,165'),
('PMEL', 'premelanosome protein ', 'P40967', '6490', 'chr12: 55,954,105-55,973,317'),
('STIL', 'SCL/TAL1 interrupting locus ', 'Q15468', '6491', 'chr1: 47,250,139-47,314,147'),
('SIM1', 'single-minded family bHLH transcription factor 1 ', 'P81133', '6492', 'chr6: 100,385,015-100,464,929'),
('SIM2', 'single-minded family bHLH transcription factor 2 ', 'Q14190', '6493', 'chr21: 36,699,133-36,749,917'),
('SKI', 'SKI proto-oncogene ', 'P12755', '6497', 'chr1: 2,228,695-2,310,119'),
('SKIL', 'SKI-like proto-oncogene ', 'P12757', '6498', 'chr3: 170,357,678-170,396,835'),
('SKP1', 'S-phase kinase-associated protein 1 ', 'P63208', '6500', 'chr5: 134,148,935-134,177,038'),
('SKP2', 'S-phase kinase-associated protein 2, E3 ubiquitin protein ligase ', 'Q13309', '6502', 'chr5: 36,151,989-36,184,319'),
('SLC1A2', 'solute carrier family 1 (glial high affinity glutamate transporter), member 2 ', 'P43004', '6506', 'chr11: 35,251,206-35,420,063'),
('ACTN4', 'actinin, alpha 4 ', 'O43707', '81', 'chr19: 38,647,649-38,731,583'),
('BLMH', 'bleomycin hydrolase ', 'Q13867', '642', 'chr17: 30,248,195-30,292,056'),
('SLC1A3', 'solute carrier family 1 (glial high affinity glutamate transporter), member 3 ', 'P43003', '6507', 'chr5: 36,606,355-36,688,334'),
('SLC1A4', 'solute carrier family 1 (glutamate/neutral amino acid transporter), member 4 ', 'P43007', '6509', 'chr2: 64,988,477-65,023,865'),
('SLC1A5', 'solute carrier family 1 (neutral amino acid transporter), member 5 ', 'Q15758', '6510', 'chr19: 46,774,883-46,788,594'),
('SLC1A6', 'solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6 ', 'P48664', '6511', 'chr19: 14,950,034-15,022,990'),
('SLC2A1', 'solute carrier family 2 (facilitated glucose transporter), member 1 ', 'P11166', '6513', 'chr1: 42,925,375-42,959,173'),
('SLC2A3', 'solute carrier family 2 (facilitated glucose transporter), member 3 ', 'P11169', '6515', 'chr12: 7,919,230-7,936,275'),
('SLC2A4', 'solute carrier family 2 (facilitated glucose transporter), member 4 ', 'P14672', '6517', 'chr17: 7,281,667-7,288,257'),
('SLC2A5', 'solute carrier family 2 (facilitated glucose/fructose transporter), member 5 ', 'P22732', '6518', 'chr1: 9,035,107-9,088,478'),
('SLC3A2', 'solute carrier family 3 (amino acid transporter heavy chain), member 2 ', 'P08195', '6520', 'chr11: 62,856,102-62,888,875'),
('SLC4A2', 'solute carrier family 4 (anion exchanger), member 2 ', 'P04920', '6522', 'chr7: 151,057,210-151,076,527'),
('BLVRB', 'biliverdin reductase B ', 'P30043', '645', 'chr19: 40,447,789-40,465,840'),
('SMTN', 'smoothelin ', 'P53814', '6525', 'chr22: 31,064,105-31,104,757'),
('SLC5A3', 'solute carrier family 5 (sodium/myo-inositol cotransporter), member 3 ', 'P53794', '6526', 'chr21: 34,073,570-34,106,262'),
('SLC5A5', 'solute carrier family 5 (sodium/iodide cotransporter), member 5 ', 'Q92911', '6528', 'chr19: 17,871,973-17,895,174'),
('SLC6A1', 'solute carrier family 6 (neurotransmitter transporter), member 1 ', 'P30531', '6529', 'chr3: 10,992,724-11,039,247'),
('SLC6A6', 'solute carrier family 6 (neurotransmitter transporter), member 6 ', 'P31641', '6533', 'chr3: 14,402,576-14,489,349'),
('SLC6A8', 'solute carrier family 6 (neurotransmitter transporter), member 8 ', 'P48029', '6535', 'chrX: 153,688,099-153,696,593'),
('SLC7A2', 'solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 ', 'P52569', '6542', 'chr8: 17,497,088-17,570,573'),
('SLC9A2', 'solute carrier family 9, subfamily A (NHE2, cation proton antiporter 2), member 2 ', 'Q9UBY0', '6549', 'chr2: 102,619,707-102,711,318'),
('SLC11A1', 'solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1 ', 'P49279', '6556', 'chr2: 218,382,029-218,396,894'),
('SLC12A2', 'solute carrier family 12 (sodium/potassium/chloride transporter), member 2 ', 'P55011', '6558', 'chr5: 128,083,766-128,189,688'),
('BNC1', 'basonuclin 1 ', 'Q01954', '646', 'chr15: 83,255,903-83,284,714'),
('SLC14A1', 'solute carrier family 14 (urea transporter), member 1 (Kidd blood group) ', 'Q13336', '6563', 'chr18: 45,724,127-45,752,520'),
('SLC15A2', 'solute carrier family 15 (oligopeptide transporter), member 2 ', 'Q16348', '6565', 'chr3: 121,894,089-121,944,102'),
('SLC18A2', 'solute carrier family 18 (vesicular monoamine transporter), member 2 ', 'Q05940', '6571', 'chr10: 117,241,093-117,279,430'),
('SLC19A1', 'solute carrier family 19 (folate transporter), member 1 ', 'P41440', '6573', 'chr21: 45,493,572-45,544,411'),
('SLC20A1', 'solute carrier family 20 (phosphate transporter), member 1 ', 'Q8WUM9', '6574', 'chr2: 112,645,857-112,663,827'),
('SLC20A2', 'solute carrier family 20 (phosphate transporter), member 2 ', 'Q08357', '6575', 'chr8: 42,416,475-42,541,926'),
('SLC25A1', 'solute carrier family 25 (mitochondrial carrier; citrate transporter), member 1 ', 'P53007', '6576', 'chr22: 19,175,575-19,178,830'),
('SLCO2A1', 'solute carrier organic anion transporter family member 2A1 ', 'Q92959', '6578', 'chr3: 133,932,696-134,052,184'),
('SLC22A1', 'solute carrier family 22 (organic cation transporter), member 1 ', 'O15245', '6580', 'chr6: 160,121,789-160,158,718'),
('SLC22A3', 'solute carrier family 22 (organic cation transporter), member 3 ', 'O75751', '6581', 'chr6: 160,348,268-160,452,581'),
('BMP1', 'bone morphogenetic protein 1 ', 'P13497', '649', 'chr8: 22,164,736-22,212,326'),
('SLC22A5', 'solute carrier family 22 (organic cation/carnitine transporter), member 5 ', 'O76082', '6584', 'chr5: 132,369,752-132,395,614'),
('SLPI', 'secretory leukocyte peptidase inhibitor ', 'P03973', '6590', 'chr20: 45,252,239-45,254,564'),
('SNAI2', 'snail family zinc finger 2 ', 'O43623', '6591', 'chr8: 48,917,768-48,921,740'),
('SMARCA1', 'SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1 ', 'P28370', '6594', 'chrX: 129,446,501-129,523,500'),
('SMARCA2', 'SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 ', 'P51531', '6595', 'chr9: 1,980,290-2,193,624'),
('SMARCA4', 'SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 ', 'P51532', '6597', 'chr19: 10,961,001-11,065,395'),
('SMARCC1', 'SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1 ', 'Q92922', '6599', 'chr3: 47,585,272-47,782,106'),
('SMARCC2', 'SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 2 ', 'Q8TAQ2', '6601', 'chr12: 56,162,983-56,189,567'),
('SMARCD1', 'SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1 ', 'Q96GM5', '6602', 'chr12: 50,084,972-50,100,712'),
('SMARCD3', 'SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3 ', 'Q6STE5', '6604', 'chr7: 151,238,764-151,277,896'),
('BMP2', 'bone morphogenetic protein 2 ', 'P12643', '650', 'chr20: 6,767,664-6,780,280'),
('SUMO3', 'small ubiquitin-like modifier 3 ', 'P55854', '6612', 'chr21: 44,805,617-44,818,779'),
('SUMO2', 'small ubiquitin-like modifier 2 ', 'P61956', '6613', 'chr17: 75,165,586-75,182,983'),
('SIGLEC1', 'sialic acid binding Ig-like lectin 1, sialoadhesin ', 'Q9BZZ2', '6614', 'chr20: 3,686,970-3,707,128'),
('SNAP25', 'synaptosome associated protein 25kDa ', 'P60880', '6616', 'chr20: 10,218,830-10,307,418'),
('SNAPC1', 'small nuclear RNA activating complex polypeptide 1 ', 'Q16533', '6617', 'chr14: 61,762,357-61,796,428'),
('SNAPC3', 'small nuclear RNA activating complex polypeptide 3 ', 'Q92966', '6619', 'chr9: 15,422,704-15,465,953'),
('SNCA', 'synuclein alpha ', 'P37840', '6622', 'chr4: 89,724,099-89,838,315'),
('FSCN1', 'fascin actin-bundling protein 1 ', 'Q16658', '6624', 'chr7: 5,592,823-5,606,655'),
('SNRPA', 'small nuclear ribonucleoprotein polypeptide A ', 'P09012', '6626', 'chr19: 40,750,637-40,765,389'),
('SNRPA1', 'small nuclear ribonucleoprotein polypeptide A\' ', 'P09661', '6627', 'chr15: 101,281,510-101,295,282'),
('BMP3', 'bone morphogenetic protein 3 ', 'P12645', '651', 'chr4: 81,030,965-81,057,531'),
('SNRPB', 'small nuclear ribonucleoprotein polypeptides B and B1 ', 'P14678', '6628', 'chr20: 2,461,634-2,470,853'),
('SNRPC', 'small nuclear ribonucleoprotein polypeptide C ', 'P09234', '6631', 'chr6: 34,757,406-34,773,794'),
('SNRPD1', 'small nuclear ribonucleoprotein D1 polypeptide ', 'P62314', '6632', 'chr18: 21,612,267-21,633,524');
INSERT INTO `geneinfo` (`gene_symbol`, `description`, `uniprot_id`, `entrez_id`, `chr_loc`) VALUES
('SNRPD2', 'small nuclear ribonucleoprotein D2 polypeptide ', 'P62316', '6633', 'chr19: 45,687,454-45,692,569'),
('SNRPD3', 'small nuclear ribonucleoprotein D3 polypeptide ', 'P62318', '6634', 'chr22: 24,555,503-24,609,980'),
('SNRPF', 'small nuclear ribonucleoprotein polypeptide F ', 'P62306', '6636', 'chr12: 95,858,928-95,903,828'),
('SNRPN', 'small nuclear ribonucleoprotein polypeptide N ', 'P63162', '6638', 'chr15: 24,823,637-24,978,723'),
('SNTA1', 'syntrophin, alpha 1 ', 'Q13424', '6640', 'chr20: 33,407,955-33,443,892'),
('SNTB1', 'syntrophin, beta 1 (dystrophin-associated protein A1, 59kDa, basic component 1) ', 'Q13884', '6641', 'chr8: 120,535,745-120,813,273'),
('SNX1', 'sorting nexin 1 ', 'Q13596', '6642', 'chr15: 64,094,123-64,146,090'),
('BMP4', 'bone morphogenetic protein 4 ', 'P12644', '652', 'chr14: 53,949,736-53,958,761'),
('SNTB2', 'syntrophin, beta 2 (dystrophin-associated protein A1, 59kDa, basic component 2) ', 'Q13425', '6645', 'chr16: 69,187,129-69,309,052'),
('SOAT1', 'sterol O-acyltransferase 1 ', 'P35610', '6646', 'chr1: 179,293,714-179,358,680'),
('SOD2', 'superoxide dismutase 2, mitochondrial ', 'P04179', '6648', 'chr6: 159,669,057-159,762,529'),
('SOD3', 'superoxide dismutase 3, extracellular ', 'P08294', '6649', 'chr4: 24,789,912-24,800,842'),
('CAPN15', 'calpain 15 ', 'O75808', '6650', 'chr16: 527,717-554,636'),
('SON', 'SON DNA binding protein ', 'P18583', '6651', 'chr21: 33,542,618-33,577,481'),
('SORD', 'sorbitol dehydrogenase ', 'Q00796', '6652', 'chr15: 45,023,104-45,077,185'),
('SORL1', 'sortilin-related receptor, L(DLR class) A repeats containing ', 'Q92673', '6653', 'chr11: 121,452,203-121,633,693'),
('SOS1', 'SOS Ras/Rac guanine nucleotide exchange factor 1 ', 'Q07889', '6654', 'chr2: 38,981,396-39,124,345'),
('SOS2', 'SOS Ras/Rho guanine nucleotide exchange factor 2 ', 'Q07890', '6655', 'chr14: 50,117,120-50,231,558'),
('BMP6', 'bone morphogenetic protein 6 ', 'P22004', '654', 'chr6: 7,726,797-7,881,422'),
('SOX4', 'SRY-box 4 ', 'Q06945', '6659', 'chr6: 21,592,768-21,598,619'),
('SOX9', 'SRY-box 9 ', 'P48436', '6662', 'chr17: 72,121,020-72,126,420'),
('SOX15', 'SRY-box 15 ', 'O60248', '6665', 'chr17: 7,588,178-7,590,170'),
('SOX12', 'SRY-box 12 ', 'O15370', '6666', 'chr20: 325,595-330,224'),
('SP3', 'Sp3 transcription factor ', 'Q02447', '6670', 'chr2: 173,906,459-173,965,702'),
('SP100', 'SP100 nuclear antigen ', 'P23497', '6672', 'chr2: 230,415,942-230,544,090'),
('UAP1', 'UDP-N-acetylglucosamine pyrophosphorylase 1 ', 'Q16222', '6675', 'chr1: 162,561,506-162,599,842'),
('SPAG4', 'sperm associated antigen 4 ', 'Q9NPE6', '6676', 'chr20: 35,615,892-35,621,049'),
('SPAM1', 'sperm adhesion molecule 1 (PH-20 hyaluronidase, zona pellucida binding) ', 'P38567', '6677', 'chr7: 123,925,237-123,971,414'),
('SPARC', 'secreted protein, acidic, cysteine-rich (osteonectin) ', 'P09486', '6678', 'chr5: 151,661,096-151,687,165'),
('BMP8B', 'bone morphogenetic protein 8b ', 'P34820', '656', 'chr1: 39,757,182-39,788,861'),
('SPAST', 'spastin ', 'Q9UBP0', '6683', 'chr2: 32,063,611-32,157,637'),
('SPINK1', 'serine peptidase inhibitor, Kazal type 1 ', 'P00995', '6690', 'chr5: 147,824,568-147,831,786'),
('SPP2', 'secreted phosphoprotein 2 ', 'Q13103', '6694', 'chr2: 234,050,679-234,077,134'),
('SPP1', 'secreted phosphoprotein 1 ', 'P10451', '6696', 'chr4: 87,975,650-87,983,426'),
('SPRR2B', 'small proline-rich protein 2B ', 'P35325', '6701', 'chr1: 153,070,224-153,070,840'),
('SPRR2G', 'small proline-rich protein 2G ', 'Q9BYE4', '6706', 'chr1: 153,149,582-153,150,869'),
('SPRR3', 'small proline-rich protein 3 ', 'Q9UBC9', '6707', 'chr1: 153,001,747-153,003,856'),
('SPTBN1', 'spectrin, beta, non-erythrocytic 1 ', 'Q01082', '6711', 'chr2: 54,456,285-54,671,445'),
('SQLE', 'squalene epoxidase ', 'Q14534', '6713', 'chr8: 124,998,497-125,022,283'),
('SRD5A1', 'steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1)', 'P18405', '6715', 'chr5: 6,633,343-6,674,386'),
('BMPR1A', 'bone morphogenetic protein receptor type IA ', 'P36894', '657', 'chr10: 86,756,601-86,932,838'),
('SRD5A2', 'steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2)', 'P31213', '6716', 'chr2: 31,522,480-31,581,067'),
('SRI', 'sorcin ', 'P30626', '6717', 'chr7: 88,205,118-88,226,993'),
('SREBF1', 'sterol regulatory element binding transcription factor 1 ', 'P36956', '6720', 'chr17: 17,810,399-17,837,002'),
('SREBF2', 'sterol regulatory element binding transcription factor 2 ', 'Q12772', '6721', 'chr22: 41,833,079-41,907,308'),
('SRM', 'spermidine synthase ', 'P19623', '6723', 'chr1: 11,054,584-11,060,024'),
('SRP9', 'signal recognition particle 9kDa ', 'P49458', '6726', 'chr1: 225,777,813-225,790,466'),
('SRP14', 'signal recognition particle 14kDa ', 'P37108', '6727', 'chr15: 40,035,739-40,039,188'),
('SRP54', 'signal recognition particle 54kDa ', 'P61011', '6729', 'chr14: 34,981,957-35,029,567'),
('SRP72', 'signal recognition particle 72kDa ', 'O76094', '6731', 'chr4: 56,466,915-56,503,680'),
('SRPK1', 'SRSF protein kinase 1 ', 'Q96SB4', '6732', 'chr6: 35,832,966-35,921,342'),
('ACTL6A', 'actin like 6A ', 'O96019', '86', 'chr3: 179,562,880-179,588,408'),
('BMPR2', 'bone morphogenetic protein receptor type II ', 'Q13873', '659', 'chr2: 202,376,936-202,567,751'),
('SRPK2', 'SRSF protein kinase 2 ', 'P78362', '6733', 'chr7: 105,110,704-105,399,308'),
('TROVE2', 'TROVE domain family member 2 ', 'P10155', '6738', 'chr1: 193,059,422-193,091,777'),
('SSB', 'Sjogren syndrome antigen B ', 'P05455', '6741', 'chr2: 169,791,933-169,812,064'),
('SSBP1', 'single-stranded DNA binding protein 1, mitochondrial ', 'Q04837', '6742', 'chr7: 141,738,321-141,787,922'),
('SSFA2', 'sperm specific antigen 2 ', 'P28290', '6744', 'chr2: 181,891,833-181,930,738'),
('SSR1', 'signal sequence receptor, alpha ', 'P43307', '6745', 'chr6: 7,268,306-7,347,446'),
('SSR3', 'signal sequence receptor, gamma (translocon-associated protein gamma) ', 'Q9UNL2', '6747', 'chr3: 156,540,140-156,555,184'),
('SSR4', 'signal sequence receptor, delta ', 'P51571', '6748', 'chrX: 153,793,516-153,798,505'),
('SSRP1', 'structure specific recognition protein 1 ', 'Q08945', '6749', 'chr11: 57,325,985-57,335,877'),
('SSTR1', 'somatostatin receptor 1 ', 'P30872', '6751', 'chr14: 38,207,999-38,213,067'),
('BNIP3', 'BCL2/adenovirus E1B 19kDa interacting protein 3 ', 'Q12983', '664', 'chr10: 131,966,455-131,982,013'),
('SSTR5', 'somatostatin receptor 5 ', 'P35346', '6755', 'chr16: 1,078,781-1,080,142'),
('STAC', 'SH3 and cysteine rich domain ', 'Q99469', '6769', 'chr3: 36,380,344-36,548,007'),
('STAR', 'steroidogenic acute regulatory protein ', 'P49675', '6770', 'chr8: 38,143,649-38,151,265'),
('STAT2', 'signal transducer and activator of transcription 2 ', 'P52630', '6773', 'chr12: 56,341,597-56,360,155'),
('STAT3', 'signal transducer and activator of transcription 3 (acute-phase response factor) ', 'P40763', '6774', 'chr17: 42,313,324-42,388,568'),
('STAT5A', 'signal transducer and activator of transcription 5A ', 'P42229', '6776', 'chr17: 42,287,547-42,311,943'),
('STAT5B', 'signal transducer and activator of transcription 5B ', 'P51692', '6777', 'chr17: 42,199,168-42,276,707'),
('STAU1', 'staufen double-stranded RNA binding protein 1 ', 'O95793', '6780', 'chr20: 49,113,339-49,188,367'),
('STC1', 'stanniocalcin 1 ', 'P52823', '6781', 'chr8: 23,841,915-23,854,807'),
('SULT1E1', 'sulfotransferase family 1E member 1 ', 'P49888 ', '6783', 'chr4: 69,841,212-69,860,152'),
('BNIP3L', 'BCL2/adenovirus E1B 19kDa interacting protein 3-like ', 'O60238', '665', 'chr8: 26,382,898-26,505,636'),
('ELOVL4', 'ELOVL fatty acid elongase 4 ', 'Q9GZR5', '6785', 'chr6: 79,914,812-79,947,580'),
('NEK4', 'NIMA-related kinase 4 ', 'P51957', '6787', 'chr3: 52,708,449-52,770,949'),
('STK4', 'serine/threonine kinase 4 ', 'Q13043', '6789', 'chr20: 44,966,474-45,079,959'),
('AURKA', 'aurora kinase A ', 'O14965', '6790', 'chr20: 56,369,389-56,392,337'),
('STK11', 'serine/threonine kinase 11 ', 'Q15831', '6794', 'chr19: 1,177,558-1,228,435'),
('STX3', 'syntaxin 3 ', 'Q13277', '6809', 'chr11: 59,713,456-59,805,882'),
('STX4', 'syntaxin 4 ', 'Q12846', '6810', 'chr16: 31,032,889-31,042,975'),
('STXBP1', 'syntaxin binding protein 1 ', 'P61764', '6812', 'chr9: 127,579,370-127,696,027'),
('STXBP2', 'syntaxin binding protein 2 ', 'Q15833', '6813', 'chr19: 7,636,881-7,647,873'),
('SULT1A3', 'sulfotransferase family 1A member 3 ', 'P0DMM9', '6818', 'chr16: 30,199,228-30,204,310'),
('BOK', 'BCL2-related ovarian killer ', 'Q9UMX3', '666', 'chr2: 241,551,424-241,574,138'),
('SUOX', 'sulfite oxidase ', 'P51687', '6821', 'chr12: 55,997,180-56,006,641'),
('SULT2A1', 'sulfotransferase family 2A member 1 ', 'Q06520', '6822', 'chr19: 47,870,466-47,886,397'),
('SUPT5H', 'SPT5 homolog, DSIF elongation factor subunit ', 'O00267', '6829', 'chr19: 39,436,156-39,476,670'),
('SUPT6H', 'SPT6 homolog, histone chaperone ', 'Q7KZ85', '6830', 'chr17: 28,662,091-28,702,684'),
('SUPV3L1', 'SUV3-like helicase ', 'Q8IYB8', '6832', 'chr10: 69,180,232-69,209,099'),
('SURF4', 'surfeit 4 ', 'O15260', '6836', 'chr9: 133,361,449-133,376,166'),
('VAMP2', 'vesicle associated membrane protein 2 ', 'P63027', '6844', 'chr17: 8,159,149-8,163,546'),
('VAMP7', 'vesicle associated membrane protein 7 ', 'P51809', '6845', 'chrX: 155,881,293-155,943,769'),
('SYK', 'spleen tyrosine kinase ', 'P43405', '6850', 'chr9: 90,801,787-90,898,549'),
('SYN1', 'synapsin I ', 'P17600', '6853', 'chrX: 47,571,898-47,619,943'),
('DST', 'dystonin ', 'Q03001', '667', 'chr6: 56,457,987-56,954,628'),
('SYN2', 'synapsin II ', 'Q92777', '6854', 'chr3: 12,004,402-12,191,400'),
('SYT1', 'synaptotagmin 1 ', 'P21579', '6857', 'chr12: 78,863,993-79,452,008'),
('TACC1', 'transforming, acidic coiled-coil containing protein 1 ', 'O75410', '6867', 'chr8: 38,728,186-38,853,028'),
('ADAM17', 'ADAM metallopeptidase domain 17 ', 'P78536', '6868', 'chr2: 9,488,486-9,555,792'),
('TADA2A', 'transcriptional adaptor 2A ', 'O75478', '6871', 'chr17: 37,406,874-37,479,730'),
('TAGLN', 'transgelin ', 'Q01995', '6876', 'chr11: 117,199,321-117,204,782'),
('TAF5', 'TATA-box binding protein associated factor 5 ', 'Q15542', '6877', 'chr10: 103,367,967-103,389,065'),
('TAF10', 'TATA-box binding protein associated factor 10 ', 'Q12962', '6881', 'chr11: 6,606,296-6,612,667'),
('TAF11', 'TATA-box binding protein associated factor 11 ', 'Q15544', '6882', 'chr6: 34,877,778-34,888,089'),
('TAF12', 'TATA-box binding protein associated factor 12 ', 'Q16514', '6883', 'chr1: 28,589,323-28,643,085'),
('FOXL2', 'forkhead box L2 ', 'P58012', '668', 'chr3: 138,944,224-138,947,140'),
('MAP3K7', 'mitogen-activated protein kinase kinase kinase 7 ', 'O43318', '6885', 'chr6: 90,513,573-90,587,045'),
('TAL1', 'T-cell acute lymphocytic leukemia 1 ', 'P17542', '6886', 'chr1: 47,216,290-47,232,220'),
('TALDO1', 'transaldolase 1 ', 'P37837', '6888', 'chr11: 747,329-765,024'),
('TARS', 'threonyl-tRNA synthetase ', 'P26639', '6897', 'chr5: 33,440,696-33,469,539'),
('TBX1', 'T-box 1 ', 'O43435', '6899', 'chr22: 19,756,703-19,783,593'),
('TBCD', 'tubulin folding cofactor D ', 'Q9BTW9', '6904', 'chr17: 82,752,064-82,945,922'),
('TBL1X', 'transducin (beta)-like 1X-linked ', 'O60907', '6907', 'chrX: 9,463,295-9,719,743'),
('TCEA3', 'transcription elongation factor A (SII), 3 ', 'O75764', '6920', 'chr1: 23,381,061-23,424,740'),
('TCEB1', 'transcription elongation factor B (SIII), polypeptide 1 (15kDa, elongin C) ', 'Q15369', '6921', 'chr8: 73,939,169-73,972,287'),
('TCEB2', 'transcription elongation factor B (SIII), polypeptide 2 (18kDa, elongin B) ', 'Q15370', '6923', 'chr16: 2,771,414-2,777,297'),
('BPGM', 'bisphosphoglycerate mutase ', 'P07738', '669', 'chr7: 134,646,808-134,679,813'),
('TCF4', 'transcription factor 4 ', 'P15884', '6925', 'chr18: 55,222,331-55,664,787'),
('HNF1A', 'HNF1 homeobox A ', 'P20823', '6927', 'chr12: 120,978,543-121,002,512'),
('TCF3', 'transcription factor 3 ', 'P15923', '6929', 'chr19: 1,609,290-1,652,605'),
('TCF7L2', 'transcription factor 7-like 2 (T-cell specific, HMG-box) ', 'Q9NQB0', '6934', 'chr10: 112,950,250-113,167,678'),
('ZEB1', 'zinc finger E-box binding homeobox 1 ', 'P37275', '6935', 'chr10: 31,318,495-31,529,814'),
('GCFC2', 'GC-rich sequence DNA-binding factor 2 ', 'P16383', '6936', 'chr2: 75,652,000-75,710,989'),
('TCF12', 'transcription factor 12 ', 'Q99081', '6938', 'chr15: 56,918,623-57,299,281'),
('TCF15', 'transcription factor 15 (basic helix-loop-helix) ', 'Q12870', '6939', 'chr20: 603,797-610,398'),
('TCF19', 'transcription factor 19 ', 'Q9Y242', '6941', 'chr6: 31,158,542-31,167,159'),
('TCF20', 'transcription factor 20 (AR1) ', 'Q9UGU0', '6942', 'chr22: 42,160,013-42,343,616'),
('BRCA1', 'breast cancer 1 ', 'P38398', '672', 'chr17: 43,044,295-43,170,245'),
('TCF21', 'transcription factor 21 ', 'O43680', '6943', 'chr6: 133,889,138-133,895,553'),
('MLX', 'MLX, MAX dimerization protein ', 'Q9UH92', '6945', 'chr17: 42,567,068-42,573,239'),
('TCOF1', 'Treacher Collins-Franceschetti syndrome 1 ', 'Q13428', '6949', 'chr5: 150,357,639-150,400,308'),
('TCP1', 't-complex 1 ', 'P17987', '6950', 'chr6: 159,778,498-159,789,749'),
('TRB ', 'T cell receptor beta locus', 'N/A', '6957', 'chr7: 142,299,051-142,874,380'),
('TRD', 'T cell receptor delta locus', 'N/A', '6964', 'chr14: 22,422,546-22,466,577'),
('TCTA', 'T-cell leukemia translocation altered ', 'P57738', '6988', 'chr3: 49,412,206-49,416,475'),
('PPP1R11', 'protein phosphatase 1 regulatory inhibitor subunit 11 ', 'O60927', '6992', 'chr6: 30,066,709-30,070,333'),
('DYNLT1', 'dynein, light chain, Tctex-type 1 ', 'P63172', '6993', 'chr6: 158,636,474-158,644,739'),
('TDG', 'thymine DNA glycosylase ', 'Q13569', '6996', 'chr12: 103,965,804-103,988,874'),
('BRCA2', 'breast cancer 2 ', 'P51587', '675', 'chr13: 32,315,474-32,400,266'),
('TDGF1', 'teratocarcinoma-derived growth factor 1 ', 'P13385', '6997', 'chr3: 46,574,534-46,582,463'),
('PRDX2', 'peroxiredoxin 2 ', 'P32119', '7001', 'chr19: 12,796,820-12,801,859'),
('TEAD4', 'TEA domain family member 4 ', 'Q15561', '7004', 'chr12: 2,959,330-3,040,673'),
('TEAD3', 'TEA domain family member 3 ', 'Q99594', '7005', 'chr6: 35,473,597-35,497,076'),
('TECTA', 'tectorin alpha ', 'O75443', '7007', 'chr11: 121,101,173-121,191,493'),
('TEK', 'TEK tyrosine kinase, endothelial ', 'Q02763', '7010', 'chr9: 27,109,141-27,230,175'),
('TEP1', 'telomerase-associated protein 1 ', 'Q99973', '7011', 'chr14: 20,365,667-20,413,429'),
('TERF1', 'telomeric repeat binding factor (NIMA-interacting) 1 ', 'P54274', '7013', 'chr8: 73,008,864-73,048,122'),
('TESK1', 'testis-specific kinase 1 ', 'Q15569', '7016', 'chr9: 35,605,305-35,610,041'),
('TF', 'transferrin ', 'P02787', '7018', 'chr3: 133,745,956-133,779,006'),
('ZFP36L1', 'ZFP36 ring finger protein-like 1 ', 'Q07352', '677', 'chr14: 68,787,660-68,796,253'),
('TFAM', 'transcription factor A, mitochondrial ', 'Q00059', '7019', 'chr10: 58,385,022-58,399,221'),
('TFCP2', 'transcription factor CP2 ', 'Q12800', '7024', 'chr12: 51,093,663-51,173,134'),
('NR2F1', 'nuclear receptor subfamily 2 group F member 1 ', 'P10589', '7025', 'chr5: 93,583,337-93,594,615'),
('NR2F2', 'nuclear receptor subfamily 2 group F member 2 ', 'P24468', '7026', 'chr15: 96,325,938-96,340,263'),
('TFDP1', 'transcription factor Dp-1 ', 'Q14186', '7027', 'chr13: 113,584,721-113,641,470'),
('TFPI', 'tissue factor pathway inhibitor ', 'P10646', '7035', 'chr2: 187,464,230-187,565,760'),
('TFR2', 'transferrin receptor 2 ', 'Q9UP52', '7036', 'chr7: 100,620,416-100,642,779'),
('TFRC', 'transferrin receptor ', 'P02786', '7037', 'chr3: 196,027,183-196,082,189'),
('TGFA', 'transforming growth factor alpha ', 'P01135', '7039', 'chr2: 70,447,280-70,554,193'),
('TGFB1', 'transforming growth factor beta 1 ', 'P01137', '7040', 'chr19: 41,301,587-41,353,911'),
('ACTN1', 'actinin, alpha 1 ', 'P12814', '87', 'chr14: 68,874,143-68,979,440'),
('ZFP36L2', 'ZFP36 ring finger protein-like 2 ', 'P47974', '678', 'chr2: 43,222,402-43,226,609'),
('TGFB1I1', 'transforming growth factor beta 1 induced transcript 1 ', 'O43294', '7041', 'chr16: 31,471,585-31,477,960'),
('TGFB2', 'transforming growth factor beta 2 ', 'P61812', '7042', 'chr1: 218,346,235-218,444,619'),
('TGFBI', 'transforming growth factor beta induced ', 'Q15582', '7045', 'chr5: 136,028,895-136,063,818'),
('TGFBR1', 'transforming growth factor beta receptor I ', 'P36897', '7046', 'chr9: 99,104,038-99,154,192'),
('TGM4', 'transglutaminase 4 ', 'P49221', '7047', 'chr3: 44,874,608-44,914,990'),
('TGFBR2', 'transforming growth factor beta receptor II ', 'P37173', '7048', 'chr3: 30,606,502-30,694,142'),
('TGFBR3', 'transforming growth factor beta receptor III ', 'Q03167', '7049', 'chr1: 91,680,343-91,906,335'),
('TGM2', 'transglutaminase 2 ', 'P21980', '7052', 'chr20: 38,127,387-38,166,578'),
('TH', 'tyrosine hydroxylase ', 'P07101', '7054', 'chr11: 2,163,929-2,171,877'),
('THBS1', 'thrombospondin 1 ', 'P07996', '7057', 'chr15: 39,581,079-39,599,466'),
('BSG', 'basigin (Ok blood group) ', 'P35613', '682', 'chr19: 571,277-583,493'),
('THBS4', 'thrombospondin 4 ', 'P35443', '7060', 'chr5: 79,991,311-80,083,287'),
('THOP1', 'thimet oligopeptidase 1 ', 'P52888', '7064', 'chr19: 2,785,460-2,815,807'),
('THRA', 'thyroid hormone receptor, alpha ', 'P10827', '7067', 'chr17: 40,058,290-40,093,867'),
('KLF10', 'Kruppel-like factor 10 ', 'Q13118', '7071', 'chr8: 102,648,779-102,655,902'),
('TIA1', 'TIA1 cytotoxic granule-associated RNA binding protein ', 'P31483', '7072', 'chr2: 70,209,444-70,248,660'),
('TIAM1', 'T-cell lymphoma invasion and metastasis 1 ', 'Q13009', '7074', 'chr21: 31,118,416-31,559,977'),
('TIE1', 'tyrosine kinase with immunoglobulin-like and EGF-like domains 1 ', 'P35590', '7075', 'chr1: 43,300,993-43,323,108'),
('TIMP1', 'TIMP metallopeptidase inhibitor 1 ', 'P01033', '7076', 'chrX: 47,582,313-47,586,789'),
('TIMP2', 'TIMP metallopeptidase inhibitor 2 ', 'P16035', '7077', 'chr17: 78,852,977-78,925,387'),
('TIMP3', 'TIMP metallopeptidase inhibitor 3 ', 'P35625', '7078', 'chr22: 32,801,701-32,863,043'),
('BST2', 'bone marrow stromal cell antigen 2 ', 'Q10589', '684', 'chr19: 17,402,939-17,405,648'),
('NKX2-1', 'NK2 homeobox 1 ', 'P43699', '7080', 'chr14: 36,516,392-36,521,149'),
('TJP1', 'tight junction protein 1 ', 'Q07157', '7082', 'chr15: 29,699,367-29,968,865'),
('TK1', 'thymidine kinase 1, soluble ', 'P04183', '7083', 'chr17: 78,174,075-78,187,233'),
('TK2', 'thymidine kinase 2, mitochondrial ', 'O00142', '7084', 'chr16: 66,508,003-66,552,544'),
('TKT', 'transketolase ', 'P29401', '7086', 'chr3: 53,224,707-53,256,052'),
('TLE1', 'transducin like enhancer of split 1 ', 'Q04724', '7088', 'chr9: 81,583,683-81,689,305'),
('TLE3', 'transducin like enhancer of split 3 ', 'Q04726', '7090', 'chr15: 70,047,790-70,098,176'),
('TLN1', 'talin 1 ', 'Q9Y490', '7094', 'chr9: 35,696,948-35,732,395'),
('SEC62', 'SEC62 homolog, preprotein translocation factor ', 'Q99442', '7095', 'chr3: 169,966,635-169,998,373'),
('TLR1', 'toll-like receptor 1 ', 'Q15399', '7096', 'chr4: 38,790,677-38,856,817'),
('BTC', 'betacellulin ', 'P35070', '685', 'chr4: 74,744,759-74,794,686'),
('TLR2', 'toll-like receptor 2 ', 'O60603', '7097', 'chr4: 153,701,500-153,705,699'),
('TLR3', 'toll-like receptor 3 ', 'O15455', '7098', 'chr4: 186,069,152-186,088,069'),
('TLR4', 'toll-like receptor 4 ', 'O00206', '7099', 'chr9: 117,704,332-117,716,871'),
('TLR5', 'toll-like receptor 5 ', 'O60602', '7100', 'chr1: 223,109,406-223,143,282'),
('TSPAN7', 'tetraspanin 7 ', 'P41732', '7102', 'chrX: 38,561,370-38,688,920'),
('TSPAN8', 'tetraspanin 8 ', 'P19075', '7103', 'chr12: 71,125,085-71,441,898'),
('TM4SF4', 'transmembrane 4 L six family member 4 ', 'P48230', '7104', 'chr3: 149,473,974-149,503,281'),
('TSPAN6', 'tetraspanin 6 ', 'O43657', '7105', 'chrX: 100,627,109-100,639,991'),
('TSPAN4', 'tetraspanin 4 ', 'O14817', '7106', 'chr11: 842,808-867,116'),
('GPR137B', 'G protein-coupled receptor 137B ', 'O60478', '7107', 'chr1: 236,142,505-236,221,865'),
('KLF9', 'Kruppel-like factor 9 ', 'Q13886', '687', 'chr9: 70,384,597-70,414,624'),
('TM7SF2', 'transmembrane 7 superfamily member 2 ', 'O76062', '7108', 'chr11: 65,111,845-65,116,384'),
('TRAPPC10', 'trafficking protein particle complex 10 ', 'P48553', '7109', 'chr21: 44,012,319-44,106,552'),
('TMF1', 'TATA element modulatory factor 1 ', 'P82094', '7110', 'chr3: 69,019,827-69,052,303'),
('TMOD1', 'tropomodulin 1 ', 'P28289', '7111', 'chr9: 97,501,180-97,601,748'),
('TMPO', 'thymopoietin ', 'P42166', '7112', 'chr12: 98,515,512-98,550,379'),
('TMPO', 'thymopoietin ', 'P42167', '7112', 'chr12: 98,515,512-98,550,379'),
('TMSB4X', 'thymosin beta 4, X-linked ', 'P62328', '7114', 'chrX: 12,975,108-12,977,227'),
('CLEC3B', 'C-type lectin domain family 3 member B ', 'P05452', '7123', 'chr3: 45,001,548-45,036,071'),
('TNF', 'tumor necrosis factor ', 'P01375', '7124', 'chr6: 31,575,567-31,578,336'),
('TNFAIP2', 'TNF alpha induced protein 2 ', 'Q03169', '7127', 'chr14: 103,123,442-103,137,439'),
('BTF3', 'basic transcription factor 3 ', 'P20290', '689', 'chr5: 73,498,408-73,505,635'),
('TNFAIP3', 'TNF alpha induced protein 3 ', 'P21580', '7128', 'chr6: 137,867,188-137,883,312'),
('TNFAIP6', 'TNF alpha induced protein 6 ', 'P98066', '7130', 'chr2: 151,357,592-151,380,048'),
('TNFRSF1B', 'tumor necrosis factor receptor superfamily member 1B ', 'P20333', '7133', 'chr1: 12,167,003-12,209,228'),
('TNNI3', 'troponin I type 3 (cardiac) ', 'P19429', '7137', 'chr19: 55,151,767-55,157,773'),
('TNNT1', 'troponin T type 1 (skeletal, slow) ', 'P13805', '7138', 'chr19: 55,132,794-55,149,354'),
('TNR', 'tenascin R ', 'Q92752', '7143', 'chr1: 175,315,194-175,743,770'),
('TNS1', 'tensin 1 ', 'Q9HBL0', '7145', 'chr2: 217,799,789-218,002,995'),
('TNXA', 'tenascin XA (pseudogene)', 'Q16473', '7146', 'chr6: 32,085,057-32,088,915'),
('TNXB', 'tenascin XB ', 'P22105', '7148', 'chr6: 32,041,154-32,115,334'),
('TOP1', 'topoisomerase (DNA) I ', 'P11387', '7150', 'chr20: 41,028,818-41,124,487'),
('BTG1', 'B-cell translocation gene 1, anti-proliferative ', 'P62324', '694', 'chr12: 92,140,278-92,145,897'),
('TOP2A', 'topoisomerase (DNA) II alpha ', 'P11388', '7153', 'chr17: 40,388,516-40,417,950'),
('TP53', 'tumor protein p53 ', 'P04637', '7157', 'chr17: 7,661,779-7,687,550'),
('TP53BP2', 'tumor protein p53 binding protein 2 ', 'Q13625', '7159', 'chr1: 223,779,899-223,845,972'),
('TPD52', 'tumor protein D52 ', 'P55327', '7163', 'chr8: 80,034,745-80,231,232'),
('TPD52L1', 'tumor protein D52-like 1 ', 'Q16890', '7164', 'chr6: 125,119,049-125,264,407'),
('TPI1', 'triosephosphate isomerase 1 ', 'P60174', '7167', 'chr12: 6,867,119-6,870,948'),
('TPM1', 'tropomyosin 1 (alpha) ', 'P09493', '7168', 'chr15: 63,042,632-63,071,915'),
('TPM2', 'tropomyosin 2 (beta) ', 'P07951', '7169', 'chr9: 35,681,992-35,691,020'),
('TPM3', 'tropomyosin 3 ', 'P06753', '7170', 'chr1: 154,155,304-154,194,648'),
('TPM4', 'tropomyosin 4 ', 'P67936', '7171', 'chr19: 16,067,021-16,103,005'),
('BUB1', 'BUB1, mitotic checkpoint serine/threonine kinase ', 'O43683', '699', 'chr2: 110,637,698-110,678,114'),
('TPMT', 'thiopurine S-methyltransferase ', 'P51580', '7172', 'chr6: 18,128,311-18,155,074'),
('TPP2', 'tripeptidyl peptidase II ', 'P29144', '7174', 'chr13: 102,597,003-102,679,958'),
('TPR', 'translocated promoter region, nuclear basket protein ', 'P12270', '7175', 'chr1: 186,311,652-186,375,693'),
('TPT1', 'tumor protein, translationally-controlled 1 ', 'P13693', '7178', 'chr13: 45,333,471-45,341,370'),
('TPTE', 'transmembrane phosphatase with tensin homology ', 'P56180', '7179', 'chr21: 10,521,553-10,606,140'),
('HSP90B1', 'heat shock protein 90kDa beta family member 1 ', 'P14625', '7184', 'chr12: 103,930,107-103,953,645'),
('TRAF1', 'TNF receptor associated factor 1 ', 'Q13077', '7185', 'chr9: 120,902,393-120,929,173'),
('TRH', 'thyrotropin-releasing hormone ', 'P20396', '7200', 'chr3: 129,974,305-129,977,938'),
('CCT3', 'chaperonin containing TCP1, subunit 3 (gamma) ', 'P49368', '7203', 'chr1: 156,308,968-156,367,873'),
('TRIP6', 'thyroid hormone receptor interactor 6 ', 'Q15654', '7205', 'chr7: 100,867,138-100,873,454'),
('BUB1B', 'BUB1B, mitotic checkpoint serine/threonine kinase ', 'O60566', '701', 'chr15: 40,161,023-40,221,136'),
('TRPC1', 'transient receptor potential cation channel, subfamily C, member 1 ', 'P48995', '7220', 'chr3: 142,724,074-142,807,888'),
('TRPC3', 'transient receptor potential cation channel, subfamily C, member 3 ', 'Q13507', '7222', 'chr4: 121,879,027-121,951,754'),
('TRPC6', 'transient receptor potential cation channel, subfamily C, member 6 ', 'Q9Y210', '7225', 'chr11: 101,451,564-101,872,562'),
('TRPS1', 'trichorhinophalangeal syndrome I ', 'Q9UHF7', '7227', 'chr8: 115,408,496-115,809,673'),
('TSN', 'translin ', 'Q15631', '7247', 'chr2: 121,737,103-121,767,853'),
('TSC2', 'tuberous sclerosis 2 ', 'P49815', '7249', 'chr16: 2,047,465-2,088,720'),
('PHLDA2', 'pleckstrin homology-like domain, family A, member 2 ', 'Q53GA4', '7262', 'chr11: 2,928,273-2,929,455'),
('TTC1', 'tetratricopeptide repeat domain 1 ', 'Q99614', '7265', 'chr5: 160,009,113-160,065,543'),
('DNAJC7', 'DnaJ heat shock protein family (Hsp40) member C7 ', 'Q99615', '7266', 'chr17: 41,976,433-42,021,376'),
('TTC3', 'tetratricopeptide repeat domain 3 ', 'P53804', '7267', 'chr21: 37,073,226-37,203,112'),
('TSPO', 'translocator protein ', 'P30536', '706', 'chr22: 43,151,514-43,163,242'),
('TTK', 'TTK protein kinase ', 'P33981', '7272', 'chr6: 80,003,887-80,042,527'),
('TTN', 'titin ', 'Q8WZ42', '7273', 'chr2: 178,525,989-178,830,802'),
('TTR', 'transthyretin ', 'P02766', '7276', 'chr18: 31,591,726-31,599,021'),
('TUBA4A', 'tubulin alpha 4a ', 'P68366', '7277', 'chr2: 219,249,711-219,278,170'),
('TUBB2A', 'tubulin beta 2A class IIa ', 'Q13885', '7280', 'chr6: 3,153,669-3,157,526'),
('TUBG1', 'tubulin gamma 1 ', 'P23258', '7283', 'chr17: 42,609,676-42,615,234'),
('TULP3', 'tubby like protein 3 ', 'O75386', '7289', 'chr12: 2,877,223-2,941,140'),
('HIRA', 'histone cell cycle regulator ', 'P54198', '7290', 'chr22: 19,330,698-19,447,450'),
('TWIST1', 'twist family bHLH transcription factor 1 ', 'Q15672', '7291', 'chr7: 19,020,991-19,117,672'),
('TNFSF4', 'tumor necrosis factor superfamily member 4 ', 'P23510', '7292', 'chr1: 173,183,734-173,207,313'),
('ACTN2', 'actinin, alpha 2 ', 'P35609', '88', 'chr1: 236,686,454-236,764,631'),
('C1QBP', 'complement component 1, q subcomponent binding protein ', 'Q07021', '708', 'chr17: 5,432,777-5,448,830'),
('TXN', 'thioredoxin ', 'P10599', '7295', 'chr9: 110,243,811-110,256,640'),
('TXNRD1', 'thioredoxin reductase 1 ', 'Q16881', '7296', 'chr12: 104,215,779-104,350,305'),
('TYMS', 'thymidylate synthetase ', 'P04818', '7298', 'chr18: 657,604-673,578'),
('TYR', 'tyrosinase ', 'P14679', '7299', 'chr11: 89,177,452-89,295,759'),
('TYRO3', 'TYRO3 protein tyrosine kinase ', 'Q06418', '7301', 'chr15: 41,557,675-41,583,586'),
('TYROBP', 'TYRO protein tyrosine kinase binding protein ', 'O43914', '7305', 'chr19: 35,904,401-35,908,295'),
('UBA52', 'ubiquitin A-52 residue ribosomal protein fusion product 1 ', 'P62987', '7311', 'chr19: 18,571,730-18,577,550'),
('UBC', 'ubiquitin C ', 'P0CG48', '7316', 'chr12: 124,911,604-124,917,368'),
('UBA1', 'ubiquitin-like modifier activating enzyme 1 ', 'P22314', '7317', 'chrX: 47,190,861-47,215,128'),
('UBA7', 'ubiquitin-like modifier activating enzyme 7 ', 'P41226', '7318', 'chr3: 49,805,207-49,813,946'),
('SERPING1', 'serpin peptidase inhibitor, clade G (C1 inhibitor), member 1 ', 'P05155', '710', 'chr11: 57,597,387-57,614,853'),
('UBE2A', 'ubiquitin conjugating enzyme E2A ', 'P49459', '7319', 'chrX: 119,574,467-119,591,083'),
('UBE2B', 'ubiquitin conjugating enzyme E2B ', 'P63146', '7320', 'chr5: 134,371,179-134,391,992'),
('UBE2D3', 'ubiquitin conjugating enzyme E2D 3 ', 'P61077', '7323', 'chr4: 102,794,383-102,868,896'),
('UBE2E1', 'ubiquitin conjugating enzyme E2E 1 ', 'P51965', '7324', 'chr3: 23,805,903-23,891,316'),
('UBE2E2', 'ubiquitin conjugating enzyme E2E 2 ', 'Q96LR5', '7325', 'chr3: 23,203,020-23,591,793'),
('UBE2H', 'ubiquitin conjugating enzyme E2H ', 'P62256', '7328', 'chr7: 129,830,732-129,952,949'),
('UBE2I', 'ubiquitin conjugating enzyme E2I ', 'P63279', '7329', 'chr16: 1,308,880-1,327,018'),
('UBE2V1', 'ubiquitin conjugating enzyme E2 variant 1 ', 'Q13404', '7335', 'chr20: 50,081,124-50,115,959'),
('UBE2V2', 'ubiquitin conjugating enzyme E2 variant 2 ', 'Q15819', '7336', 'chr8: 48,008,400-48,064,708'),
('UBTF', 'upstream binding transcription factor, RNA polymerase I ', 'P17480', '7343', 'chr17: 44,205,033-44,221,626'),
('C1QA', 'complement component 1, q subcomponent, A chain ', 'P02745', '712', 'chr1: 22,636,506-22,639,608'),
('UCHL1', 'ubiquitin C-terminal hydrolase L1 ', 'P09936', '7345', 'chr4: 41,256,413-41,268,455'),
('UCHL3', 'ubiquitin C-terminal hydrolase L3 ', 'P15374', '7347', 'chr13: 75,549,480-75,606,020'),
('UCP1', 'uncoupling protein 1 (mitochondrial, proton carrier) ', 'P25874', '7350', 'chr4: 140,559,434-140,568,805'),
('UCP2', 'uncoupling protein 2 (mitochondrial, proton carrier) ', 'P55851', '7351', 'chr11: 73,974,667-73,983,307'),
('UCP3', 'uncoupling protein 3 (mitochondrial, proton carrier) ', 'P55916', '7352', 'chr11: 74,000,281-74,009,435'),
('UFD1L', 'ubiquitin fusion degradation 1 like (yeast) ', 'Q92890', '7353', 'chr22: 19,449,910-19,479,215'),
('SLC35A2', 'solute carrier family 35 (UDP-galactose transporter), member A2 ', 'P78381', '7355', 'chrX: 48,903,180-48,911,958'),
('UGCG', 'UDP-glucose ceramide glucosyltransferase ', 'Q16739', '7357', 'chr9: 111,896,766-111,935,369'),
('UGDH', 'UDP-glucose 6-dehydrogenase ', 'O60701', '7358', 'chr4: 39,498,755-39,528,311'),
('UGP2', 'UDP-glucose pyrophosphorylase 2 ', 'Q16851', '7360', 'chr2: 63,840,940-63,891,562'),
('C1R', 'complement component 1, r subcomponent ', 'P00736', '715', 'chr12: 7,080,209-7,092,607'),
('UGT2B4', 'UDP glucuronosyltransferase 2 family, polypeptide B4 ', 'P06133', '7363', 'chr4: 69,480,165-69,526,014'),
('UCK2', 'uridine-cytidine kinase 2 ', 'Q9BZX2', '7371', 'chr1: 165,827,531-165,911,618'),
('UMPS', 'uridine monophosphate synthetase ', 'P11172', '7372', 'chr3: 124,730,366-124,749,273'),
('COL14A1', 'collagen, type XIV, alpha 1 ', 'Q05707', '7373', 'chr8: 120,059,780-120,372,036'),
('UNG', 'uracil DNA glycosylase ', 'P13051', '7374', 'chr12: 109,097,574-109,110,992'),
('NR1H2', 'nuclear receptor subfamily 1 group H member 2 ', 'P55055', '7376', 'chr19: 50,329,653-50,382,982'),
('UPP1', 'uridine phosphorylase 1 ', 'Q16831', '7378', 'chr7: 48,088,628-48,108,733'),
('UQCRB', 'ubiquinol-cytochrome c reductase binding protein ', 'P14927', '7381', 'chr8: 96,225,920-96,235,634'),
('UQCRC1', 'ubiquinol-cytochrome c reductase core protein I ', 'P31930', '7384', 'chr3: 48,599,002-48,610,976'),
('UQCRC2', 'ubiquinol-cytochrome c reductase core protein II ', 'P22695', '7385', 'chr16: 21,952,660-21,983,660'),
('C1S', 'complement component 1, s subcomponent ', 'P09871', '716', 'chr12: 6,988,259-7,071,032'),
('UQCRFS1', 'ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1 ', 'P47985', '7386', 'chr19: 29,205,321-29,213,541'),
('UQCRH', 'ubiquinol-cytochrome c reductase hinge protein ', 'P07919', '7388', 'chr1: 46,303,631-46,316,776'),
('UROD', 'uroporphyrinogen decarboxylase ', 'P06132', '7389', 'chr1: 45,012,147-45,015,575'),
('USF2', 'upstream transcription factor 2, c-fos interacting ', 'Q15853', '7392', 'chr19: 35,268,978-35,279,821'),
('USP1', 'ubiquitin specific peptidase 1 ', 'O94782', '7398', 'chr1: 62,436,297-62,451,804'),
('KDM6A', 'lysine (K)-specific demethylase 6A ', 'O15550', '7403', 'chrX: 44,873,177-45,112,602'),
('UTY', 'ubiquitously transcribed tetratricopeptide repeat containing, Y-linked ', 'O14607', '7404', 'chrY: 13,248,379-13,480,673'),
('VAV1', 'vav guanine nucleotide exchange factor 1 ', 'P15498', '7409', 'chr19: 6,772,714-6,857,366'),
('VCAM1', 'vascular cell adhesion molecule 1 ', 'P19320', '7412', 'chr1: 100,719,742-100,739,045'),
('VCP', 'valosin containing protein ', 'P55072', '7415', 'chr9: 35,056,064-35,073,249'),
('C3', 'complement component 3 ', 'P01024', '718', 'chr19: 6,677,704-6,730,562'),
('VDAC2', 'voltage-dependent anion channel 2 ', 'P45880', '7417', 'chr10: 75,210,154-75,231,448'),
('VDAC3', 'voltage-dependent anion channel 3 ', 'Q9Y277', '7419', 'chr8: 42,391,624-42,405,897'),
('VDR', 'vitamin D (1,25- dihydroxyvitamin D3) receptor ', 'P11473', '7421', 'chr12: 47,841,537-47,943,048'),
('VEGFA', 'vascular endothelial growth factor A ', 'P15692', '7422', 'chr6: 43,770,184-43,786,487'),
('VEGFB', 'vascular endothelial growth factor B ', 'P49765', '7423', 'chr11: 64,234,538-64,238,793'),
('VEGFC', 'vascular endothelial growth factor C ', 'P49767', '7424', 'chr4: 176,683,538-176,792,727'),
('EZR', 'ezrin ', 'P15311', '7430', 'chr6: 158,765,741-158,819,412'),
('VIM', 'vimentin ', 'P08670', '7431', 'chr10: 17,228,259-17,237,593'),
('VLDLR', 'very low density lipoprotein receptor ', 'P98155', '7436', 'chr9: 2,621,834-2,660,053'),
('BEST1', 'bestrophin 1 ', 'O76090', '7439', 'chr11: 61,949,821-61,965,515'),
('C4A', 'complement component 4A (Rodgers blood group) ', 'P0C0L4', '720', 'chr6: 31,982,024-32,002,681'),
('TRPV1', 'transient receptor potential cation channel, subfamily V, member 1 ', 'Q8NER1', '7442', 'chr17: 3,565,444-3,609,411'),
('VRK1', 'vaccinia related kinase 1 ', 'Q99986', '7443', 'chr14: 96,797,304-96,931,722'),
('VTN', 'vitronectin ', 'P04004', '7448', 'chr17: 28,367,276-28,373,091'),
('VWF', 'von Willebrand factor ', 'P04275', '7450', 'chr12: 5,948,874-6,124,770'),
('CLIP2', 'CAP-Gly domain containing linker protein 2 ', 'Q9UDT6', '7461', 'chr7: 74,289,475-74,405,943'),
('CORO2A', 'coronin, actin binding protein, 2A ', 'Q92828', '7464', 'chr9: 98,120,975-98,192,640'),
('WEE1', 'WEE1 G2 checkpoint kinase ', 'P30291', '7465', 'chr11: 9,573,681-9,593,457'),
('WHSC1', 'Wolf-Hirschhorn syndrome candidate 1 ', 'O96028', '7468', 'chr4: 1,871,424-1,982,207'),
('WNT2', 'wingless-type MMTV integration site family member 2 ', 'P09544', '7472', 'chr7: 117,276,631-117,323,289'),
('WNT3', 'wingless-type MMTV integration site family member 3 ', 'P56703', '7473', 'chr17: 46,762,506-46,833,154'),
('C4B', 'complement component 4B (Chido blood group) ', 'P0C0L5', '721', 'chr6: 32,014,762-32,035,418'),
('WNT5A', 'wingless-type MMTV integration site family member 5A ', 'P41221', '7474', 'chr3: 55,465,715-55,490,539'),
('WNT6', 'wingless-type MMTV integration site family member 6 ', 'Q9Y6F9', '7475', 'chr2: 218,859,821-218,874,233'),
('WNT2B', 'wingless-type MMTV integration site family member 2B ', 'Q93097', '7482', 'chr1: 112,466,541-112,530,165'),
('WRB', 'tryptophan rich basic protein ', 'O00258', '7485', 'chr21: 39,380,244-39,428,528'),
('WT1', 'Wilms tumor 1 ', 'P19544', '7490', 'chr11: 32,387,775-32,435,630'),
('XBP1', 'X-box binding protein 1 ', 'P17861', '7494', 'chr22: 28,794,555-28,800,597'),
('XDH', 'xanthine dehydrogenase ', 'P47989', '7498', 'chr2: 31,334,321-31,414,715'),
('XIST', 'X inactive specific transcript (non-protein coding)', 'N/A', '7503', 'chrX: 73,820,651-73,852,753'),
('XPA', 'xeroderma pigmentosum, complementation group A ', 'P23025', '7507', 'chr9: 97,674,909-97,697,357'),
('XPC', 'xeroderma pigmentosum, complementation group C ', 'Q01831', '7508', 'chr3: 14,145,147-14,178,783'),
('CAPN5', 'calpain 5 ', 'O15484', '726', 'chr11: 77,066,932-77,126,155'),
('XPO1', 'exportin 1 ', 'O14980', '7514', 'chr2: 61,477,849-61,538,626'),
('XRCC4', 'X-ray repair complementing defective repair in Chinese hamster cells 4 ', 'Q13426', '7518', 'chr5: 83,077,498-83,353,787'),
('XRCC5', 'X-ray repair complementing defective repair in Chinese hamster cells 5 ', 'P13010', '7520', 'chr2: 216,107,464-216,206,303'),
('YY1', 'YY1 transcription factor ', 'P25490', '7528', 'chr14: 100,238,298-100,282,792'),
('YWHAB', 'tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta ', 'P31946', '7529', 'chr20: 44,885,676-44,908,532'),
('YWHAE', 'tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon ', 'P62258', '7531', 'chr17: 1,344,272-1,400,378'),
('YWHAH', 'tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta ', 'Q04917', '7533', 'chr22: 31,944,461-31,957,603'),
('YWHAZ', 'tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta ', 'P63104', '7534', 'chr8: 100,916,525-100,953,388'),
('ZFP36', 'ZFP36 ring finger protein ', 'P26651', '7538', 'chr19: 39,406,813-39,409,412'),
('ZFPL1', 'zinc finger protein-like 1 ', 'O95159', '7542', 'chr11: 65,084,223-65,088,400'),
('C5AR1', 'complement component 5a receptor 1 ', 'P21730', '728', 'chr19: 47,290,023-47,322,066'),
('ZFX', 'zinc finger protein, X-linked ', 'P17010', '7543', 'chrX: 24,149,173-24,216,255'),
('ZFY', 'zinc finger protein, Y-linked ', 'P08048', '7544', 'chrY: 2,935,281-2,982,506'),
('ZIC1', 'Zic family member 1 ', 'Q15915', '7545', 'chr3: 147,393,422-147,510,293'),
('ZNF2', 'zinc finger protein 2 ', 'Q9BSG1', '7549', 'chr2: 95,165,432-95,184,317'),
('ZNF12', 'zinc finger protein 12 ', 'P17014', '7559', 'chr7: 6,688,433-6,706,923'),
('ZNF14', 'zinc finger protein 14 ', 'P17017', '7561', 'chr19: 19,710,471-19,733,097'),
('ZNF17', 'zinc finger protein 17 ', 'P17021', '7565', 'chr19: 57,411,163-57,421,939'),
('ZNF19', 'zinc finger protein 19 ', 'P17023', '7567', 'chr16: 71,464,555-71,565,089'),
('ZNF20', 'zinc finger protein 20 ', 'P17024', '7568', 'chr19: 12,092,843-12,140,407'),
('ZNF182', 'zinc finger protein 182 ', 'P17025', '7569', 'chrX: 47,974,851-48,003,978'),
('ACVR1', 'activin A receptor type I ', 'Q04771', '90', 'chr2: 157,736,444-157,875,862'),
('C6', 'complement component 6 ', 'P13671', '729', 'chr5: 41,142,234-41,261,438'),
('ZNF22', 'zinc finger protein 22 ', 'P17026', '7570', 'chr10: 45,000,475-45,005,326'),
('ZNF23', 'zinc finger protein 23 ', 'P17027', '7571', 'chr16: 71,447,597-71,463,095'),
('ZNF24', 'zinc finger protein 24 ', 'P17028', '7572', 'chr18: 35,332,212-35,345,482'),
('ZNF33A', 'zinc finger protein 33A ', 'Q06730', '7581', 'chr10: 38,010,650-38,065,088'),
('ZKSCAN1', 'zinc finger with KRAB and SCAN domains 1 ', 'P17029', '7586', 'chr7: 100,015,572-100,041,689'),
('MZF1', 'myeloid zinc finger 1 ', 'P28698', '7593', 'chr19: 58,561,931-58,573,575'),
('ZNF43', 'zinc finger protein 43 ', 'P17038', '7594', 'chr19: 21,804,949-21,852,125'),
('ZNF75A', 'zinc finger protein 75a ', 'Q96N20', '7627', 'chr16: 3,305,406-3,318,852'),
('ZNF84', 'zinc finger protein 84 ', 'P51523', '7637', 'chr12: 133,037,292-133,063,304'),
('ZNF85', 'zinc finger protein 85 ', 'Q03923', '7639', 'chr19: 20,923,222-20,950,697'),
('C7', 'complement component 7 ', 'P10643', '730', 'chr5: 40,909,252-40,982,939'),
('ZNF91', 'zinc finger protein 91 ', 'Q05481', '7644', 'chr19: 23,304,991-23,395,560'),
('ZNF222', 'zinc finger protein 222 ', 'Q9UK12', '7673', 'chr19: 44,025,342-44,033,112'),
('ZNF124', 'zinc finger protein 124 ', 'Q15973', '7678', 'chr1: 247,121,975-247,172,016'),
('ZNF133', 'zinc finger protein 133 ', 'P52736', '7692', 'chr20: 18,288,283-18,316,996'),
('ZNF136', 'zinc finger protein 136 ', 'P52737', '7695', 'chr19: 12,163,064-12,189,881'),
('ZNF138', 'zinc finger protein 138 ', 'P52744', '7697', 'chr7: 64,794,388-64,833,681'),
('ZNF140', 'zinc finger protein 140 ', 'P52738', '7699', 'chr12: 133,079,838-133,107,544'),
('ZNF141', 'zinc finger protein 141 ', 'Q15928', '7700', 'chr4: 337,814-384,864'),
('ZBTB16', 'zinc finger and BTB domain containing 16 ', 'Q05516', '7704', 'chr11: 114,059,593-114,250,676'),
('TRIM25', 'tripartite motif containing 25 ', 'Q14258', '7706', 'chr17: 56,887,909-56,914,038'),
('C8G', 'complement component 8, gamma polypeptide ', 'P07360', '733', 'chr9: 136,945,246-136,946,974'),
('ZNF148', 'zinc finger protein 148 ', 'Q9UQR1', '7707', 'chr3: 125,225,561-125,375,354'),
('ZBTB17', 'zinc finger and BTB domain containing 17 ', 'Q13105', '7709', 'chr1: 15,941,869-15,976,132'),
('VEZF1', 'vascular endothelial zinc finger 1 ', 'Q14119', '7716', 'chr17: 57,971,547-57,988,259'),
('TRIM26', 'tripartite motif containing 26 ', 'Q12899', '7726', 'chr6: 30,184,455-30,213,427'),
('ZNF175', 'zinc finger protein 175 ', 'Q9Y473', '7728', 'chr19: 51,571,298-51,592,508'),
('ZNF185', 'zinc finger protein 185 (LIM domain) ', 'O15231', '7739', 'chrX: 152,914,442-152,973,480'),
('ZSCAN26', 'zinc finger and SCAN domain containing 26 ', 'Q16670', '7741', 'chr6: 28,267,010-28,278,224'),
('ZNF189', 'zinc finger protein 189 ', 'O75820', '7743', 'chr9: 101,398,873-101,410,660'),
('ZSCAN9', 'zinc finger and SCAN domain containing 9 ', 'O15535', '7746', 'chr6: 28,224,886-28,233,482'),
('ZMYM2', 'zinc finger, MYM-type 2 ', 'Q9UBW7', '7750', 'chr13: 19,958,670-20,091,829'),
('MPPED2', 'metallophosphoesterase domain containing 2 ', 'Q15777', '744', 'chr11: 30,384,493-30,586,872'),
('ZNF200', 'zinc finger protein 200 ', 'P98182', '7752', 'chr16: 3,222,325-3,236,221'),
('ZNF205', 'zinc finger protein 205 ', 'O95201', '7755', 'chr16: 3,112,560-3,120,517'),
('ZNF207', 'zinc finger protein 207 ', 'O43670', '7756', 'chr17: 32,350,117-32,381,886'),
('ZNF213', 'zinc finger protein 213 ', 'O14771', '7760', 'chr16: 3,129,777-3,142,805'),
('ZFAND5', 'zinc finger, AN1-type domain 5 ', 'O76080', '7763', 'chr9: 72,351,425-72,365,235'),
('ZNF217', 'zinc finger protein 217 ', 'O75362', '7764', 'chr20: 53,567,065-53,609,907'),
('ZNF224', 'zinc finger protein 224 ', 'Q9NZL3', '7767', 'chr19: 44,094,339-44,109,886'),
('ZNF226', 'zinc finger protein 226 ', 'Q9NYT6', '7769', 'chr19: 44,165,073-44,178,381'),
('ZNF112', 'zinc finger protein 112 ', 'Q9UJU3', '7771', 'chr19: 44,326,555-44,367,217'),
('ZNF230', 'zinc finger protein 230 ', 'Q9UIE0', '7773', 'chr19: 44,002,948-44,013,926'),
('MYRF', 'myelin regulatory factor ', 'Q9Y2G1', '745', 'chr11: 61,752,642-61,788,518'),
('ZNF236', 'zinc finger protein 236 ', 'Q9UL36', '7776', 'chr18: 76,822,607-76,970,727'),
('SLC30A1', 'solute carrier family 30 (zinc transporter), member 1 ', 'Q9Y6M5', '7779', 'chr1: 211,571,568-211,578,742'),
('ZP3', 'zona pellucida glycoprotein 3 (sperm receptor) ', 'P21754', '7784', 'chr7: 76,397,518-76,442,071'),
('ZYX', 'zyxin ', 'Q15942', '7791', 'chr7: 143,381,080-143,391,111'),
('PRDM2', 'PR domain containing 2, with ZNF domain ', 'Q13029', '7799', 'chr1: 13,700,198-13,825,079'),
('DNALI1', 'dynein, axonemal, light intermediate chain 1 ', 'O14645', '7802', 'chr1: 37,556,919-37,566,857'),
('PTP4A1', 'protein tyrosine phosphatase type IVA, member 1 ', 'Q93096', '7803', 'chr6: 63,521,748-63,583,587'),
('LAPTM5', 'lysosomal protein transmembrane 5 ', 'Q13571', '7805', 'chr1: 30,732,469-30,757,820'),
('DAP3', 'death associated protein 3 ', 'P51398', '7818', 'chr1: 155,687,960-155,739,010'),
('BTG2', 'BTG family member 2 ', 'P78543', '7832', 'chr1: 203,305,491-203,309,602'),
('PTTG1IP', 'pituitary tumor-transforming 1 interacting protein ', 'P53801', '754', 'chr21: 44,849,585-44,873,903'),
('RNF103', 'ring finger protein 103 ', 'O00237', '7844', 'chr2: 86,603,393-86,623,866'),
('TUBA1A', 'tubulin alpha 1a ', 'Q71U36', '7846', 'chr12: 49,184,796-49,189,324'),
('PAX8', 'paired box 8 ', 'Q06710', '7849', 'chr2: 113,215,997-113,278,950'),
('IL1R2', 'interleukin 1 receptor, type II ', 'P27930', '7850', 'chr2: 101,991,844-102,028,544'),
('MALL', 'mal, T-cell differentiation protein-like ', 'Q13021', '7851', 'chr2: 110,083,870-110,116,566'),
('CXCR4', 'chemokine (C-X-C motif) receptor 4 ', 'P61073', '7852', 'chr2: 136,114,349-136,118,165'),
('SCG2', 'secretogranin II ', 'P13521', '7857', 'chr2: 223,596,940-223,602,503'),
('IFRD2', 'interferon-related developmental regulator 2 ', 'Q12894', '7866', 'chr3: 50,287,732-50,292,918'),
('SEMA3B', 'sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B ', 'Q13214', '7869', 'chr3: 50,267,558-50,277,546'),
('SLMAP', 'sarcolemma associated protein ', 'Q14BN4', '7871', 'chr3: 57,755,450-57,929,168'),
('C21orf2', 'chromosome 21 open reading frame 2 ', 'O43822', '755', 'chr21: 44,328,944-44,339,402'),
('RAB7A', 'RAB7A, member RAS oncogene family ', 'P51149', '7879', 'chr3: 128,726,122-128,814,796'),
('SLBP', 'stem-loop binding protein ', 'Q14493', '7884', 'chr4: 1,692,800-1,712,555'),
('ST8SIA4', 'ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4 ', 'Q92187', '7903', 'chr5: 100,806,935-100,903,266'),
('REEP5', 'receptor accessory protein 5 ', 'Q00765', '7905', 'chr5: 112,876,379-112,922,539'),
('DEK', 'DEK proto-oncogene ', 'P35659', '7913', 'chr6: 18,223,868-18,264,823'),
('PRRC2A', 'proline-rich coiled-coil 2A ', 'P48634', '7916', 'chr6: 31,620,720-31,637,771'),
('PLA2G7', 'phospholipase A2 group VII ', 'Q13093', '7941', 'chr6: 46,704,201-46,735,693'),
('TFEB', 'transcription factor EB ', 'P19484', '7942', 'chr6: 41,683,978-41,736,259'),
('EPM2A', 'epilepsy, progressive myoclonus type 2A, Lafora disease (laforin) ', 'O95278', '7957', 'chr6: 145,382,535-145,736,023'),
('MTERF1', 'mitochondrial transcription termination factor 1 ', 'Q99551', '7978', 'chr7: 91,692,008-91,880,720'),
('TMEM50B', 'transmembrane protein 50B ', 'P56557', '757', 'chr21: 33,432,485-33,480,011'),
('SHFM1', 'split hand/foot malformation (ectrodactyly) type 1 ', 'P60896', '7979', 'chr7: 96,481,626-96,709,891'),
('TFPI2', 'tissue factor pathway inhibitor 2 ', 'P48307', '7980', 'chr7: 93,885,397-93,890,991'),
('ARHGEF5', 'Rho guanine nucleotide exchange factor 5 ', 'Q12774', '7984', 'chr7: 144,355,288-144,380,632'),
('UBXN8', 'UBX domain protein 8 ', 'O00124', '7993', 'chr8: 30,732,247-30,767,006'),
('KAT6A', 'K(lysine) acetyltransferase 6A ', 'Q92794', '7994', 'chr8: 41,929,479-42,051,990'),
('NR4A3', 'nuclear receptor subfamily 4 group A member 3 ', 'Q92570', '8013', 'chr9: 99,821,855-99,866,891'),
('BRD3', 'bromodomain containing 3 ', 'Q15059', '8019', 'chr9: 134,030,305-134,068,535'),
('STAM', 'signal transducing adaptor molecule ', 'Q92783', '8027', 'chr10: 17,644,125-17,715,914'),
('MLLT10', 'myeloid/lymphoid or mixed-lineage leukemia; translocated to, 10 ', 'P55197', '8028', 'chr10: 21,524,675-21,743,630'),
('CCDC6', 'coiled-coil domain containing 6 ', 'Q16204', '8030', 'chr10: 59,788,763-59,906,656'),
('CA2', 'carbonic anhydrase II ', 'P00918', '760', 'chr8: 85,463,852-85,481,493'),
('NCOA4', 'nuclear receptor coactivator 4 ', 'Q13772', '8031', 'chr10: 46,005,088-46,030,714'),
('SLC25A16', 'solute carrier family 25 (mitochondrial carrier), member 16 ', 'P16260', '8034', 'chr10: 68,477,999-68,527,474'),
('ADAM12', 'ADAM metallopeptidase domain 12 ', 'O43184', '8038', 'chr10: 126,012,381-126,388,455'),
('FOSL1', 'FOS-like antigen 1 ', 'P15407', '8061', 'chr11: 65,892,049-65,900,573'),
('CUL5', 'cullin 5 ', 'Q93034', '8065', 'chr11: 108,008,733-108,107,776'),
('PTP4A2', 'protein tyrosine phosphatase type IVA, member 2 ', 'Q12974', '8073', 'chr1: 31,906,421-31,944,856'),
('MFAP5', 'microfibrillar associated protein 5 ', 'Q13361', '8076', 'chr12: 8,637,346-8,662,888'),
('SSPN', 'sarcospan ', 'Q14714', '8082', 'chr12: 26,121,991-26,299,290'),
('FXR1', 'fragile X mental retardation, autosomal homolog 1 ', 'P51114', '8087', 'chr3: 180,868,141-180,982,753'),
('YEATS4', 'YEATS domain containing 4 ', 'O95619', '8089', 'chr12: 69,359,703-69,390,796'),
('CA3', 'carbonic anhydrase III ', 'P07451', '761', 'chr8: 85,373,436-85,449,040'),
('HMGA2', 'high mobility group AT-hook 2 ', 'P52926', '8091', 'chr12: 65,824,131-65,966,295'),
('CDK2AP1', 'cyclin-dependent kinase 2 associated protein 1 ', 'O14519', '8099', 'chr12: 123,260,971-123,272,334'),
('PABPN1', 'poly(A) binding protein, nuclear 1 ', 'Q86U42', '8106', 'chr14: 23,321,289-23,326,185'),
('DPF3', 'D4, zinc and double PHD fingers, family 3 ', 'Q92784', '8110', 'chr14: 72,619,296-72,894,116'),
('PWAR5', 'Prader Willi/Angelman region R  5', 'N/A', '8123', 'chr15: 24,985,053-24,988,232'),
('ANP32A', 'acidic nuclear phosphoprotein 32 family member A ', 'P39687', '8125', 'chr15: 68,778,535-68,820,897'),
('NPRL3', 'NPR3-like, GATOR1 complex subunit ', 'Q12980', '8131', 'chr16: 84,271-138,860'),
('SLC7A5', 'solute carrier family 7 (amino acid transporter light chain, L system), member 5 ', 'Q01650', '8140', 'chr16: 87,830,023-87,869,488'),
('TAF15', 'TATA-box binding protein associated factor 15 ', 'Q92804', '8148', 'chr17: 35,713,791-35,864,615'),
('COIL', 'coilin ', 'P38432', '8161', 'chr17: 56,938,187-56,961,054'),
('ACVR1B', 'activin A receptor type IB ', 'P36896', '91', 'chr12: 51,951,667-51,997,078'),
('CA4', 'carbonic anhydrase IV ', 'P22748', '762', 'chr17: 60,149,936-60,170,899'),
('AKAP1', 'A-kinase anchoring protein 1 ', 'Q92667', '8165', 'chr17: 57,085,092-57,121,349'),
('SYMPK', 'symplekin ', 'Q92797', '8189', 'chr19: 45,815,410-45,863,290'),
('CLPP', 'caseinolytic mitochondrial matrix peptidase proteolytic subunit ', 'Q16740', '8192', 'chr19: 6,361,452-6,368,908'),
('MKKS', 'McKusick-Kaufman syndrome ', 'Q9NPJ1', '8195', 'chr20: 10,401,009-10,434,222'),
('GDF5', 'growth differentiation factor 5 ', 'P43026', '8200', 'chr20: 35,433,347-35,454,746'),
('NCOA3', 'nuclear receptor coactivator 3 ', 'Q9Y6Q9', '8202', 'chr20: 47,501,902-47,656,877'),
('NRIP1', 'nuclear receptor interacting protein 1 ', 'P48552', '8204', 'chr21: 14,961,235-15,065,936'),
('CHAF1B', 'chromatin assembly factor 1 subunit B ', 'Q13112', '8208', 'chr21: 36,385,378-36,419,015'),
('DGCR6', 'DiGeorge syndrome critical region gene 6 ', 'Q14129', '8214', 'chr22: 18,906,028-18,914,238'),
('USP11', 'ubiquitin specific peptidase 11 ', 'P51784', '8237', 'chrX: 47,232,690-47,248,328'),
('CA8', 'carbonic anhydrase VIII ', 'P35219', '767', 'chr8: 60,187,347-60,281,412'),
('SMC1A', 'structural maintenance of chromosomes 1A ', 'Q14683', '8243', 'chrX: 53,374,149-53,422,728'),
('TMEM187', 'transmembrane protein 187 ', 'Q14656', '8269', 'chrX: 153,972,327-153,983,195'),
('ARID1A', 'AT-rich interaction domain 1A ', 'O14497', '8289', 'chr1: 26,693,236-26,782,104'),
('COLQ', 'collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase ', 'Q9Y215', '8292', 'chr3: 15,450,133-15,521,751'),
('TRRAP', 'transformation/transcription domain-associated protein ', 'Q9Y4A5', '8295', 'chr7: 98,877,933-99,013,243'),
('PICALM', 'phosphatidylinositol binding clathrin assembly protein ', 'Q13492', '8301', 'chr11: 85,957,684-86,069,882'),
('KLRC4', 'killer cell lectin-like receptor subfamily C, member 4 ', 'O43908', '8302', 'chr12: 10,407,382-10,409,757'),
('ACOX2', 'acyl-CoA oxidase 2, branched chain ', 'Q99424', '8309', 'chr3: 58,505,136-58,537,319'),
('ACOX3', 'acyl-CoA oxidase 3, pristanoyl ', 'O15254', '8310', 'chr4: 8,366,282-8,440,723'),
('AXIN1', 'axin 1 ', 'O15169', '8312', 'chr16: 287,440-352,673'),
('CA11', 'carbonic anhydrase XI ', 'O75493', '770', 'chr19: 48,637,942-48,646,312'),
('BAP1', 'BRCA1 associated protein 1 ', 'Q92560', '8314', 'chr3: 52,401,013-52,410,350');
INSERT INTO `geneinfo` (`gene_symbol`, `description`, `uniprot_id`, `entrez_id`, `chr_loc`) VALUES
('CDC7', 'cell division cycle 7 ', 'O00311', '8317', 'chr1: 91,500,893-91,525,764'),
('FZD4', 'frizzled class receptor 4 ', 'Q9ULV1', '8322', 'chr11: 86,945,679-86,955,391'),
('FZD6', 'frizzled class receptor 6 ', 'O60353', '8323', 'chr8: 103,298,433-103,332,866'),
('FZD7', 'frizzled class receptor 7 ', 'O75084', '8324', 'chr2: 202,034,587-202,038,445'),
('FZD8', 'frizzled class receptor 8 ', 'Q9H461', '8325', 'chr10: 35,638,249-35,642,278'),
('HIST1H2AC', 'histone cluster 1, H2ac ', 'Q93077', '8334', 'chr6: 26,124,145-26,139,116'),
('HIST1H2BH', 'histone cluster 1, H2bh ', 'Q93079', '8345', 'chr6: 26,251,651-26,253,710'),
('HIST1H2BC', 'histone cluster 1, H2bc ', 'P62807', '8347', 'chr6: 26,114,873-26,123,926'),
('HIST2H2BE', 'histone cluster 2, H2be ', 'Q16778', '8349', 'chr1: 149,884,459-149,886,652'),
('CA12', 'carbonic anhydrase XII ', 'O43570', '771', 'chr15: 63,321,378-63,382,161'),
('HIST1H3D', 'histone cluster 1 H3 family member d', 'P68431', '8351', 'chr6: 26,195,595-26,199,293'),
('HIST1H4A', 'histone cluster 1, H4d ', 'P62805', '8360', 'chr6: 26,188,765-26,189,076'),
('MAD1L1', 'MAD1 mitotic arrest deficient-like 1 (yeast) ', 'Q9Y6D9', '8379', 'chr7: 1,815,793-2,233,243'),
('OR3A3', 'olfactory receptor family 3 subfamily A member 3 ', 'P47888', '8392', 'chr17: 3,411,370-3,424,070'),
('PIP5K1B', 'phosphatidylinositol-4-phosphate 5-kinase, type I, beta ', 'O14986', '8395', 'chr9: 68,705,414-69,009,176'),
('PIP4K2B', 'phosphatidylinositol-5-phosphate 4-kinase, type II, beta ', 'P78356', '8396', 'chr17: 38,765,689-38,800,126'),
('SPARCL1', 'SPARC like 1 ', 'Q14515', '8404', 'chr4: 87,473,335-87,531,061'),
('TAGLN2', 'transgelin 2 ', 'P37802', '8407', 'chr1: 159,918,107-159,925,732'),
('ULK1', 'unc-51 like autophagy activating kinase 1 ', 'O75385', '8408', 'chr12: 131,894,651-131,923,167'),
('UXT', 'ubiquitously expressed prefoldin like chaperone ', 'Q9UBK9', '8409', 'chrX: 47,651,798-47,659,161'),
('CACNA1C', 'calcium channel, voltage-dependent, L type, alpha 1C subunit ', 'Q13936', '775', 'chr12: 1,970,786-2,697,950'),
('EEA1', 'early endosome antigen 1 ', 'Q15075', '8411', 'chr12: 92,770,637-92,929,331'),
('BCAR3', 'breast cancer anti-estrogen resistance 3 ', 'O75815', '8412', 'chr1: 93,561,786-93,847,150'),
('STX7', 'syntaxin 7 ', 'O15400', '8417', 'chr6: 132,445,867-132,513,198'),
('CMAHP', 'cytidine monophospho-N-acetylneuraminic acid hydroxylase, pseudogene', 'Q9Y471', '8418', 'chr6: 25,081,068-25,166,555'),
('STK24', 'serine/threonine kinase 24 ', 'Q9Y6E0', '8428', 'chr13: 98,445,185-98,577,940'),
('NR0B2', 'nuclear receptor subfamily 0 group B member 2 ', 'Q15466', '8431', 'chr1: 26,911,489-26,913,966'),
('RECK', 'reversion-inducing-cysteine-rich protein with kazal motifs ', 'O95980', '8434', 'chr9: 36,036,433-36,124,451'),
('RAD54L', 'RAD54-like (S. cerevisiae) ', 'Q92698', '8438', 'chr1: 46,247,688-46,278,473'),
('NSMAF', 'neutral sphingomyelinase activation associated factor ', 'Q92636', '8439', 'chr8: 58,583,504-58,659,844'),
('GNPAT', 'glyceronephosphate O-acyltransferase ', 'O15228', '8443', 'chr1: 231,241,207-231,277,973'),
('CACNA1E', 'calcium channel, voltage-dependent, R type, alpha 1E subunit ', 'Q15878', '777', 'chr1: 181,413,102-181,808,084'),
('DYRK2', 'dual specificity tyrosine-(Y)-phosphorylation regulated kinase 2 ', 'Q92630', '8445', 'chr12: 67,648,338-67,665,406'),
('DUSP11', 'dual specificity phosphatase 11 ', 'O75319', '8446', 'chr2: 73,762,184-73,780,157'),
('DHX16', 'DEAH (Asp-Glu-Ala-His) box polypeptide 16 ', 'O60231', '8449', 'chr6: 30,653,119-30,673,037'),
('CUL4B', 'cullin 4B ', 'Q13620', '8450', 'chrX: 120,524,609-120,575,794'),
('CUL4A', 'cullin 4A ', 'Q13619', '8451', 'chr13: 113,208,193-113,267,108'),
('CUL3', 'cullin 3 ', 'Q13618', '8452', 'chr2: 224,470,150-224,585,397'),
('CUL2', 'cullin 2 ', 'Q13617', '8453', 'chr10: 35,008,551-35,090,642'),
('TTF2', 'transcription termination factor, RNA polymerase II ', 'Q9UNY4', '8458', 'chr1: 117,060,303-117,107,453'),
('TPST2', 'tyrosylprotein sulfotransferase 2 ', 'O60704', '8459', 'chr22: 26,521,983-26,596,717'),
('TPST1', 'tyrosylprotein sulfotransferase 1 ', 'O60507', '8460', 'chr7: 66,205,199-66,420,543'),
('DDR1', 'discoidin domain receptor tyrosine kinase 1 ', 'Q08345', '780', 'chr6: 30,876,421-30,900,156'),
('TEAD2', 'TEA domain family member 2 ', 'Q15562', '8463', 'chr19: 49,340,595-49,362,457'),
('SUPT3H', 'SPT3 homolog, SAGA and STAGA complex component ', 'O75486', '8464', 'chr6: 44,809,317-45,377,953'),
('SMARCA5', 'SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5 ', 'O60264', '8467', 'chr4: 143,513,463-143,557,486'),
('SORBS2', 'sorbin and SH3 domain containing 2 ', 'O94875', '8470', 'chr4: 185,585,444-185,956,652'),
('IRS4', 'insulin receptor substrate 4 ', 'O14654', '8471', 'chrX: 108,732,482-108,736,409'),
('OGT', 'O-linked N-acetylglucosamine (GlcNAc) transferase ', 'O15294', '8473', 'chrX: 71,533,083-71,575,897'),
('CDC42BPA', 'CDC42 binding protein kinase alpha (DMPK-like) ', 'Q5VT25', '8476', 'chr1: 226,989,865-227,318,474'),
('HIRIP3', 'HIRA interacting protein 3 ', 'Q9BW71', '8479', 'chr16: 29,992,321-29,996,436'),
('RAE1', 'ribonucleic acid export 1 ', 'P78406', '8480', 'chr20: 57,351,010-57,379,211'),
('OFD1', 'oral-facial-digital syndrome 1 ', 'O75665', '8481', 'chrX: 13,734,745-13,769,353'),
('CACNA2D1', 'calcium channel, voltage-dependent, alpha 2/delta subunit 1 ', 'P54289', '781', 'chr7: 81,946,444-82,443,798'),
('SEMA7A', 'semaphorin 7A, GPI membrane anchor (John Milton Hagen blood group) ', 'O75326', '8482', 'chr15: 74,409,289-74,434,467'),
('CILP', 'cartilage intermediate layer protein ', 'O75339', '8483', 'chr15: 65,194,758-65,211,488'),
('RGS5', 'regulator of G-protein signaling 5 ', 'O15539', '8490', 'chr1: 163,111,121-163,321,791'),
('MAP4K3', 'mitogen-activated protein kinase kinase kinase kinase 3 ', 'Q8IVH8', '8491', 'chr2: 39,249,266-39,437,312'),
('PRSS12', 'protease, serine 12 ', 'P56730', '8492', 'chr4: 118,280,038-118,353,003'),
('PKP4', 'plakophilin 4 ', 'Q99569', '8502', 'chr2: 158,456,964-158,682,879'),
('PEX3', 'peroxisomal biogenesis factor 3 ', 'P56589', '8504', 'chr6: 143,450,807-143,490,010'),
('ENC1', 'ectodermal-neural cortex 1 (with BTB domain) ', 'O14682', '8507', 'chr5: 74,627,406-74,641,424'),
('NIPSNAP1', 'nipsnap homolog 1 (C. elegans) ', 'Q9BPW8', '8508', 'chr22: 29,554,808-29,581,337'),
('ITGA10', 'integrin subunit alpha 10 ', 'O75578', '8515', 'chr1: 145,891,208-145,910,189'),
('CACNB3', 'calcium channel, voltage-dependent, beta 3 subunit ', 'P54284', '784', 'chr12: 48,813,794-48,828,941'),
('IKBKAP', 'inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase complex-associated protein ', 'O95163', '8518', 'chr9: 108,867,517-108,934,116'),
('IFITM1', 'interferon induced transmembrane protein 1 ', 'P13164', '8519', 'chr11: 313,506-315,272'),
('GAS7', 'growth arrest specific 7 ', 'O60861', '8522', 'chr17: 9,910,609-10,198,551'),
('DGKZ', 'diacylglycerol kinase, zeta ', 'Q13574', '8525', 'chr11: 46,332,905-46,380,554'),
('CPZ', 'carboxypeptidase Z ', 'Q66K79', '8532', 'chr4: 8,592,660-8,619,759'),
('CAMK1', 'calcium/calmodulin-dependent protein kinase I ', 'Q14012', '8536', 'chr3: 9,757,342-9,769,992'),
('AGPS', 'alkylglycerone phosphate synthase ', 'O00116', '8540', 'chr2: 177,392,644-177,559,299'),
('LMO4', 'LIM domain only 4 ', 'P61968', '8543', 'chr1: 87,328,468-87,348,923'),
('BLZF1', 'basic leucine zipper nuclear factor 1 ', 'Q9H2G9', '8548', 'chr1: 169,367,970-169,396,540'),
('LGR5', 'leucine-rich repeat containing G protein-coupled receptor 5 ', 'O75473', '8549', 'chr12: 71,439,770-71,586,310'),
('CAD', 'carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase ', 'P27708', '790', 'chr2: 27,217,390-27,243,943'),
('BHLHE40', 'basic helix-loop-helix family member e40 ', 'O14503', '8553', 'chr3: 4,979,116-4,985,323'),
('CDC14B', 'cell division cycle 14B ', 'O60729', '8555', 'chr9: 96,490,241-96,619,830'),
('CDC14A', 'cell division cycle 14A ', 'Q9UNH5', '8556', 'chr1: 100,345,025-100,520,277'),
('CDK10', 'cyclin-dependent kinase 10 ', 'Q15131', '8558', 'chr16: 89,680,737-89,696,364'),
('PRPF18', 'pre-mRNA processing factor 18 ', 'Q99633', '8559', 'chr10: 13,586,927-13,630,868'),
('DENR', 'density-regulated protein ', 'O43583', '8562', 'chr12: 122,752,774-122,771,064'),
('KMO', 'kynurenine 3-monooxygenase (kynurenine 3-hydroxylase) ', 'O15229', '8564', 'chr1: 241,532,134-241,595,642'),
('YARS', 'tyrosyl-tRNA synthetase ', 'P54577', '8565', 'chr1: 32,775,237-32,818,153'),
('PDXK', 'pyridoxal (pyridoxine, vitamin B6) kinase ', 'O00764', '8566', 'chr21: 43,719,094-43,762,307'),
('MKNK1', 'MAP kinase interacting serine/threonine kinase 1 ', 'Q9BUB5', '8569', 'chr1: 46,557,408-46,616,843'),
('ACVR2A', 'activin A receptor type IIA ', 'P27037', '92', 'chr2: 147,844,517-147,930,826'),
('CALB2', 'calbindin 2 ', 'P22676', '794', 'chr16: 71,358,713-71,390,438'),
('KHSRP', 'KH-type splicing regulatory protein ', 'Q92945', '8570', 'chr19: 6,413,348-6,424,794'),
('PDLIM4', 'PDZ and LIM domain 4 ', 'P50479', '8572', 'chr5: 132,257,671-132,273,454'),
('CASK', 'calcium/calmodulin-dependent serine protein kinase (MAGUK family) ', 'O14936', '8573', 'chrX: 41,514,934-41,923,463'),
('AKR7A2', 'aldo-keto reductase family 7, member A2 ', 'O43488', '8574', 'chr1: 19,303,965-19,312,146'),
('PRKRA', 'protein kinase, interferon-inducible double stranded RNA dependent activator ', 'O75569', '8575', 'chr2: 178,431,414-178,451,512'),
('TMEFF1', 'transmembrane protein with EGF-like and two follistatin-like domains 1 ', 'Q8IYR6', '8577', 'chr9: 100,473,113-100,577,636'),
('SCARF1', 'scavenger receptor class F member 1 ', 'Q14162', '8578', 'chr17: 1,633,858-1,645,747'),
('TNFSF11', 'tumor necrosis factor superfamily member 11 ', 'O14788', '8600', 'chr13: 42,562,736-42,608,013'),
('SLC25A12', 'solute carrier family 25 (aspartate/glutamate carrier), member 12 ', 'O75746', '8604', 'chr2: 171,784,370-171,999,859'),
('PLA2G4C', 'phospholipase A2 group IVC ', 'Q9UP65', '8605', 'chr19: 48,047,843-48,110,817'),
('CALD1', 'caldesmon 1 ', 'Q05682', '800', 'chr7: 134,744,252-134,970,728'),
('RUVBL1', 'RuvB-like AAA ATPase 1 ', 'Q9Y265', '8607', 'chr3: 128,064,778-128,153,914'),
('KLF7', 'Kruppel-like factor 7 (ubiquitous) ', 'O75840', '8609', 'chr2: 207,074,137-207,167,267'),
('PLPP1', 'phospholipid phosphatase 1 ', 'O14494', '8611', 'chr5: 55,424,854-55,535,050'),
('PLPP3', 'phospholipid phosphatase 3 ', 'O14495', '8613', 'chr1: 56,494,747-56,645,301'),
('STC2', 'stanniocalcin 2 ', 'O76061', '8614', 'chr5: 173,314,713-173,329,503'),
('CDK13', 'cyclin-dependent kinase 13 ', 'Q14004', '8621', 'chr7: 39,950,037-40,097,134'),
('PDE8B', 'phosphodiesterase 8B ', 'O95263', '8622', 'chr5: 77,210,449-77,429,807'),
('PSMG1', 'proteasome (prosome, macropain) assembly chaperone 1 ', 'O95456', '8624', 'chr21: 39,174,769-39,183,851'),
('JRK', 'Jrk helix-turn-helix protein ', 'O75564', '8629', 'chr8: 142,657,460-142,681,968'),
('HSD17B6', 'hydroxysteroid (17-beta) dehydrogenase 6 ', 'O14756', '8630', 'chr12: 56,752,161-56,787,790'),
('CALM2', 'calmodulin 2', 'P62158', '805', 'chr2: 47,160,082-47,176,601'),
('UNC5C', 'unc-5 netrin receptor C ', 'O95185', '8633', 'chr4: 95,162,504-95,549,206'),
('RTCA', 'RNA 3\'-terminal phosphate cyclase ', 'O00442', '8634', 'chr1: 100,266,207-100,292,769'),
('RNASET2', 'ribonuclease T2 ', 'O00584', '8635', 'chr6: 166,929,504-166,957,191'),
('SSNA1', 'Sjogren syndrome nuclear autoantigen 1 ', 'O43805', '8636', 'chr9: 137,188,647-137,190,370'),
('AOC3', 'amine oxidase, copper containing 3 ', 'Q16853', '8639', 'chr17: 42,851,184-42,858,130'),
('AKR1C3', 'aldo-keto reductase family 1, member C3 ', 'P42330', '8644', 'chr10: 5,035,354-5,107,686'),
('NCOA1', 'nuclear receptor coactivator 1 ', 'Q15788', '8648', 'chr2: 24,491,914-24,770,702'),
('LAMTOR3', 'late endosomal/lysosomal adaptor, MAPK and MTOR activator 3 ', 'Q9UHA4', '8649', 'chr4: 99,878,336-99,894,490'),
('NUMB', 'numb homolog (Drosophila) ', 'P49757', '8650', 'chr14: 73,275,107-73,463,642'),
('SOCS1', 'suppressor of cytokine signaling 1 ', 'O15524', '8651', 'chr16: 11,254,405-11,256,179'),
('CALM3', 'calmodulin 3', 'P62158', '808', 'chr14: 90,396,502-90,408,261'),
('PDE5A', 'phosphodiesterase 5A ', 'O76074', '8654', 'chr4: 119,494,395-119,628,991'),
('DYNLL1', 'dynein, light chain, LC8-type 1 ', 'P63167', '8655', 'chr12: 120,469,850-120,498,493'),
('TNKS', 'tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase ', 'O95271', '8658', 'chr8: 9,555,914-9,782,346'),
('IRS2', 'insulin receptor substrate 2 ', 'Q9Y4H2', '8660', 'chr13: 109,752,698-109,786,568'),
('EIF3A', 'eukaryotic translation initiation factor 3 subunit A ', 'Q14152', '8661', 'chr10: 119,033,670-119,080,823'),
('EIF3B', 'eukaryotic translation initiation factor 3 subunit B ', 'P55884', '8662', 'chr7: 2,354,086-2,380,745'),
('EIF3J', 'eukaryotic translation initiation factor 3 subunit J ', 'O75822', '8669', 'chr15: 44,537,057-44,563,029'),
('SLC4A4', 'solute carrier family 4 (sodium bicarbonate cotransporter), member 4 ', 'Q9Y6R1', '8671', 'chr4: 71,186,757-71,572,087'),
('EIF4G3', 'eukaryotic translation initiation factor 4 gamma, 3 ', 'O43432', '8672', 'chr1: 20,806,292-21,176,888'),
('VAMP4', 'vesicle associated membrane protein 4 ', 'O75379', '8674', 'chr1: 171,700,160-171,742,247'),
('CALR', 'calreticulin ', 'P27797', '811', 'chr19: 12,938,578-12,944,489'),
('STX11', 'syntaxin 11 ', 'O75558', '8676', 'chr6: 144,150,526-144,188,370'),
('PEA15', 'phosphoprotein enriched in astrocytes 15 ', 'Q15121', '8682', 'chr1: 160,205,337-160,215,376'),
('SRSF9', 'serine/arginine-rich splicing factor 9 ', 'Q13242', '8683', 'chr12: 120,461,668-120,469,793'),
('JRKL', 'JRK-like ', 'Q9Y4A0', '8690', 'chr11: 96,389,989-96,507,574'),
('HYAL2', 'hyaluronoglucosaminidase 2 ', 'Q12891', '8692', 'chr3: 50,317,790-50,322,906'),
('GALNT4', 'polypeptide N-acetylgalactosaminyltransferase 4 ', 'Q8N4A0', '8693', 'chr12: 89,519,408-89,524,806'),
('CDC23', 'cell division cycle 23 ', 'Q9UJX2', '8697', 'chr5: 138,187,648-138,213,343'),
('DNAH11', 'dynein, axonemal, heavy chain 11 ', 'Q96DT5', '8701', 'chr7: 21,543,215-21,901,839'),
('B4GALT4', 'UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 4 ', 'O60513', '8702', 'chr3: 119,211,732-119,241,103'),
('B3GALT4', 'Beta-1,3-galactosyltransferase 4 ', 'O96024', '8705', 'chr6: 33,277,132-33,284,832'),
('CALU', 'calumenin ', 'O43852', '813', 'chr7: 128,739,292-128,771,807'),
('B3GALT2', 'Beta-1,3-galactosyltransferase 2 ', 'O43825', '8707', 'chr1: 193,179,045-193,186,654'),
('TRADD', 'TNFRSF1A-associated via death domain ', 'Q15628', '8717', 'chr16: 67,154,180-67,160,298'),
('TNFRSF25', 'tumor necrosis factor receptor superfamily member 25 ', 'Q93038', '8718', 'chr1: 6,461,151-6,466,195'),
('EDF1', 'endothelial differentiation-related factor 1 ', 'O60869', '8721', 'chr9: 136,862,119-136,866,286'),
('CTSF', 'cathepsin F ', 'Q9UBX1', '8722', 'chr11: 66,563,463-66,568,841'),
('SNX4', 'sorting nexin 4 ', 'O95219', '8723', 'chr3: 125,446,644-125,520,197'),
('SNX3', 'sorting nexin 3 ', 'O60493', '8724', 'chr6: 108,211,222-108,261,260'),
('URI1', 'URI1 prefoldin-like chaperone ', 'O94763', '8725', 'chr19: 29,923,644-30,016,608'),
('CTNNAL1', 'catenin alpha-like 1 ', 'Q9UBT7', '8727', 'chr9: 108,942,569-109,013,529'),
('ADAM19', 'ADAM metallopeptidase domain 19 ', 'Q9H013', '8728', 'chr5: 157,395,534-157,575,775'),
('CAMK2D', 'calcium/calmodulin-dependent protein kinase II delta ', 'Q13557', '817', 'chr4: 113,451,032-113,761,927'),
('GBF1', 'golgi brefeldin A resistant guanine nucleotide exchange factor 1 ', 'Q92538', '8729', 'chr10: 102,245,532-102,382,899'),
('RIPK1', 'receptor interacting serine/threonine kinase 1 ', 'Q13546', '8737', 'chr6: 3,063,991-3,115,187'),
('CRADD', 'CASP2 and RIPK1 domain containing adaptor with death domain ', 'P78560', '8738', 'chr12: 93,677,375-93,894,840'),
('TNFSF13', 'tumor necrosis factor superfamily member 13 ', 'O75888', '8741', 'chr17: 7,558,292-7,561,608'),
('TNFSF10', 'tumor necrosis factor superfamily member 10 ', 'P50591', '8743', 'chr3: 172,505,508-172,523,507'),
('ADAM23', 'ADAM metallopeptidase domain 23 ', 'O75077', '8745', 'chr2: 206,443,539-206,621,130'),
('ADAM21', 'ADAM metallopeptidase domain 21 ', 'Q9UKJ8', '8747', 'chr14: 70,452,157-70,459,899'),
('ADAM9', 'ADAM metallopeptidase domain 9 ', 'Q13443', '8754', 'chr8: 38,996,869-39,105,144'),
('ADAM6', 'ADAM metallopeptidase domain 6 (pseudogene)', 'N/A', '8755', 'chr14: 105,969,729-105,972,269'),
('CDS2', 'CDP-diacylglycerol synthase 2 ', 'O95674', '8760', 'chr20: 5,126,786-5,197,887'),
('CANX', 'calnexin ', 'P27824', '821', 'chr5: 179,678,628-179,730,925'),
('CD164', 'CD164 molecule, sialomucin ', 'Q04900', '8763', 'chr6: 109,366,514-109,382,457'),
('RAB11A', 'RAB11A, member RAS oncogene family ', 'P62491', '8766', 'chr15: 65,726,054-65,891,991'),
('RIPK2', 'receptor interacting serine/threonine kinase 2 ', 'O43353', '8767', 'chr8: 89,757,747-89,791,063'),
('FADD', 'Fas associated via death domain ', 'Q13158', '8772', 'chr11: 70,203,163-70,207,390'),
('SNAP23', 'synaptosome associated protein 23kDa ', 'O00161', '8773', 'chr15: 42,491,233-42,545,356'),
('MTMR1', 'myotubularin related protein 1 ', 'Q13613', '8776', 'chrX: 150,692,971-150,765,103'),
('RIOK3', 'RIO kinase 3 ', 'O14730', '8780', 'chr18: 23,452,823-23,486,603'),
('PSPHP1', 'phosphoserine phosphatase pseudogene 1', 'O15172', '8781', 'chr7: 55,764,797-55,773,288'),
('DLK1', 'delta-like 1 homolog (Drosophila) ', 'P80370', '8788', 'chr14: 100,725,705-100,738,224'),
('FBP2', 'fructose-bisphosphatase 2 ', 'O00757', '8789', 'chr9: 94,558,720-94,593,793'),
('CAPG', 'capping protein (actin filament), gelsolin-like ', 'P40121', '822', 'chr2: 85,394,748-85,418,432'),
('TNFRSF11A', 'tumor necrosis factor receptor superfamily member 11a ', 'Q9Y6Q6', '8792', 'chr18: 62,325,287-62,391,292'),
('TNFRSF10C', 'tumor necrosis factor receptor superfamily member 10c ', 'O14798', '8794', 'chr8: 23,084,355-23,117,437'),
('PEX11B', 'peroxisomal biogenesis factor 11 beta ', 'O96011', '8799', 'chr1: 145,911,350-145,918,837'),
('SUCLG1', 'succinate-CoA ligase, alpha subunit ', 'P53597', '8802', 'chr2: 84,423,523-84,460,045'),
('SUCLA2', 'succinate-CoA ligase, ADP-forming, beta subunit ', 'Q9P2R7', '8803', 'chr13: 47,936,491-48,001,354'),
('CREG1', 'cellular repressor of E1A-stimulated genes 1 ', 'O75629', '8804', 'chr1: 167,529,677-167,553,767'),
('IL18R1', 'interleukin 18 receptor 1 ', 'Q13478', '8809', 'chr2: 102,311,529-102,398,775'),
('BANF1', 'barrier to autointegration factor 1 ', 'O75531', '8815', 'chr11: 66,002,079-66,004,149'),
('DCAF5', 'DDB1 and CUL4 associated factor 5 ', 'Q96JK2', '8816', 'chr14: 69,050,881-69,153,150'),
('FGF18', 'fibroblast growth factor 18 ', 'O76093', '8817', 'chr5: 171,419,656-171,457,623'),
('CAPN3', 'calpain 3 ', 'P20807', '825', 'chr15: 42,359,500-42,412,318'),
('INPP4B', 'inositol polyphosphate-4-phosphatase type II B ', 'O15327', '8821', 'chr4: 142,023,160-142,847,432'),
('IQGAP1', 'IQ motif containing GTPase activating protein 1 ', 'P46940', '8826', 'chr15: 90,388,218-90,502,243'),
('NRP2', 'neuropilin 2 ', 'O60462', '8828', 'chr2: 205,681,990-205,798,133'),
('NRP1', 'neuropilin 1 ', 'O14786', '8829', 'chr10: 33,177,492-33,336,262'),
('SYNGAP1', 'synaptic Ras GTPase activating protein 1 ', 'Q96PV0', '8831', 'chr6: 33,419,661-33,457,541'),
('GMPS', 'guanine monophosphate synthase ', 'P49915', '8833', 'chr3: 155,870,536-155,944,026'),
('TMEM11', 'transmembrane protein 11 ', 'P17152', '8834', 'chr17: 21,197,280-21,214,624'),
('SOCS2', 'suppressor of cytokine signaling 2 ', 'O14508', '8835', 'chr12: 93,569,814-93,583,487'),
('GGH', 'gamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase) ', 'Q92820', '8836', 'chr8: 63,015,079-63,039,171'),
('CFLAR', 'CASP8 and FADD like apoptosis regulator ', 'O15519', '8837', 'chr2: 201,116,104-201,176,687'),
('SERPINA3', 'serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3 ', 'P01011', '12', 'chr14: 94,612,377-94,624,055'),
('ACVR2B', 'activin A receptor type IIB ', 'Q13705', '93', 'chr3: 38,453,851-38,493,142'),
('CAPS', 'calcyphosine ', 'Q13938', '828', 'chr19: 5,911,707-5,915,877'),
('WISP2', 'WNT1 inducible signaling pathway protein 2 ', 'O76076', '8839', 'chr20: 44,714,844-44,728,509'),
('WISP1', 'WNT1 inducible signaling pathway protein 1 ', 'O95388', '8840', 'chr8: 133,191,039-133,230,344'),
('HDAC3', 'histone deacetylase 3 ', 'O15379', '8841', 'chr5: 141,620,876-141,636,870'),
('ALKBH1', 'alkB homolog 1, histone H2A dioxygenase ', 'Q13686', '8846', 'chr14: 77,672,404-77,708,020'),
('TSC22D1', 'TSC22 domain family member 1 ', 'Q15714', '8848', 'chr13: 44,432,143-44,577,147'),
('KAT2B', 'K(lysine) acetyltransferase 2B ', 'Q92831', '8850', 'chr3: 20,040,023-20,154,404'),
('ASAP2', 'ArfGAP with SH3 domain, ankyrin repeat and PH domain 2 ', 'O43150', '8853', 'chr2: 9,206,765-9,405,683'),
('ALDH1A2', 'aldehyde dehydrogenase 1 family member A2 ', 'O94788', '8854', 'chr15: 57,953,424-58,497,866'),
('APLN', 'apelin ', 'Q9ULZ1', '8862', 'chrX: 129,645,259-129,654,937'),
('SYNJ1', 'synaptojanin 1 ', 'O43426', '8867', 'chr21: 32,628,759-32,728,048'),
('CAPZA1', 'capping protein (actin filament) muscle Z-line, alpha 1 ', 'P52907', '829', 'chr1: 112,619,173-112,671,619'),
('IER3', 'immediate early response 3 ', 'P46695', '8870', 'chr6: 30,743,199-30,744,554'),
('SYNJ2', 'synaptojanin 2 ', 'O15056', '8871', 'chr6: 157,981,887-158,099,176'),
('CDC123', 'cell division cycle 123 ', 'O75794', '8872', 'chr10: 12,195,965-12,250,589'),
('ARHGEF7', 'Rho guanine nucleotide exchange factor 7 ', 'Q14155', '8874', 'chr13: 111,114,559-111,305,737'),
('VNN1', 'vanin 1 ', 'O95497', '8876', 'chr6: 132,681,590-132,714,049'),
('SPHK1', 'sphingosine kinase 1 ', 'Q9NYA1', '8877', 'chr17: 76,376,584-76,387,860'),
('SQSTM1', 'sequestosome 1 ', 'Q13501', '8878', 'chr5: 179,806,398-179,838,078'),
('FUBP1', 'far upstream element (FUSE) binding protein 1 ', 'Q96AE4', '8880', 'chr1: 77,944,055-77,979,110'),
('ZPR1', 'ZPR1 zinc finger ', 'O75312', '8882', 'chr11: 116,773,799-116,788,050'),
('NAE1', 'NEDD8 activating enzyme E1 subunit 1 ', 'Q13564', '8883', 'chr16: 66,802,875-66,873,256'),
('CAST', 'calpastatin ', 'P20810', '831', 'chr5: 96,525,267-96,779,595'),
('TAX1BP1', 'Tax1 (human T-cell leukemia virus type I) binding protein 1 ', 'Q86VP1', '8887', 'chr7: 27,739,331-27,844,564'),
('EIF2B4', 'eukaryotic translation initiation factor 2B subunit delta ', 'Q9UI10', '8890', 'chr2: 27,364,352-27,370,486'),
('EIF2B3', 'eukaryotic translation initiation factor 2B subunit gamma ', 'Q9NR50', '8891', 'chr1: 44,850,522-44,986,722'),
('EIF2B5', 'eukaryotic translation initiation factor 2B subunit epsilon ', 'Q13144', '8893', 'chr3: 184,135,038-184,145,311'),
('BUD31', 'BUD31 homolog ', 'P41223', '8896', 'chr7: 99,408,641-99,419,616'),
('MTMR2', 'myotubularin related protein 2 ', 'Q13614', '8898', 'chr11: 95,832,882-95,925,315'),
('PRPF4B', 'pre-mRNA processing factor 4B ', 'Q13523', '8899', 'chr6: 4,021,267-4,064,983'),
('CCNA1', 'cyclin A1 ', 'P78396', '8900', 'chr13: 36,431,520-36,442,882'),
('AP1S2', 'adaptor related protein complex 1 sigma 2 subunit ', 'P56377', '8905', 'chrX: 15,825,806-15,854,931'),
('AP1G2', 'adaptor related protein complex 1 gamma 2 subunit ', 'O75843', '8906', 'chr14: 23,559,565-23,568,070'),
('CAPZB', 'capping protein (actin filament) muscle Z-line, beta ', 'P47756', '832', 'chr1: 19,338,776-19,485,539'),
('GYG2', 'glycogenin 2 ', 'O15488', '8908', 'chrX: 2,828,788-2,882,820'),
('CACNA1G', 'calcium channel, voltage-dependent, T type, alpha 1G subunit ', 'O43497', '8913', 'chr17: 50,561,068-50,627,474'),
('TIMELESS', 'timeless circadian clock ', 'Q9UNS1', '8914', 'chr12: 56,416,373-56,449,403'),
('BCL10', 'B-cell CLL/lymphoma 10 ', 'O95999', '8915', 'chr1: 85,266,248-85,277,090'),
('HERC3', 'HECT and RLD domain containing E3 ubiquitin protein ligase 3 ', 'Q15034', '8916', 'chr4: 88,521,048-88,708,542'),
('MBD4', 'methyl-CpG binding domain 4 DNA glycosylase ', 'O95243', '8930', 'chr3: 129,430,944-129,440,179'),
('FAM127A', 'family with sequence similarity 127 member A ', 'A6ZKI3', '8933', 'chrX: 135,032,366-135,033,546'),
('RAB29', 'RAB29, member RAS oncogene family ', 'O14966', '8934', 'chr1: 205,767,986-205,775,460'),
('SKAP2', 'src kinase associated phosphoprotein 2 ', 'O75563', '8935', 'chr7: 26,667,062-26,995,239'),
('KYNU', 'kynureninase ', 'Q16719', '8942', 'chr2: 142,877,498-143,055,832'),
('CASP1', 'caspase 1 ', 'P29466', '834', 'chr11: 105,025,443-105,035,250'),
('AP3D1', 'adaptor related protein complex 3, delta 1 subunit ', 'O14617', '8943', 'chr19: 2,100,988-2,164,465'),
('BTRC', 'beta-transducin repeat containing E3 ubiquitin protein ligase ', 'Q9Y297', '8945', 'chr10: 101,354,033-101,557,321'),
('HIST1H2AG', 'histone cluster 1, H2ag ', 'P0C0S8', '8969', 'chr6: 27,133,042-27,135,291'),
('H1FX', 'H1 histone family member X ', 'Q92522', '8971', 'chr3: 129,314,771-129,316,277'),
('MGAM', 'maltase-glucoamylase ', 'O43451', '8972', 'chr7: 141,907,813-142,106,747'),
('P4HA2', 'prolyl 4-hydroxylase, alpha polypeptide II ', 'O15460', '8974', 'chr5: 132,191,838-132,295,315'),
('USP13', 'ubiquitin specific peptidase 13 (isopeptidase T-3) ', 'Q92995', '8975', 'chr3: 179,652,755-179,789,401'),
('WASL', 'Wiskott-Aldrich syndrome-like ', 'O00401', '8976', 'chr7: 123,681,935-123,749,067'),
('HSPB3', 'heat shock protein family B (small) member 3 ', 'Q12988', '8988', 'chr5: 54,455,601-54,456,384'),
('SELENBP1', 'selenium binding protein 1 ', 'Q13228', '8991', 'chr1: 151,364,302-151,372,733'),
('CASP4', 'caspase 4 ', 'P49662', '837', 'chr11: 104,942,866-104,969,436'),
('ATP6V0E1', 'ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1 ', 'O15342', '8992', 'chr5: 172,983,757-173,035,445'),
('LIMD1', 'LIM domains containing 1 ', 'Q9UGP4', '8994', 'chr3: 45,555,394-45,686,338'),
('NOL3', 'nucleolar protein 3 ', 'O60936', '8996', 'chr16: 67,170,154-67,175,735'),
('TAF1C', 'TATA-box binding protein associated factor, RNA polymerase I, C ', 'Q15572', '9013', 'chr16: 84,177,847-84,187,070'),
('TAF1B', 'TATA-box binding protein associated factor, RNA polymerase I, B ', 'Q53T94', '9014', 'chr2: 9,843,354-9,934,416'),
('TAF1A', 'TATA-box binding protein associated factor, RNA polymerase I, A ', 'Q15573', '9015', 'chr1: 222,557,902-222,589,933'),
('SLC25A14', 'solute carrier family 25 (mitochondrial carrier, brain), member 14 ', 'O95258', '9016', 'chrX: 130,339,888-130,373,361'),
('MPZL1', 'myelin protein zero-like 1 ', 'O95297', '9019', 'chr1: 167,721,192-167,791,919'),
('SOCS3', 'suppressor of cytokine signaling 3 ', 'O14543', '9021', 'chr17: 78,356,778-78,360,077'),
('CLIC3', 'chloride intracellular channel 3 ', 'O95833', '9022', 'chr9: 136,994,635-136,996,803'),
('CASP6', 'caspase 6 ', 'P55212', '839', 'chr4: 109,688,622-109,703,583'),
('CH25H', 'cholesterol 25-hydroxylase ', 'O95992', '9023', 'chr10: 89,205,629-89,207,314'),
('RNF8', 'ring finger protein 8, E3 ubiquitin protein ligase ', 'O76064', '9025', 'chr6: 37,353,972-37,394,738'),
('BAZ1B', 'bromodomain adjacent to zinc finger domain 1B ', 'Q9UIG0', '9031', 'chr7: 73,440,398-73,522,278'),
('SEMA5A', 'sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and sh', 'Q13591', '9037', 'chr5: 9,035,026-9,546,075'),
('UBE2M', 'ubiquitin conjugating enzyme E2M ', 'P61081', '9040', 'chr19: 58,555,712-58,558,960'),
('SPAG9', 'sperm associated antigen 9 ', 'O60271', '9043', 'chr17: 50,962,174-51,120,865'),
('BTAF1', 'B-TFIID TATA-box binding protein associated factor 1 ', 'O14981', '9044', 'chr10: 91,923,769-92,030,325'),
('RPL14', 'ribosomal protein L14 ', 'P50914', '9045', 'chr3: 40,457,292-40,468,587'),
('AIP', 'aryl hydrocarbon receptor interacting protein ', 'O00170', '9049', 'chr11: 67,483,041-67,491,103'),
('PSTPIP2', 'proline-serine-threonine phosphatase interacting protein 2 ', 'Q9H939', '9050', 'chr18: 45,983,536-46,072,272'),
('CASP8', 'caspase 8 ', 'Q14790', '841', 'chr2: 201,233,443-201,287,711'),
('GPRC5A', 'G protein-coupled receptor, class C, group 5, member A ', 'Q8NFJ5', '9052', 'chr12: 12,890,782-12,917,937'),
('MAP7', 'microtubule associated protein 7 ', 'Q14244', '9053', 'chr6: 136,342,281-136,550,819'),
('PRC1', 'protein regulator of cytokinesis 1 ', 'O43663', '9055', 'chr15: 90,966,038-90,995,629'),
('SLC7A7', 'solute carrier family 7 (amino acid transporter light chain, y+L system), member 7 ', 'Q9UM01', '9056', 'chr14: 22,773,222-22,829,820'),
('SLC7A6', 'solute carrier family 7 (amino acid transporter light chain, y+L system), member 6 ', 'Q92536', '9057', 'chr16: 68,264,516-68,301,823'),
('PAPSS2', '3\'-phosphoadenosine 5\'-phosphosulfate synthase 2 ', 'O95340', '9060', 'chr10: 87,659,613-87,747,705'),
('ANGPTL1', 'angiopoietin like 1 ', 'O95841', '9068', 'chr1: 178,849,705-178,871,052'),
('ASH2L', 'ash2 (absent, small, or homeotic)-like (Drosophila) ', 'Q9UBL3', '9070', 'chr8: 38,105,242-38,144,076'),
('CLDN1', 'claudin 1 ', 'O95832', '9076', 'chr3: 190,305,701-190,322,475'),
('DIRAS3', 'DIRAS family, GTP-binding RAS-like 3 ', 'O95661', '9077', 'chr1: 68,045,962-68,051,631'),
('CASP9', 'caspase 9 ', 'P55211', '842', 'chr1: 15,490,832-15,526,534'),
('LDB2', 'LIM domain binding 2 ', 'O43679', '9079', 'chr4: 16,501,541-16,898,809'),
('PKMYT1', 'protein kinase, membrane associated tyrosine/threonine 1 ', 'Q99640', '9088', 'chr16: 2,968,024-2,980,539'),
('UNC119', 'unc-119 lipid binding chaperone ', 'Q13432', '9094', 'chr17: 28,546,707-28,552,668'),
('USP6', 'ubiquitin specific peptidase 6 ', 'P35125', '9098', 'chr17: 5,116,438-5,175,034'),
('USP2', 'ubiquitin specific peptidase 2 ', 'O75604', '9099', 'chr11: 119,355,215-119,381,726'),
('RGN', 'regucalcin ', 'Q15493', '9104', 'chrX: 47,078,355-47,093,314'),
('MTMR4', 'myotubularin related protein 4 ', 'Q9NYA4', '9110', 'chr17: 58,489,529-58,517,905'),
('NMI', 'N-myc and STAT interactor ', 'Q13287', '9111', 'chr2: 151,270,465-151,290,057'),
('MTA1', 'metastasis associated 1 ', 'Q13330', '9112', 'chr14: 105,419,820-105,470,729'),
('LATS1', 'large tumor suppressor kinase 1 ', 'O95835', '9113', 'chr6: 149,658,153-149,718,256'),
('CAV1', 'caveolin 1 ', 'Q03135', '857', 'chr7: 116,524,785-116,561,184'),
('ATP6V0D1', 'ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d1 ', 'P61421', '9114', 'chr16: 67,438,014-67,481,237'),
('SLC16A6', 'solute carrier family 16 member 6 ', 'O15403', '9120', 'chr17: 68,267,026-68,291,267'),
('SLC16A3', 'solute carrier family 16 (monocarboxylate transporter), member 3 ', 'O15427', '9123', 'chr17: 82,228,397-82,261,129'),
('PDLIM1', 'PDZ and LIM domain 1 ', 'O00151', '9124', 'chr10: 95,237,572-95,291,024'),
('SMC3', 'structural maintenance of chromosomes 3 ', 'Q9UQE7', '9126', 'chr10: 110,567,691-110,604,636'),
('PRPF3', 'pre-mRNA processing factor 3 ', 'O43395', '9129', 'chr1: 150,321,476-150,353,195'),
('FAM50A', 'family with sequence similarity 50 member A ', 'Q14320', '9130', 'chrX: 154,444,126-154,450,654'),
('AIFM1', 'apoptosis inducing factor, mitochondria associated 1 ', 'O95831', '9131', 'chrX: 130,129,362-130,165,887'),
('CCNB2', 'cyclin B2 ', 'O95067', '9133', 'chr15: 59,105,078-59,125,045'),
('CCNE2', 'cyclin E2 ', 'O96020', '9134', 'chr8: 94,879,770-94,896,678'),
('ACYP1', 'acylphosphatase 1, erythrocyte (common) type ', 'P07311', '97', 'chr14: 75,053,221-75,069,483'),
('CAV2', 'caveolin 2 ', 'P51636', '858', 'chr7: 116,287,380-116,508,541'),
('RABEP1', 'rabaptin, RAB GTPase binding effector protein 1 ', 'Q15276', '9135', 'chr17: 5,282,265-5,385,812'),
('CBFA2T2', 'core-binding factor, runt domain, alpha subunit 2; translocated to, 2 ', 'O43439', '9139', 'chr20: 33,490,075-33,650,036'),
('ATG12', 'autophagy related 12 ', 'O94817', '9140', 'chr5: 115,828,200-115,841,858'),
('PDCD5', 'programmed cell death 5 ', 'O14737', '9141', 'chr19: 32,581,068-32,587,452'),
('SYNGR3', 'synaptogyrin 3 ', 'O43761', '9143', 'chr16: 1,989,660-1,994,275'),
('SYNGR2', 'synaptogyrin 2 ', 'O43760', '9144', 'chr17: 78,168,558-78,173,527'),
('NEMF', 'nuclear export mediator factor ', 'O60524', '9147', 'chr14: 49,782,083-49,853,203'),
('EXO1', 'exonuclease 1 ', 'Q9UQ84', '9156', 'chr1: 241,847,967-241,895,148'),
('EBAG9', 'estrogen receptor binding site associated, antigen, 9 ', 'O00559', '9166', 'chr8: 109,539,711-109,565,996'),
('TMSB10', 'thymosin beta 10 ', 'P63313', '9168', 'chr2: 84,905,625-84,906,675'),
('RUNX2', 'runt-related transcription factor 2 ', 'Q13950', '860', 'chr6: 45,328,157-45,664,349'),
('SCAF11', 'SR-related CTD-associated factor 11 ', 'Q99590', '9169', 'chr12: 45,919,131-45,992,120'),
('IL1RL1', 'interleukin 1 receptor-like 1 ', 'Q01638', '9173', 'chr2: 102,311,502-102,352,037'),
('MAP3K13', 'mitogen-activated protein kinase kinase kinase 13 ', 'O43283', '9175', 'chr3: 185,282,941-185,489,097'),
('OSMR', 'oncostatin M receptor ', 'Q99650', '9180', 'chr5: 38,845,858-38,945,596'),
('ARHGEF2', 'Rho/Rac guanine nucleotide exchange factor 2 ', 'Q92974', '9181', 'chr1: 155,946,851-156,007,070'),
('RASSF9', 'Ras association (RalGDS/AF-6) domain family (N-terminal) member 9 ', 'O75901', '9182', 'chr12: 85,800,697-85,836,570'),
('BUB3', 'BUB3 mitotic checkpoint protein ', 'O43684', '9184', 'chr10: 123,154,277-123,170,467'),
('REPS2', 'RALBP1 associated Eps domain containing 2 ', 'Q8NFH8', '9185', 'chrX: 16,946,691-17,153,280'),
('ZBED1', 'zinc finger, BED-type containing 1 ', 'O96006', '9189', 'chrX: 2,486,414-2,500,967'),
('SLC16A7', 'solute carrier family 16 (monocarboxylate transporter), member 7 ', 'O60669', '9194', 'chr12: 59,596,067-59,789,855'),
('RUNX1', 'runt-related transcription factor 1 ', 'Q01196', '861', 'chr21: 34,787,801-36,004,667'),
('SLC33A1', 'solute carrier family 33 (acetyl-CoA transporter), member 1 ', 'O00400', '9197', 'chr3: 155,821,024-155,854,429'),
('HACD1', '3-hydroxyacyl-CoA dehydratase 1 ', 'B0YJ81', '9200', 'chr10: 17,589,032-17,617,377'),
('DCLK1', 'doublecortin like kinase 1 ', 'O15075', '9201', 'chr13: 35,768,652-36,131,306'),
('ZMYM3', 'zinc finger, MYM-type 3 ', 'Q14202', '9203', 'chrX: 71,239,624-71,255,146'),
('ZMYM6', 'zinc finger, MYM-type 6 ', 'O95789', '9204', 'chr1: 34,986,165-35,031,968'),
('ZMYM5', 'zinc finger, MYM-type 5 ', 'Q9UJ78', '9205', 'chr13: 19,823,482-19,863,636'),
('LRRFIP1', 'leucine rich repeat (in FLII) interacting protein 1 ', 'Q32MZ4', '9208', 'chr2: 237,627,576-237,813,682'),
('LRRFIP2', 'leucine rich repeat (in FLII) interacting protein 2 ', 'Q9Y608', '9209', 'chr3: 37,052,656-37,183,689'),
('BMP15', 'bone morphogenetic protein 15 ', 'O95972', '9210', 'chrX: 50,910,784-50,916,607'),
('AURKB', 'aurora kinase B ', 'Q96GD4', '9212', 'chr17: 8,204,733-8,210,600'),
('RUNX3', 'runt-related transcription factor 3 ', 'Q13761', '864', 'chr1: 24,899,511-24,965,121'),
('FCMR', 'Fc fragment of IgM receptor ', 'O60667', '9214', 'chr1: 206,904,386-206,923,247'),
('LARGE', 'like-glycosyltransferase ', 'O95461', '9215', 'chr22: 33,162,226-33,922,841'),
('VAPB', 'VAMP (vesicle-associated membrane protein)-associated protein B and C ', 'O95292', '9217', 'chr20: 58,389,122-58,451,101'),
('VAPA', 'VAMP associated protein A ', 'Q9P0L0', '9218', 'chr18: 9,914,002-9,960,021'),
('MAGI1', 'membrane associated guanylate kinase, WW and PDZ domain containing 1 ', 'Q96QZ7', '9223', 'chr3: 65,353,525-66,038,834'),
('DLGAP1', 'discs, large (Drosophila) homolog-associated protein 1 ', 'O14490', '9229', 'chr18: 3,496,032-4,455,335'),
('RAB11B', 'RAB11B, member RAS oncogene family ', 'Q15907', '9230', 'chr19: 8,389,981-8,404,434'),
('DLG5', 'discs, large homolog 5 (Drosophila) ', 'Q8TDM6', '9231', 'chr10: 77,790,791-77,926,526'),
('PTTG1', 'pituitary tumor-transforming 1 ', 'O95997', '9232', 'chr5: 160,421,822-160,428,744'),
('IL32', 'interleukin 32 ', 'P24001', '9235', 'chr16: 3,065,297-3,082,192'),
('CBFB', 'core-binding factor, beta subunit ', 'Q13951', '865', 'chr16: 67,029,116-67,101,058'),
('CCPG1', 'cell cycle progression 1 ', 'Q9ULG6', '9236', 'chr15: 55,340,032-55,408,510'),
('TBRG4', 'transforming growth factor beta regulator 4 ', 'Q969Z0', '9238', 'chr7: 45,100,100-45,112,047'),
('DHRS3', 'dehydrogenase/reductase (SDR family) member 3 ', 'O75911', '9249', 'chr1: 12,567,910-12,617,731'),
('RPS6KA5', 'ribosomal protein S6 kinase, 90kDa, polypeptide 5 ', 'O75582', '9252', 'chr14: 90,847,862-91,060,636'),
('MFHAS1', 'malignant fibrous histiocytoma amplified sequence 1 ', 'Q9Y4C4', '9258', 'chr8: 8,783,354-8,893,645'),
('PDLIM7', 'PDZ and LIM domain 7 ', 'Q9NR12', '9260', 'chr5: 177,483,394-177,497,606'),
('MAPKAPK2', 'mitogen-activated protein kinase-activated protein kinase 2 ', 'P49137', '9261', 'chr1: 206,684,944-206,734,283'),
('STK17B', 'serine/threonine kinase 17b ', 'O94768', '9262', 'chr2: 196,133,566-196,176,503'),
('CYTH3', 'cytohesin 3 ', 'O43739', '9265', 'chr7: 6,161,776-6,272,644'),
('CYTH2', 'cytohesin 2 ', 'Q99418 ', '9266', 'chr19: 48,469,032-48,482,314'),
('CBLB', 'Cbl proto-oncogene B, E3 ubiquitin protein ligase ', 'Q13191', '868', 'chr3: 105,655,461-105,869,552'),
('ITGB1BP1', 'integrin subunit beta 1 binding protein 1 ', 'O14713', '9270', 'chr2: 9,403,475-9,423,547'),
('MED14', 'mediator complex subunit 14 ', 'O60244', '9282', 'chrX: 40,648,306-40,735,858'),
('NPIPA1', 'nuclear pore complex interacting protein family member A1 ', 'Q9UND3', '9284', 'chr16: 14,922,802-14,952,060'),
('ADGRG1', 'adhesion G protein-coupled receptor G1 ', 'Q9Y653', '9289', 'chr16: 57,610,652-57,665,580'),
('SRSF11', 'serine/arginine-rich splicing factor 11 ', 'Q05519', '9295', 'chr1: 70,205,682-70,253,052'),
('ATP6V1F', 'ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F ', 'Q16864', '9296', 'chr7: 128,862,826-128,865,844'),
('SNORD30', 'small nucleolar R , C/D box 30 ', 'N/A', '9299', 'chr11: 62,853,663-62,853,732'),
('SNORD28', 'small nucleolar R , C/D box 28', 'N/A', '9300', 'chr11: 62,854,621-62,854,695'),
('SNORD27', 'small nucleolar R , C/D box 27', 'N/A', '9301', 'chr11: 62,855,012-62,855,083'),
('SOCS6', 'suppressor of cytokine signaling 6 ', 'O14544', '9306', 'chr18: 70,288,901-70,330,200'),
('CBLN1', 'cerebellin 1 precursor ', 'P23435', '869', 'chr16: 49,277,917-49,281,831'),
('CD83', 'CD83 molecule ', 'Q01151', '9308', 'chr6: 14,117,256-14,136,918'),
('ASIC3', 'acid sensing ion channel subunit 3 ', 'Q9UHC3', '9311', 'chr7: 151,048,292-151,052,756'),
('KLF4', 'Kruppel-like factor 4 (gut) ', 'O43474', '9314', 'chr9: 107,484,852-107,490,482'),
('NREP', 'neuronal regeneration related protein ', 'Q16612', '9315', 'chr5: 111,662,621-111,997,464'),
('PTER', 'phosphotriesterase related ', 'Q96BW5', '9317', 'chr10: 16,436,943-16,513,745'),
('TRIP13', 'thyroid hormone receptor interactor 13 ', 'Q15645', '9319', 'chr5: 892,643-919,357'),
('TRIP11', 'thyroid hormone receptor interactor 11 ', 'Q15643', '9321', 'chr14: 91,965,991-92,040,896'),
('TRIP10', 'thyroid hormone receptor interactor 10 ', 'Q15642', '9322', 'chr19: 6,737,925-6,751,526'),
('ZNHIT3', 'zinc finger, HIT-type containing 3 ', 'Q15649', '9326', 'chr17: 36,486,629-36,499,310'),
('GTF3C4', 'general transcription factor IIIC subunit 4 ', 'Q9UKN8', '9329', 'chr9: 132,670,035-132,694,955'),
('SERPINH1', 'serpin peptidase inhibitor, clade H (heat shock protein 47), member 1, (collagen binding protein 1) ', 'P50454', '871', 'chr11: 75,562,056-75,572,783'),
('B4GALT6', 'UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 6 ', 'Q9UBX8', '9331', 'chr18: 31,622,247-31,685,836'),
('CD163', 'CD163 molecule ', 'Q86VB7', '9332', 'chr12: 7,470,813-7,503,893'),
('B4GALT5', 'UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5 ', 'O43286', '9334', 'chr20: 49,632,945-49,713,878'),
('TCEAL1', 'transcription elongation factor A (SII)-like 1 ', 'Q15170', '9338', 'chrX: 103,628,704-103,630,953'),
('VAMP3', 'vesicle associated membrane protein 3 ', 'Q15836', '9341', 'chr1: 7,771,269-7,781,432'),
('SNAP29', 'synaptosome associated protein 29kDa ', 'O95721', '9342', 'chr22: 20,858,983-20,891,218'),
('TAOK2', 'TAO kinase 2 ', 'Q9UL54', '9344', 'chr16: 29,973,641-29,992,261'),
('SLIT2', 'slit guidance ligand 2 ', 'O94813', '9353', 'chr4: 20,253,260-20,620,561'),
('LHX2', 'LIM homeobox 2 ', 'P50458', '9355', 'chr9: 124,001,670-124,033,301'),
('PPIG', 'peptidylprolyl isomerase G (cyclophilin G) ', 'Q13427', '9360', 'chr2: 169,584,340-169,641,406'),
('CBR1', 'carbonyl reductase 1 ', 'P16152', '873', 'chr21: 36,069,941-36,073,166'),
('RAB33A', 'RAB33A, member RAS oncogene family ', 'Q14088', '9363', 'chrX: 130,171,649-130,184,870'),
('RAB28', 'RAB28, member RAS oncogene family ', 'P51157', '9364', 'chr4: 13,361,354-13,484,365'),
('KL', 'klotho ', 'Q9UEF7', '9365', 'chr13: 33,016,433-33,066,145'),
('RAB9A', 'RAB9A, member RAS oncogene family ', 'P51151', '9367', 'chrX: 13,689,125-13,710,506'),
('ADIPOQ', 'adiponectin, C1Q and collagen domain containing ', 'Q15848', '9370', 'chr3: 186,842,690-186,858,463'),
('PLAA', 'phospholipase A2-activating protein ', 'Q9Y263', '9373', 'chr9: 26,904,083-26,947,463'),
('PPT2', 'palmitoyl-protein thioesterase 2 ', 'Q9UMR5', '9374', 'chr6: 32,153,441-32,163,680'),
('TM9SF2', 'transmembrane 9 superfamily member 2 ', 'Q99805', '9375', 'chr13: 99,501,417-99,564,006'),
('COX5A', 'cytochrome c oxidase subunit Va ', 'P20674', '9377', 'chr15: 74,919,791-74,938,168'),
('NRXN1', 'neurexin 1 ', 'Q9ULB1', '9378', 'chr2: 49,918,505-51,225,575'),
('CBS', 'cystathionine-beta-synthase ', 'P35520', '875', 'chr21: 43,053,191-43,076,943'),
('GRHPR', 'glyoxylate reductase/hydroxypyruvate reductase ', 'Q9UBQ7', '9380', 'chr9: 37,422,666-37,436,990'),
('LIPG', 'lipase, endothelial ', 'Q9Y5X9', '9388', 'chr18: 49,560,699-49,599,182'),
('CIAO1', 'cytosolic iron-sulfur assembly component 1 ', 'O76071', '9391', 'chr2: 96,266,132-96,273,349'),
('HS6ST1', 'heparan sulfate 6-O-sulfotransferase 1 ', 'O60243', '9394', 'chr2: 128,236,716-128,318,577'),
('NMT2', 'N-myristoyltransferase 2 ', 'O60551', '9397', 'chr10: 15,102,584-15,168,693'),
('STOML1', 'stomatin like 1 ', 'Q9UBI4', '9399', 'chr15: 73,978,923-73,994,622'),
('RECQL4', 'RecQ helicase-like 4 ', 'O94761', '9401', 'chr8: 144,511,288-144,517,845'),
('SELENOF', '15 kDa selenoprotein ', 'O60613', '9403', 'chr1: 86,862,445-86,914,424'),
('LPXN', 'leupaxin ', 'O60711', '9404', 'chr11: 58,526,871-58,578,220'),
('ZRANB2', 'zinc finger, RAN-binding domain containing 2 ', 'O95218', '9406', 'chr1: 71,063,291-71,081,297'),
('ADA', 'adenosine deaminase ', 'P00813', '100', 'chr20: 44,619,522-44,652,233'),
('CCK', 'cholecystokinin ', 'P06307', '885', 'chr3: 42,257,825-42,266,207'),
('SNRNP40', 'small nuclear ribonucleoprotein, U5 40kDa subunit ', 'Q96DI7', '9410', 'chr1: 31,259,568-31,296,782'),
('ARHGAP29', 'Rho GTPase activating protein 29 ', 'Q52LW3', '9411', 'chr1: 94,148,988-94,275,068'),
('MED21', 'mediator complex subunit 21 ', 'Q13503', '9412', 'chr12: 27,022,546-27,066,343'),
('FAM189A2', 'family with sequence similarity 189 member A2 ', 'Q15884', '9413', 'chr9: 69,324,572-69,392,455'),
('TJP2', 'tight junction protein 2 ', 'Q9UDY2', '9414', 'chr9: 69,121,264-69,255,208'),
('FADS2', 'fatty acid desaturase 2 ', 'O95864', '9415', 'chr11: 61,792,980-61,867,354'),
('DDX23', 'DEAD (Asp-Glu-Ala-Asp) box polypeptide 23 ', 'Q9BUQ8', '9416', 'chr12: 48,829,764-48,852,842'),
('CRIPT', 'cysteine-rich PDZ-binding protein ', 'Q9P021', '9419', 'chr2: 46,616,416-46,625,742'),
('ZNF264', 'zinc finger protein 264 ', 'O43296', '9422', 'chr19: 57,191,500-57,222,846'),
('KCNK6', 'potassium channel, two pore domain subfamily K, member 6 ', 'Q9Y257', '9424', 'chr19: 38,319,844-38,332,076'),
('CCKBR', 'cholecystokinin B receptor ', 'P32239', '887', 'chr11: 6,259,736-6,272,127'),
('CDYL', 'chromodomain protein, Y-like ', 'Q9Y232', '9425', 'chr6: 4,706,159-4,955,551'),
('ECEL1', 'endothelin converting enzyme-like 1 ', 'O95672', '9427', 'chr2: 232,479,827-232,487,828'),
('CHST2', 'carbohydrate (N-acetylglucosamine-6-O) sulfotransferase 2 ', 'Q9Y4C5', '9435', 'chr3: 143,119,331-143,124,014'),
('MED17', 'mediator complex subunit 17 ', 'Q9NVC6', '9440', 'chr11: 93,784,227-93,814,963'),
('MED7', 'mediator complex subunit 7 ', 'O43513', '9443', 'chr5: 157,137,412-157,159,019'),
('QKI', 'QKI, KH domain containing, RNA binding ', 'Q96PU8', '9444', 'chr6: 163,414,000-163,578,596'),
('ITM2B', 'integral membrane protein 2B ', 'Q9Y287', '9445', 'chr13: 48,233,158-48,270,357'),
('GSTO1', 'glutathione S-transferase omega 1 ', 'P78417', '9446', 'chr10: 104,235,356-104,267,459'),
('MAP4K4', 'mitogen-activated protein kinase kinase kinase kinase 4 ', 'O95819', '9448', 'chr2: 101,696,850-101,894,689'),
('ITM2A', 'integral membrane protein 2A ', 'O43736', '9452', 'chrX: 79,360,384-79,367,667'),
('KRIT1', 'KRIT1, ankyrin repeat containing ', 'O00522', '889', 'chr7: 92,198,969-92,246,166'),
('HOMER3', 'homer scaffolding protein 3 ', 'Q9NSC5', '9454', 'chr19: 18,929,201-18,941,261'),
('HOMER1', 'homer scaffolding protein 1 ', 'Q86YM7', '9456', 'chr5: 79,372,636-79,514,217'),
('RASAL2', 'RAS protein activator like 2 ', 'Q9UJF2 ', '9462', 'chr1: 178,094,141-178,484,147'),
('AKAP7', 'A-kinase anchoring protein 7 ', 'O43687 ', '9465', 'chr6: 131,135,666-131,283,535'),
('AKAP7', 'A-kinase anchoring protein 7 ', 'Q9P0M2', '9465', 'chr6: 131,135,666-131,283,535'),
('SH3BP5', 'SH3-domain binding protein 5 (BTK-associated) ', 'O60239', '9467', 'chr3: 15,254,853-15,341,368'),
('PCYT1B', 'phosphate cytidylyltransferase 1, choline, beta ', 'Q9Y5K3', '9468', 'chrX: 24,558,087-24,672,677'),
('CHST3', 'carbohydrate (chondroitin 6) sulfotransferase 3 ', 'Q7LGC8', '9469', 'chr10: 71,964,365-72,013,564'),
('EIF4E2', 'eukaryotic translation initiation factor 4E family member 2 ', 'O60573', '9470', 'chr2: 232,550,052-232,583,644'),
('AKAP6', 'A-kinase anchoring protein 6 ', 'Q13023', '9472', 'chr14: 32,329,273-32,837,681'),
('CCNA2', 'cyclin A2 ', 'P20248', '890', 'chr4: 121,816,444-121,823,933'),
('THEMIS2', 'thymocyte selection associated family member 2 ', 'Q5TEJ8', '9473', 'chr1: 27,872,543-27,886,685'),
('ROCK2', 'Rho-associated, coiled-coil containing protein kinase 2 ', 'O75116', '9475', 'chr2: 11,179,761-11,348,330'),
('MED20', 'mediator complex subunit 20 ', 'Q9H944', '9477', 'chr6: 41,905,354-41,921,139'),
('MAPK8IP1', 'mitogen-activated protein kinase 8 interacting protein 1 ', 'Q9UQF2', '9479', 'chr11: 45,885,651-45,906,465'),
('PGS1', 'phosphatidylglycerophosphate synthase 1 ', 'Q32NB8', '9489', 'chr17: 78,378,640-78,425,114'),
('KIF23', 'kinesin family member 23 ', 'Q02241', '9493', 'chr15: 69,414,246-69,448,427'),
('SLC4A8', 'solute carrier family 4, sodium bicarbonate cotransporter, member 8 ', 'Q2Y0W8', '9498', 'chr12: 51,391,317-51,515,763'),
('MYOT', 'myotilin ', 'Q9UBF9', '9499', 'chr5: 137,867,791-137,887,851'),
('RPH3AL', 'rabphilin 3A-like (without C2 domains) ', 'Q9UNE2', '9501', 'chr17: 212,389-386,254'),
('ADAMTS1', 'ADAM metallopeptidase with thrombospondin type 1 motif 1 ', 'Q9UHI8', '9510', 'chr21: 26,835,747-26,845,409'),
('CCNB1', 'cyclin B1 ', 'P14635', '891', 'chr5: 69,167,010-69,178,245'),
('PMPCB', 'peptidase (mitochondrial processing) beta ', 'O75439', '9512', 'chr7: 103,297,422-103,329,511'),
('STXBP5L', 'syntaxin binding protein 5 like ', 'Q9Y2K9', '9515', 'chr3: 120,908,072-121,424,761'),
('LITAF', 'lipopolysaccharide-induced TNF factor ', 'Q99732', '9516', 'chr16: 11,547,722-11,636,381'),
('SPTLC2', 'serine palmitoyltransferase, long chain base subunit 2 ', 'O15270', '9517', 'chr14: 77,505,997-77,616,773'),
('GDF15', 'growth differentiation factor 15 ', 'Q99988', '9518', 'chr19: 18,374,731-18,389,176'),
('NPEPPS', 'aminopeptidase puromycin sensitive ', 'P55786', '9520', 'chr17: 47,522,942-47,623,276'),
('EEF1E1', 'eukaryotic translation elongation factor 1 epsilon 1 ', 'O43324', '9521', 'chr6: 8,073,360-8,102,578'),
('SCAMP1', 'secretory carrier membrane protein 1 ', 'O15126', '9522', 'chr5: 78,360,583-78,479,071'),
('VPS4B', 'vacuolar protein sorting 4 homolog B (S. cerevisiae) ', 'O75351', '9525', 'chr18: 63,389,190-63,422,483'),
('MPDU1', 'mannose-P-dolichol utilization defect 1 ', 'O75352', '9526', 'chr17: 7,583,529-7,592,789'),
('CCND2', 'cyclin D2 ', 'P30279', '894', 'chr12: 4,273,772-4,305,350'),
('TMEM59', 'transmembrane protein 59 ', 'Q9BXS4', '9528', 'chr1: 54,026,681-54,053,504'),
('BAG5', 'BCL2 associated athanogene 5 ', 'Q9UL15', '9529', 'chr14: 103,556,544-103,562,831'),
('BAG2', 'BCL2 associated athanogene 2 ', 'O95816', '9532', 'chr6: 57,172,326-57,189,833'),
('POLR1C', 'polymerase (RNA) I polypeptide C ', 'O15160', '9533', 'chr6: 43,509,702-43,529,585'),
('PTGES', 'prostaglandin E synthase ', 'O14684', '9536', 'chr9: 129,738,331-129,753,047'),
('CXCL14', 'chemokine (C-X-C motif) ligand 14 ', 'O95715', '9547', 'chr5: 135,570,679-135,579,279'),
('ATP6V1G1', 'ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1 ', 'O75348', '9550', 'chr9: 114,587,746-114,598,373'),
('MRPL33', 'mitochondrial ribosomal protein L33 ', 'O75394', '9553', 'chr2: 27,771,717-27,988,087'),
('SEC22B', 'SEC22 homolog B, vesicle trafficking protein (gene/pseudogene) ', 'O75396', '9554', 'chr1: 120,150,898-120,176,515'),
('H2AFY', 'H2A histone family member Y ', 'O75367', '9555', 'chr5: 135,333,900-135,399,914'),
('CCND3', 'cyclin D3 ', 'P30281', '896', 'chr6: 41,934,933-42,050,357'),
('CHD1L', 'chromodomain helicase DNA binding protein 1-like ', 'Q86WJ1', '9557', 'chr1: 147,242,641-147,295,766'),
('VPS26A', 'VPS26 retromer complex component A ', 'O75436', '9559', 'chr10: 69,123,512-69,172,861'),
('MINPP1', 'multiple inositol-polyphosphate phosphatase 1 ', 'Q9UNW1', '9562', 'chr10: 87,504,875-87,553,460'),
('H6PD', 'hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase) ', 'O95479', '9563', 'chr1: 9,234,775-9,271,337'),
('GABBR2', 'gamma-aminobutyric acid (GABA) B receptor, 2 ', 'O75899', '9568', 'chr9: 98,288,082-98,709,197'),
('GOSR2', 'golgi SNAP receptor complex member 2 ', 'O14653', '9570', 'chr17: 46,923,075-46,975,524'),
('NR1D1', 'nuclear receptor subfamily 1 group D member 1 ', 'P20393', '9572', 'chr17: 40,092,787-40,100,725'),
('CDC42BPB', 'CDC42 binding protein kinase beta (DMPK-like) ', 'Q9Y5S2', '9578', 'chr14: 102,932,379-103,057,462'),
('PREPL', 'prolyl endopeptidase-like ', 'Q4J6C6', '9581', 'chr2: 44,316,281-44,361,862'),
('APOBEC3B', 'apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B ', 'Q9UH17', '9582', 'chr22: 38,982,347-38,992,804'),
('CCNF', 'cyclin F ', 'P41002', '899', 'chr16: 2,429,394-2,458,854'),
('RBM39', 'RNA binding motif protein 39 ', 'Q14498', '9584', 'chr20: 35,701,347-35,742,312'),
('KIF20B', 'kinesin family member 20B ', 'Q96Q89', '9585', 'chr10: 89,701,610-89,774,939'),
('CREB5', 'cAMP responsive element binding protein 5 ', 'Q02930', '9586', 'chr7: 28,299,321-28,825,894'),
('PRDX6', 'peroxiredoxin 6 ', 'P30041', '9588', 'chr1: 173,477,266-173,488,807');
INSERT INTO `geneinfo` (`gene_symbol`, `description`, `uniprot_id`, `entrez_id`, `chr_loc`) VALUES
('WTAP', 'Wilms tumor 1 associated protein ', 'Q15007', '9589', 'chr6: 159,725,585-159,756,319'),
('IER2', 'immediate early response 2 ', 'Q9BTL4', '9592', 'chr19: 13,150,415-13,154,908'),
('PDIA4', 'protein disulfide isomerase family A member 4 ', 'P13667', '9601', 'chr7: 149,003,062-149,028,641'),
('NFE2L3', 'nuclear factor, erythroid 2 like 3 ', 'Q9Y4A8', '9603', 'chr7: 26,152,240-26,187,125'),
('RNF14', 'ring finger protein 14 ', 'Q9UBS8', '9604', 'chr5: 141,958,328-141,990,291'),
('VPS9D1', 'VPS9 domain containing 1 ', 'Q9Y2B5', '9605', 'chr16: 89,707,134-89,720,986'),
('CCNG1', 'cyclin G1 ', 'P51959', '900', 'chr5: 163,437,569-163,446,151'),
('CARTPT', 'CART prepropeptide ', 'Q16568', '9607', 'chr5: 71,719,163-71,721,048'),
('NCOR1', 'nuclear receptor corepressor 1 ', 'O75376', '9611', 'chr17: 16,029,157-16,218,185'),
('NCOR2', 'nuclear receptor corepressor 2 ', 'Q9Y618', '9612', 'chr12: 124,324,415-124,567,589'),
('AATK', 'apoptosis-associated tyrosine kinase ', 'Q6ZMQ8', '9625', 'chr17: 81,117,295-81,166,077'),
('GUCA1C', 'guanylate cyclase activator 1C ', 'O95843', '9626', 'chr3: 108,907,792-108,953,895'),
('SNCAIP', 'synuclein alpha interacting protein ', 'Q9Y6H5', '9627', 'chr5: 122,311,354-122,464,219'),
('NUP155', 'nucleoporin 155kDa ', 'O75694', '9631', 'chr5: 37,288,137-37,371,181'),
('ISG15', 'ISG15 ubiquitin-like modifier ', 'P05161', '9636', 'chr1: 1,001,138-1,014,541'),
('FEZ1', 'fasciculation and elongation protein zeta 1 ', 'Q99689', '9638', 'chr11: 125,445,745-125,496,317'),
('ARHGEF10', 'Rho guanine nucleotide exchange factor 10 ', 'O15013', '9639', 'chr8: 1,823,976-1,958,641'),
('CCNG2', 'cyclin G2 ', 'Q16589', '901', 'chr4: 77,157,151-77,433,388'),
('ZNF592', 'zinc finger protein 592 ', 'Q92610 ', '9640', 'chr15: 84,748,635-84,806,432'),
('MORF4L2', 'mortality factor 4 like 2 ', 'Q15014', '9643', 'chrX: 103,675,496-103,688,158'),
('MICAL2', 'microtubule associated monooxygenase, calponin and LIM domain containing 2 ', 'O94851', '9645', 'chr11: 12,094,008-12,263,789'),
('PPM1F', 'protein phosphatase, Mg2+/Mn2+ dependent 1F ', 'P49593', '9647', 'chr22: 21,919,420-21,952,837'),
('RALGPS1', 'Ral GEF with PH domain and SH3 binding motif 1 ', 'Q5JS13', '9649', 'chr9: 126,914,774-127,223,166'),
('MTFR1', 'mitochondrial fission regulator 1 ', 'Q15390', '9650', 'chr8: 65,644,734-65,771,261'),
('HS2ST1', 'heparan sulfate 2-O-sulfotransferase 1 ', 'Q7LGA3', '9653', 'chr1: 86,914,648-87,109,998'),
('SOCS5', 'suppressor of cytokine signaling 5 ', 'O75159', '9655', 'chr2: 46,698,952-46,763,129'),
('MDC1', 'mediator of DNA damage checkpoint 1 ', 'Q14676', '9656', 'chr6: 30,699,807-30,717,889'),
('PDE4DIP', 'phosphodiesterase 4D interacting protein ', 'Q5VU43', '9659', 'chr1: 148,808,181-149,048,286'),
('ADAM8', 'ADAM metallopeptidase domain 8 ', 'P78325', '101', 'chr10: 133,262,403-133,276,868'),
('CCNT1', 'cyclin T1 ', 'O60563', '904', 'chr12: 48,688,458-48,716,998'),
('CEP135', 'centrosomal protein 135kDa ', 'Q66GS9', '9662', 'chr4: 55,948,871-56,033,363'),
('KIAA0430', 'KIAA0430 ', 'Q9Y4F3', '9665', 'chr16: 15,594,386-15,643,166'),
('EIF5B', 'eukaryotic translation initiation factor 5B ', 'O60841', '9669', 'chr2: 99,337,353-99,401,326'),
('SDC3', 'syndecan 3 ', 'O75056', '9672', 'chr1: 30,869,467-30,908,761'),
('SLC25A44', 'solute carrier family 25 member 44 ', 'Q96H78', '9673', 'chr1: 156,193,932-156,212,796'),
('PPIP5K1', 'diphosphoinositol pentakisphosphate kinase 1 ', 'Q6PFW1', '9677', 'chr15: 43,533,462-43,590,253'),
('FAM53B', 'family with sequence similarity 53 member B ', 'Q14153', '9679', 'chr10: 124,619,292-124,744,269'),
('N4BP1', 'NEDD4 binding protein 1 ', 'O75113', '9683', 'chr16: 48,538,726-48,620,148'),
('GREB1', 'growth regulation by estrogen in breast cancer 1 ', 'Q4ZG55', '9687', 'chr2: 11,482,341-11,642,788'),
('NUP93', 'nucleoporin 93kDa ', 'Q8N1F7', '9688', 'chr16: 56,730,105-56,850,286'),
('CCNT2', 'cyclin T2 ', 'O60583', '905', 'chr2: 134,918,235-134,959,342'),
('BZW1', 'basic leucine zipper and W2 domains 1 ', 'Q7L1Q6', '9689', 'chr2: 200,810,594-200,827,338'),
('UBE3C', 'ubiquitin protein ligase E3C ', 'Q15386', '9690', 'chr7: 157,138,913-157,269,372'),
('KIAA0391', 'KIAA0391 ', 'O15091', '9692', 'chr14: 35,121,846-35,277,614'),
('EMC2', 'ER membrane protein complex subunit 2 ', 'Q15006', '9694', 'chr8: 108,443,601-108,486,918'),
('EDEM1', 'ER degradation enhancer, mannosidase alpha-like 1 ', 'Q92611', '9695', 'chr3: 5,187,646-5,219,957'),
('CROCC', 'ciliary rootlet coiled-coil, rootletin ', 'Q5TZA2', '9696', 'chr1: 16,740,273-16,972,979'),
('TRAM2', 'translocation associated membrane protein 2 ', 'Q15035', '9697', 'chr6: 52,497,402-52,576,915'),
('PUM1', 'pumilio RNA binding family member 1 ', 'Q14671', '9698', 'chr1: 30,931,506-31,065,991'),
('RIMS2', 'regulating synaptic membrane exocytosis 2 ', 'Q9UQ26', '9699', 'chr8: 103,500,748-104,256,094'),
('ESPL1', 'extra spindle pole bodies like 1, separase ', 'Q14674', '9700', 'chr12: 53,268,299-53,293,643'),
('CCT6A', 'chaperonin containing TCP1, subunit 6A (zeta 1) ', 'P40227', '908', 'chr7: 56,051,630-56,063,989'),
('CEP57', 'centrosomal protein 57kDa ', 'Q86XR8', '9702', 'chr11: 95,789,965-95,832,693'),
('KIAA0355', 'KIAA0355 ', 'O15063', '9710', 'chr19: 34,254,537-34,355,586'),
('USP6NL', 'USP6 N-terminal like ', 'Q92738', '9712', 'chr10: 11,453,946-11,611,754'),
('CCDC144A', 'coiled-coil domain containing 144A ', 'A2RUR9', '9720', 'chr17: 16,689,537-16,777,881'),
('SEMA3E', 'sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3E ', 'O15041', '9723', 'chr7: 83,363,906-83,649,010'),
('TMEM63A', 'transmembrane protein 63A ', 'O94886', '9725', 'chr1: 225,845,536-225,882,369'),
('ZNF646', 'zinc finger protein 646 ', 'O15015', '9726', 'chr16: 31,074,422-31,084,196'),
('RAB11FIP3', 'RAB11 family interacting protein 3 (class II) ', 'O75154', '9727', 'chr16: 425,619-523,011'),
('SECISBP2L', 'SECIS binding protein 2-like ', 'Q93073', '9728', 'chr15: 48,988,476-49,046,563'),
('CEP104', 'centrosomal protein 104kDa ', 'O60308', '9731', 'chr1: 3,812,081-3,857,214'),
('CD1D', 'CD1d molecule ', 'P15813', '912', 'chr1: 158,179,947-158,184,896'),
('SART3', 'squamous cell carcinoma antigen recognized by T-cells 3 ', 'Q15020', '9733', 'chr12: 108,522,580-108,561,400'),
('HDAC9', 'histone deacetylase 9 ', 'Q9UKV0', '9734', 'chr7: 18,086,949-19,002,416'),
('KNTC1', 'kinetochore associated 1 ', 'P50748', '9735', 'chr12: 122,527,246-122,626,396'),
('USP34', 'ubiquitin specific peptidase 34 ', 'Q70CQ2', '9736', 'chr2: 61,187,463-61,470,769'),
('TCAF1', 'TRPM8 channel-associated factor 1 ', 'Q9Y4C2', '9747', 'chr7: 143,851,375-143,902,198'),
('SLK', 'STE20 like kinase ', 'Q9H2G2 ', '9748', 'chr10: 103,967,201-104,029,233'),
('PHACTR2', 'phosphatase and actin regulator 2 ', 'O75167', '9749', 'chr6: 143,536,845-143,831,185'),
('FAM65B', 'family with sequence similarity 65 member B ', 'Q9Y4F9', '9750', 'chr6: 24,804,282-25,042,018'),
('PCDHA9', 'protocadherin alpha 9 ', 'Q9Y5H5', '9752', 'chr5: 140,847,463-141,012,344'),
('STARD8', 'StAR related lipid transfer domain containing 8 ', 'Q92502', '9754', 'chrX: 68,647,666-68,725,842'),
('CD4', 'CD4 molecule ', 'P01730', '920', 'chr12: 6,786,858-6,820,808'),
('KMT2B', 'lysine (K)-specific methyltransferase 2B ', 'Q9UMN6', '9757', 'chr19: 35,718,019-35,738,878'),
('FRMPD4', 'FERM and PDZ domain containing 4 ', 'Q14CM0', '9758', 'chrX: 12,138,466-12,724,523'),
('HDAC4', 'histone deacetylase 4 ', 'P56524', '9759', 'chr2: 239,048,168-239,401,654'),
('TOX', 'thymocyte selection associated high mobility group box ', 'O94900', '9760', 'chr8: 58,805,418-59,119,208'),
('MLEC', 'malectin ', 'Q14165', '9761', 'chr12: 120,686,869-120,701,864'),
('LZTS3', 'Leucine zipper putative tumor suppressor 3  ', 'O60299', '9762', 'chr20: 3,162,617-3,173,592'),
('KIAA0513', 'KIAA0513 ', 'O60268', '9764', 'chr16: 85,027,751-85,094,230'),
('ZFYVE16', 'zinc finger, FYVE domain containing 16 ', 'Q7Z3T8', '9765', 'chr5: 80,408,013-80,479,350'),
('SUSD6', 'sushi domain containing 6 ', 'Q92537', '9766', 'chr14: 69,611,596-69,715,142'),
('JADE3', 'jade family PHD finger 3 ', 'Q92613', '9767', 'chrX: 46,912,276-47,061,242'),
('CD5L', 'CD5 molecule like ', 'O43866', '922', 'chr1: 157,830,914-157,898,256'),
('KIAA0101', 'KIAA0101 ', 'Q15004', '9768', 'chr15: 64,364,311-64,387,687'),
('TMEM94', 'transmembrane protein 94 ', 'Q12767', '9772', 'chr17: 75,441,159-75,500,090'),
('BCLAF1', 'BCL2-associated transcription factor 1 ', 'Q9NYF8', '9774', 'chr6: 136,256,627-136,289,851'),
('ATG13', 'autophagy related 13 ', 'O75143', '9776', 'chr11: 46,617,527-46,674,818'),
('KIAA0232', 'KIAA0232 ', 'Q92628', '9778', 'chr4: 6,781,375-6,884,170'),
('TBC1D5', 'TBC1 domain family member 5 ', 'Q92609', '9779', 'chr3: 17,157,162-18,444,817'),
('PIEZO1', 'piezo-type mechanosensitive ion channel component 1 ', 'Q92508', '9780', 'chr16: 88,715,343-88,785,211'),
('RNF144A', 'ring finger protein 144A ', 'P50876', '9781', 'chr2: 6,917,392-7,068,286'),
('MATR3', 'matrin 3 ', 'P43243', '9782', 'chr5: 139,293,648-139,331,677'),
('DLGAP5', 'discs, large (Drosophila) homolog-associated protein 5 ', 'Q15398', '9787', 'chr14: 55,148,112-55,191,678'),
('CD6', 'CD6 molecule ', 'P30203', '923', 'chr11: 60,971,680-61,020,377'),
('MTSS1', 'metastasis suppressor 1 ', 'O43312', '9788', 'chr8: 124,550,790-124,728,429'),
('SPCS2', 'signal peptidase complex subunit 2 ', 'Q15005', '9789', 'chr11: 74,949,247-74,979,031'),
('PTDSS1', 'phosphatidylserine synthase 1 ', 'P48651', '9791', 'chr8: 96,261,715-96,336,995'),
('CKAP5', 'cytoskeleton associated protein 5 ', 'Q14008', '9793', 'chr11: 46,743,048-46,846,308'),
('IST1', 'increased sodium tolerance 1 homolog (yeast) ', 'P53990', '9798', 'chr16: 71,845,996-71,931,199'),
('MRPL19', 'mitochondrial ribosomal protein L19 ', 'P49406', '9801', 'chr2: 75,646,783-75,690,851'),
('TOMM20', 'translocase of outer mitochondrial membrane 20 homolog (yeast) ', 'Q15388', '9804', 'chr1: 235,109,336-235,128,936'),
('SPOCK2', 'sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2 ', 'Q92563', '9806', 'chr10: 72,059,035-72,089,032'),
('CTIF', 'CBP80/20-dependent translation initiation factor ', 'O43310', '9811', 'chr18: 48,539,046-48,863,217'),
('EFCAB14', 'EF-hand calcium binding domain 14 ', 'O75071', '9813', 'chr1: 46,675,159-46,719,064'),
('CD9', 'CD9 molecule ', 'P21926', '928', 'chr12: 6,199,715-6,238,271'),
('GIT2', 'G protein-coupled receptor kinase interacting ArfGAP 2 ', 'Q14161', '9815', 'chr12: 109,929,792-109,996,389'),
('NUP58', 'nucleoporin 58kDa ', 'Q9BVL2', '9818', 'chr13: 25,301,524-25,349,800'),
('TSC22D2', 'TSC22 domain family member 2 ', 'O75157', '9819', 'chr3: 150,408,335-150,466,431'),
('CUL7', 'cullin 7 ', 'Q14999', '9820', 'chr6: 43,037,617-43,053,945'),
('RB1CC1', 'RB1 inducible coiled-coil 1 ', 'Q8TDY2', '9821', 'chr8: 52,622,456-52,745,843'),
('ARHGAP11A', 'Rho GTPase activating protein 11A ', 'Q6P4F7', '9824', 'chr15: 32,615,144-32,639,949'),
('TRIM14', 'tripartite motif containing 14 ', 'Q14142', '9830', 'chr9: 98,069,275-98,119,212'),
('ZNF623', 'zinc finger protein 623 ', 'O75123', '9831', 'chr8: 143,636,013-143,656,418'),
('JAKMIP2', 'janus kinase and microtubule interacting protein 2 ', 'Q96AA8', '9832', 'chr5: 147,585,439-147,782,848'),
('MELK', 'maternal embryonic leucine zipper kinase ', 'Q14680', '9833', 'chr9: 36,572,862-36,677,683'),
('CD14', 'CD14 molecule ', 'P08571', '929', 'chr5: 140,631,728-140,633,701'),
('GINS1', 'GINS complex subunit 1 (Psf1 homolog) ', 'Q14691', '9837', 'chr20: 25,407,727-25,452,628'),
('ZEB2', 'zinc finger E-box binding homeobox 2 ', 'O60315', '9839', 'chr2: 144,364,364-144,524,583'),
('ZBTB24', 'zinc finger and BTB domain containing 24 ', 'O43167', '9841', 'chr6: 109,462,594-109,483,237'),
('HEPH', 'hephaestin ', 'Q9BQS7', '9843', 'chrX: 66,162,549-66,268,867'),
('ELMO1', 'engulfment and cell motility 1 ', 'Q92556', '9844', 'chr7: 36,854,361-37,449,249'),
('C2CD5', 'C2 calcium-dependent domain containing 5 ', 'Q86YS7', '9847', 'chr12: 22,448,583-22,544,546'),
('MFAP3L', 'microfibrillar associated protein 3 like ', 'O75121', '9848', 'chr4: 169,986,597-170,033,031'),
('ZNF518A', 'zinc finger protein 518A ', 'Q6AHZ1', '9849', 'chr10: 96,129,715-96,205,288'),
('EPM2AIP1', 'EPM2A (laforin) interacting protein 1 ', 'Q7L775', '9852', 'chr3: 36,985,043-36,993,168'),
('FARP2', 'FERM, ARH/RhoGEF and pleckstrin domain protein 2 ', 'O94887', '9855', 'chr2: 241,356,243-241,494,841'),
('CD27', 'CD27 molecule ', 'P26842', '939', 'chr12: 6,444,867-6,451,718'),
('CEP170', 'centrosomal protein 170kDa ', 'Q5SW79', '9859', 'chr1: 243,124,428-243,255,348'),
('LRIG2', 'leucine-rich repeats and immunoglobulin-like domains 2 ', 'O94898', '9860', 'chr1: 113,073,209-113,132,260'),
('MAGI2', 'membrane associated guanylate kinase, WW and PDZ domain containing 2 ', 'Q86UL8', '9863', 'chr7: 78,017,057-79,453,574'),
('SEC24D', 'SEC24 homolog D, COPII coat complex component ', 'O94855', '9871', 'chr4: 118,722,823-118,838,683'),
('FCHSD2', 'FCH and double SH3 domains 2 ', 'O94868', '9873', 'chr11: 72,836,745-73,142,261'),
('TLK1', 'tousled like kinase 1 ', 'Q9UKI8', '9874', 'chr2: 170,990,823-171,231,314'),
('ZC3H11A', 'zinc finger CCCH-type containing 11A ', 'O75152', '9877', 'chr1: 203,795,714-203,854,999'),
('TOX4', 'TOX high mobility group box family member 4 ', 'O94842', '9878', 'chr14: 21,476,597-21,499,175'),
('DDX46', 'DEAD (Asp-Glu-Ala-Asp) box polypeptide 46 ', 'Q7L014', '9879', 'chr5: 134,758,771-134,855,133'),
('TBC1D4', 'TBC1 domain family member 4 ', 'O60343', '9882', 'chr13: 75,284,665-75,482,114'),
('ADAM10', 'ADAM metallopeptidase domain 10 ', 'O14672', '102', 'chr15: 58,588,807-58,749,978'),
('CD28', 'CD28 molecule ', 'P10747', '940', 'chr2: 203,706,475-203,738,912'),
('PLPPR4', 'phospholipid phosphatase related 4 ', 'Q7Z2D5', '9890', 'chr1: 99,263,953-99,309,590'),
('NUAK1', 'NUAK family, SNF1-like kinase, 1 ', 'O60285', '9891', 'chr12: 106,063,340-106,140,033'),
('TECPR2', 'tectonin beta-propeller repeat containing 2 ', 'O15040', '9895', 'chr14: 102,362,963-102,502,481'),
('SV2B', 'synaptic vesicle glycoprotein 2B ', 'Q7L1I2', '9899', 'chr15: 91,099,950-91,301,309'),
('SV2A', 'synaptic vesicle glycoprotein 2A ', 'Q7L0J3', '9900', 'chr1: 149,903,318-149,917,882'),
('SLC35E2', 'solute carrier family 35 member E2 ', 'P0CK97', '9906', 'chr1: 1,724,838-1,745,992'),
('AP5Z1', 'adaptor related protein complex 5, zeta 1 subunit ', 'O43299', '9907', 'chr7: 4,775,622-4,794,312'),
('G3BP2', 'GTPase activating protein (SH3 domain) binding protein 2 ', 'Q9UN86', '9908', 'chr4: 75,642,782-75,724,525'),
('RABGAP1L', 'RAB GTPase activating protein 1-like ', 'Q5R372', '9910', 'chr1: 174,159,410-174,995,308'),
('SUPT7L', 'SPT7-like STAGA complex gamma subunit ', 'O94864', '9913', 'chr2: 27,650,812-27,663,840'),
('TNFRSF8', 'tumor necrosis factor receptor superfamily member 8 ', 'P28908', '943', 'chr1: 12,063,377-12,144,207'),
('FAM20B', 'family with sequence similarity 20 member B ', 'O75063', '9917', 'chr1: 179,025,804-179,076,562'),
('NCAPD2', 'non-SMC condensin I complex subunit D2 ', 'Q15021', '9918', 'chr12: 6,493,356-6,531,955'),
('IQSEC1', 'IQ motif and Sec7 domain 1 ', 'Q6DN90', '9922', 'chr3: 12,897,220-13,073,117'),
('ZBTB40', 'zinc finger and BTB domain containing 40 ', 'Q9NUA8 ', '9923', 'chr1: 22,451,851-22,531,157'),
('ZBTB5', 'zinc finger and BTB domain containing 5 ', 'O15062', '9925', 'chr9: 37,438,114-37,465,399'),
('LPGAT1', 'lysophosphatidylglycerol acyltransferase 1 ', 'Q92604', '9926', 'chr1: 211,743,457-211,830,772'),
('MFN2', 'mitofusin 2 ', 'O95140', '9927', 'chr1: 11,980,181-12,013,514'),
('KIF14', 'kinesin family member 14 ', 'Q15058', '9928', 'chr1: 200,551,497-200,620,734'),
('JOSD1', 'Josephin domain containing 1 ', 'Q15040', '9929', 'chr22: 38,685,543-38,701,556'),
('HELZ', 'helicase with zinc finger ', 'P42694', '9931', 'chr17: 67,070,438-67,245,989'),
('CD33', 'CD33 molecule ', 'P20138', '945', 'chr19: 51,225,064-51,243,860'),
('PUM3', 'pumilio RNA binding family member 3 ', 'Q15397', '9933', 'chr9: 2,720,469-2,844,241');
COMMIT;

/*!40101 SET CHARACTER_SET_CLIENT=@OLD_CHARACTER_SET_CLIENT */;
/*!40101 SET CHARACTER_SET_RESULTS=@OLD_CHARACTER_SET_RESULTS */;
/*!40101 SET COLLATION_CONNECTION=@OLD_COLLATION_CONNECTION */;
